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Abstract 
Trypanosomes are protozoan parasites causing sleeping sickness in humans. 
The parasites live free in the bloodstream and the central nervous system of 
mammalian hosts and also within the midgut of the vector, the tsetse fly. The parasite 
plasma membrane represents the interface between both hosts and parasite, and 
trypanosomes accumulate many essential metabolites via specific transport processes. 
Very little is known about amino acid requirements in trypanosomes or about 
amino acid metabolism. The aims of this thesis are to investigate amino acid 
transporters with a particular interest in bloodstream form trypanosomes. The long 
term goal underlying this study is to assess the possibility of using amino acid 
transporters as gate ways for entry for drugs into the parasite. From this perspective, 
transporters for amino acids of low abundance in human serum are of particular 
interest since the quantity of drugs that would be needed to compete with the natural 
substrate should be lower than for a more abundant substrate. 
Two approaches have been used to investigate the nature of amino acid 
transport in T. brucei. The flrst approach involved studying the uptake of 
radio labelled amino acids by the parasite, the second approach involved the 
identiflcation, cloning and expression in a heterologous system of a gene encoding for 
a putative amino acid transporter. 
The biochemical approach revealed that methionine uptake was of relatively 
high affmity in procyclic and bloodstream forms and dependent on a proton motive 
force. The recognition motif of this transporter encompasses the amino acid core as 
well as the two carbon atoms of the side chain. 
The anionic amino acids, aspartate and glutamate, were shown to be taken up 
poorly or not at all by specific transport mechanisms in the two forms of the parasite. 
The aromatic amino acids, phenylalanine, tyrosine and tryptophan, are taken up via 
several different routes indicating the importance of these amino acids for the 
parasite. 
The cloning and expression of TbAA TP 1 in Xenopus oocytes revealed that this 
gene encodes for an amino acid transporter that is able to transport tyrosine, 
glutamine and glutamate. 
ii 
TbAATPI is the first member of what was subsequently shown to be a family 
of genes, encompassing at least twelve members present on three different 
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1.1. The parasite 
1.1.1. Parasitism 
What is a parasite? 
The textbook definition of a parasite is: "Any organism that spends all or part 
of its life cycle in (endoparasites) or on (ectoparasites) another living organism of a 
different species (its host), from which it obtains nourishment and/or protection, and 
to which it is usually detrimental" (Oxford Dictionary of Molecular Biology and 
Biochemistry, 1997). 
Read gave a more refined definition of parasitism describing three main 
properties: infectiousness, establishment and transmission. Infectiousness is a 
short-term process involving a degree of tolerance to an instantaneous exposure to a 
new environment. Transmission depends on a successful establishment (growth and 
persistence). One key issue for a successful establishment of the parasite is its ability 
to tolerate or to evade the host immune system (Zelmer, 1998). As it will appear in 
this introduction, Trypanosoma brucei is a parasite highly adapted to its mammalian 
host. 
1.1.2. Taxonomy 
African trypanosomes belong to the order of Kinetoplastida and to the class 
of the Mastigophora and of the phylum Protozoa. The order of Kinetoplastida is 
divided into two suborders: the Bodonina, which contain two flagellar and the 
Trypanosomatina, containing one flagellum (Vickerman, 1994). 
The family of the Trypanosomatidae contains eight different genera among 
which are found numerous pathogens. Trypanosoma brucei (the agent of sleeping 
sickness) and Trypanosoma cruzi (causing Chagas' disease) are both members of the 
same genus Trypanosoma while Leishmania spp (the agent of leishmaniasis) are 
incorporated the Leishmania genus. The genus Trypanosoma is subdivided into seven 
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representing members of the Kinetoplastidae 
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This subdivision is based on where the parasite proliferates in the insect. The 
Stercoraria develop in the hindgut of their insect vector and the Salivaria develop in 
the insect foregut and salivary glands. Trypanosoma brucei belongs to the Salivaria 
and Trypanosoma cruz; belongs to the Stercoraria (Stevens and Gibson, 19998). 
Evolutionary trees suggest a split between Salivarian and all the non-
Salivarian trypanosomes followed by a split of the latter into two clades. One clade 
contains parasites of birds, reptilians, Stercoraria that infect mammals, and a second 
clade contains trypanosomes offish and amphibians (transmitted by leeches) (Haag et 
al., 1998). 
There are twenty-four known species of trypanosome and evolutionary trees 
support the idea of monophyly (a monophylogenic group contains an ancestor and all 
its descendents) of trypanosomes (Stevens and Gibson, 19998). Phylogenic evidence 
suggests that the infection of humans by T. bruce; and T. cruz; evolved over very 
different time scales. T. bruce; seems to have co-evolved with primates over 15 
millions years and with the genus Homo over 3 million years. Human infection by T. 
cruzi, however, could not have originated more than 30, 000-40, 000 years ago, when 
humans started to migrate to the Americas (Stevens and Gibson, 1999b). 
1.1.3. Life cycle 
In the course of their development, African trypanosomes encounter several 
very different environments including the blood of a mammalian host and the gut of 
the tsetse fly insect vector. They respond with dramatic changes in morphology, 
metabolism, and gene expression. 
When an infected tsetse fly takes a blood meal from a mammal, it introduces 
metacyclic forms of the parasite into the skin of the mammalian host. The 
metacyclics migrate through tissues and reach the bloodstream where they transform 
into bloodstream form trypanosomes and multiply by binary fission (Vickerman, 
1985). 
In the bloodstream, the trypanosomes initially injected as metacyclic forms by 
the insect transform into two different forms: a proliferative long-slender form and a 
non-proliferative short-stumpy form. A characteristic of trypanosomal infections is 
the fluctuation of the parasitemia due to the ability of the parasites to evade the host's 
4 
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immune system. This evasion is achieved by modification of the surface coat of the 
parasite made of variable surface glycoprotein (VSG). This process is named 
antigenic variation (Turner et. ai, 1999). The slender forms divide and the parasite 
population increases reaching a peak. Above a critical cell density the population of 
slender forms initiates the differentiation into stumpy forms which are incapable of 
division. The humoral immune response produced by the host induces a clearance of 
the slender forms first and then the stumpy forms. The parasites that have undergone 
an antigenic switch can proliferate and create a new peack of parasitemia (being 
ahead of the immune system) (Matthews, 1999). 
Slender-form 
differentiation to the 
stumpy forms 
Prol i ferat ion 
of slender forms 
tumpy cells predominate, 
slender death 
Time 
j Stumpy and slender 
cell death 
Figure 1.2: Representation of the different phases of the course of a Trypanosoma brucei 
bloodstream parasitemia. A first wave of parasitemia consisting in three phases: I) proliferation, 2) a 
maximum parasitemia, 3) a decrease of parasitemia as a result of the antibody-mediated clearance is 
represented in blue. In green is an outgrowth of slender form parasites that have undergone antigenic 
switching (modified from Mathews, 1999). 
The stumpy forms are unable to divide in the bloodstream but they are the 
only forms capable of continuing their life cycle in the vector (Matthews, 1999). On 
the other hand the slender forms are very well adapted to the glucose rich 
environment of the bloodstream. This differentiation between two forms present in 
the bloodstream enables the parasite to fulfil two vital requirements: transmission to 
the vector and proliferation. The life cycle of T brucei offers a good illustration of 
the characteristics of parasitism defined earlier: the parasite is able to adapt quickly to 
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a new environment (infectiousness), it can grow and persist inside its host 
(establishment) and be transmitted (via the stumpy forms). 
The transmission of the parasite from its mammalian host to another tsetse 
fly takes place when the insect takes a blood meal from an infected mammal. The 
passage from the blood environment to the midgut of the fly provokes the death of the 
slender forms and the transformation of the stumpy forms into procyclic forms. This 
transformation occurs in the posterior part of the midgut of the insect and involves 
dramatic changes for the parasite. 
One of the major changes at this stage is the loss of the variable surface 
glycoprotein (VSG) coat which is replaced by a procyclin coat also named P ARP for 
procyclic acidic repetitive proteins (Roditi et ai., 1998). There are two types of 
procyclin defined by the presence of two different peptide repeats: one is composed 
of an EP (glutamate, proline) dipeptide repeat and the other by a GPEET (glycine, 
proline, glutamate, glutamate, threonine) repeat (Matthews, 1999). The role of this 
P ARP coat includes protection against digestion by hydro lases (Roditi et ai., 1998). 
Additional morphological changes occur in the procyclic forms. These 
include an increase of the body length, an elongation of the kinetoplast and a 
branching of the mitochondrion (Vickerman, 1985). 
The invasion process of the Salivarian trypanosomes, however, does not stop 
in the midgut of the insect. From the midgut, procyclics invade the oesophagus, then 
the mouthparts before reaching the salivary duct and then the salivary glands. The 
glands contain a population of four different stages of trypanosomes. The 
epimastigote stage is a highly proliferative form of trypanosomes which attaches by 
their flagellum to the epithelial cells of the gland lumen. The trypomastigote, also 
called the pre-metacyclic stage, are dividing forms with reduced flagellipodia 
(dendritic outgrowths of the flagellum) (Vickerman, 1985). The metacyclic stage in 
which the mitochondrion is unbranched and the glycosomes are more round. Mature 
metacyclics are covered in a coat of variable antigens and are unable to divide. 
Mature metacyclics reside free in the lumen of the gland, which distinguishes them 
from nascent metacyclics, and the mature forms are ready to be injected into the host. 
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Figure 1.3: Schematic diagram of the Trypanosoma brucei developmental cycle in mammals 
and the tsetse fly (copied from Vickennan, 1985). 
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1.1.4. Morphology, molecular biology and biochemistry. 
A 







Figure 1.4: Diagram of Trypanosoma brucei rhodesiense as seen at the level of the electron 
microscope A) epimastigote stage B) bloodstream trypomastigote (copied from Mulligan, 1970). 
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1.1.4.1. Plasma membrane: 
In any cell type, the plasma membrane encloses the cell and maintains the 
essential difference between the cytosol and the extracellular environment. It is a 
dynamic structure composed of lipids arranged as a bilayer which provides the basic 
structure of the membrane and creates a barrier to the entry of most hydrophilic 
molecules. The plasma membrane also contains a series of different proteins, 
including transporters, which allow the specific acquisition of some nutrients by the 
cell, receptors which act like sensors for external signals and, in the case of 
trypanosomes, variable antigens which form a protective coat allowing the parasite to 
avoid the immune system (Alberts et al., 1994). 
The most abundant lipids in most membranes are the phospholipids. They are 
composed of a polar head of choline, ethanolamine or serine, phosphate and glycerol 
and of a hydrophobic fatty acid tail. The length and the degree of saturation of the 
fatty acid tail determine the fluidity of the membrane. In trypanosomes, phospholipids 
represent 80% of the total lipids (Patnaik et al., 1993). Phosphatidyl choline (PC) and 
phosphatidyl ethanolamine (PE) are the most abundant lipids in both bloodstream and 
procyclic forms. There is no significant difference in the chain length or in the degree 
of saturation of fatty acyl chains in bloodstream forms while in procyclic forms the 
polyunsaturated fatty acid chain decreases in the order PC, PE, PI (Patnaik et al., 
1993). 
Cholesterol is present in large amounts in eukaryotic cells. This molecule is 
oriented in the bilayer with its hydroxyl group pointing towards the polar head groups 
of the phospholipids and it tends to render the membrane more rigid. Trypanosomes 
seem to have a particularly high amount of cholesterol in their membranes (13.8 
J-Lmoles per mg of protein in trypanosomes compared with 0.89 J-Lmoles per mg of 
protein in rat erythrocytes) (Caroll and McCrorie, 1986). 
Glycolipids are sugar-containing lipid molecules present in the non 
cytoplasmic phase of the lipid bilayer. Gangliosides, the most complex of the 
glycolipids, have been found at an exceptionally high level in trypanosomes 
comparable to the level of phospholipids (344 and 359 J-Lg per mg of protein 
respectively for the gangliosides and the phospholipids) (Caroll and McCrorie, 1986). 
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Trypanosoma brucei has a very limited capacity to synthesized fatty acids and 
depends mainly on exogenous sources. 
The membrane bilayer also contains numerous proteins associated in different 
ways to the plasma membrane. Some proteins are embedded in the bilayer as a-
helices non-covalently attached to the lipids. An example, in trypanosomes of 
proteins forming a single helix in the bilayer are those belonging to the family of 
adenylate/guanylate cyclases which is probably a receptor family, transducing host 
derived signals (Borst and Fairlamb, 1998). Multipass proteins are represented 
mainly by channels which allow ions to cross the membrane and by transporters for 
the uptake of specific nutrients. 
1 2 3 4 
Figure 1.5 : Ways of association of membrane proteins with the lipid bilayer. I) single pass 
2) multipass 3) covalently attached lipid or 4) via a oligosaccharide attached to a phospholipid. 
(Modified from Alberts et aI. , 1994). 
Other membrane proteins are simply attached to the membrane by a fatty acid 
molecule (myristyl anchor) or a prenyl group (farnesyl anchor) present in their 
structure. 
Most proteins are anchored to the membrane via an 0 ligosaccharide attached 
to a phospholipid, like glycosylpbospbatidylinositol (OPI) (Ferguson, 1999). This 
mode of attachment to the membrane is, in trypanosomes, of particular interest 
because it is the mode of attachment of the variant surface glycoprotein (VSO). 
Bloodstream form trypanosomes are entirely covered by a densely packed single 
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species ofVSG. These VSGs form a monolayer acting as a physical barrier protecting 
the plasma membrane against the components of the humoral immune response 
(Turner, 1999). The protection against the specific immune response is achieved 
through the switching of expression between VSG genes. The switching rate is very 
high: 1 in 100 trypanosomes switch their VAT per generation. Each VSG is about 
500 amino acids long and is composed of an N-terminal signal peptide of about 20 
amino acids, a variable region (360 amino acids) and a C-terminal region of about 
120 amino acids. The C-terminal portion is in contact with the membrane and the N-
terminal part is the antigenic determinant (Donelson and Rice-Fitch, 1985). 
A corset of cross-linked microtubules underlies the plasma membrane. These 
microtubules are present around the whole cell body apart from a deep invagination 
in the plasma membrane called the flagellar pocket from which the flagellum exits 
(Gull, 1999). Because ofthls absence of micro tubules, the flagellar pocket is the only 
part of the plasma membrane where endocytosis and exocytosis can occur (Balber, 
1990). Endocytocis is a receptor-mediated phenomenon. Receptors for low density 
lipoprotein (LDL-R) (Coppens and Courtoy, 2000), high density lipoprotein (HDL-R) 
also called cysteine-rich acidic integral membrane protein (CRAM) (Lee et a/., 1990, 
Liu et al., 2000), and transferrin (Tf-R) have been described in the flagellar pocket of 
trypanosomes. The Tf-R receptor is not a transmembrane protein but is attached, like 
the VSGs, to the plasma membrane by a GPI-anchor. The flagellar pocket also 
harbours a putative receptor for the trypanosome lytic factor which appears to kill 
trypanosomes by generating peroxides (Hager et al., 1994, Molina Portela et al., 
2000). 
Thus the plasma membrane of trypanosomes appears to be much more than a 
simple structure enclosing the cytosol. It is a very elaborate and dynamic system 
combining two functions: a barrier protecting the trypanosome against the host 
immune system and gateway for nutrients. 
1.1.4.2. The key cytosolic metabolic pathways 
Amino acid and S-Adenosylmethionine metabolism: 
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Amino acids metabolism has been poorly studied in trypanosomes and there is 
a paucity of data on this subject. 
Chappell et al. (1972) measured free amino acids in the cytosol of 
bloodstream forms of T. b. gambiense. Alanine was the most abundant amino acid 
and represents 47 % of the free pool. Incubation of the parasite in the presence of 
radio labelled glucose led to the incorporation of radio label into 70 % of the alanine 
pool. Glutamate represents the second most abundant amino acid (12 %), followed by 
arginine (8.2 %) and taurine (6.2%). The aromatic amino acids (phenylalanine and 
tyrosine), methionine, glutamine, proline, valine were detected at trace levels only 
(Chappell et al., 1972). 
Cysteine is an essential growth factor for bloodstream form trypanosomes 
and is involved in protein biosynthesis, and in the production of glutathione and 
trypanothione (Duszenko et al., 1992). 
Methionine, apart from its role in protein synthesis is also adenosylated by S-
adenosylmethionine synthase to form S-adenosylmethionine (Bacchi et al., 1995). 
S-Adenosylmethionine is an important metabolite in trypanosomes as in its 
decarboxylated form it is the source of aminopropyl groups for polyamine synthesis, 
and it is also a donor of methyl groups for protein and lipid methylation (8Golberg et 
al., 1997). Methionine is used at least ten times more in methylation reactions than it 
is incorporated into protein (bGoldberg et al., 1997). The transfer of a methyl group 
occurs when S-adenosylmethionine is transformed to S-adenosylhomocysteine by a 
methyltransferase. S-adenosylhomocysteine is then hydrolysed to homocysteine and 
adenosine and methionine is regenerated by transfer of a methyl group from N-
methyltetrahydrofolate to homocysteine by homocysteine methyltransferase (Bacchi 
et al., 1995). 
Aromatic amino acids (tyrosine, phenylalanine, tryptophan) are involved in 
recycling the methionine pool by transamination to a-ketomethiobutyrate (KMTB) 
(Berger et al., 1996). 
Proline is the preferred oxidizable substrate for the procyclic forms (Evans 
and Brown, 1972). The proline ring is opened and oxidized to a-ketoglutarate and 




Putrescine and spermidine are present in procyclic and bloodstream forms of 
T. brucei. Unlike Trypanosoma cruzi, T. brucei has very little or no spermine. The 
polyamine biosynthetic pathway begins with the decarboxylation of ornithine by 
onithine decarboxylase (ODC) to form putrescine. Spermidine is then formed by the 
transfer of an aminopropyl group coming from the decarboxylated form of S-
adenosylmethionine (dAdoMet) (Fairlamb and Le Quesne, 1997). 
The role of polyamines in trypanosomes is not known but inhibitors of ODC 
like D,L-a difluoromethylomithine lead to an arrest of trypanosomal growth. 
Moreover, polyamine biosynthetic pathway is critical in the synthesis of a unique 
thiol-spermidine conjugate called trypanothione (Fairlamb and Le Quesne, 1997) in 
these organisms. 
Thiol metabolism: 
As a defense against reactive oxygen molecules (which arise internally 
through respiration or from the host), African trypanosomes possess a low molecular 
weight thiol conjugate that plays a similar role to that of glutathione in mammals. 
This molecule, called trypanothione, consists of two glutathione molecules linked by 
a spermidine moiety. The biosynthetic pathway oftrypanothione comprises two steps: 
1) the formation of glutathionylspermidine from spermidine and glutathione by 
glutathionylspermidine synthetase, 2) the formation of trypanothione from 
glutathionylspermidine and glutathione by trypanothione synthetase (Fairlamb, 1990). 
13 
Chapter!: Introduction 
Methionine + ATP 
Transmethylation 
Homocysteine +-- S-Adenosylhomocysteine ........ E--- S-Adenosylmethionine 
Trans -sulphuration ~ Serine 
Ornithine I 1 Cystathionine 
Glutamate + Cysteine 
l 
yGluCys 





Putrescine I . . ~ Decarboxylated S-;denosYlmethlomne 
I . . I Methylthioadcnosinc . Spenmdme . 
• GS H ---. ~ 
+ I Glutathionylspermidine 
GSH ---. ~ 
I Trypanothione 
Figure 1.6: Polyamine biosynthetic pathway in African trypanosomes. aSH: glutathione. 
The pentose-phosphate pathway: 
The pentose phosphate pathway is a metabolic pathway in which glucose 6-
phosphate is converted to ribose 5-phosphate and provides NADPH. This later serves 
as a hydrogen donor important in biosynthetic processes but also plays an important 
role in the defence against oxidative stress. The first three enzymes of this pathway, 
glucose-6-phosphate dehydrogenase, 6-phosphogluconolactonase and 6-
phosphogluconate dehydrogenase have been cloned and characterised. Most of the 
enzymes of the pentose phosphate pathway are present in the cytosol, however the 
three first enzymes of the pathway seem to be mainly located in the glycosome 
(Barrett, 1997, Duffieux et al. ,2000). 
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Most of the enzymes involved in these pathways are pH sensitive and the 
parasite needs to regulate its cytoplasmic pH. Unlike in Leishmania where the process 
is regulated by the combined action of I-t pumps and cr channels, trypanosomes 
appear to regulate their pH mainly by the H+ pump (Viera, 1998). 
Like any other cell type, trypanosomes need to have the ability to regulate 
their cell volume in response to hypo or hyper-tonicity. In plants, fungi and lower 
eukayotes this process is achieved utilizing amino acids (alanine, glutamate, 
glutamine, proline, glycine) and sugar (Viera, 1998). It is not known how 
trypanosomes regulate their cell volume but studies done in Leishmania might give 
an indication. It has been shown in promastigote forms of Leishmania major that the 
cell swelling following a sudden decrease in osmolality is regulated by anionic amino 
acid channels (Blum et al., 1999). 
1.1.4.3. The glycosomes 
Glycosomes are organelles found in all members of the order Kinetoplastida. 
In trypanosomes they are present in procyclic and bloodstream forms and represent 
approximately 4 % of the total volume of the cell (Vickerman, 1985). It appears that 
these organelles, surrounded by a single membrane, are related to peroxisomes of 
other eukaryotes. The term glycosome was coined to reflect the fact that these 
organelles contain the first seven enzymes of glycolysis (Michels et al., 2000). 
Bloodstream forms, because of the lack of a functional Kreb's cycle and respiratory 
chain, are entirely dependent on glycolysis for ATP production and most of the 
glycolytic enzymes are localized in the glycosomes. 
Glucose is the main energy source but fructose, mannose or glycerol can be 
used as alternatives. All of the enzymes involved in the glycolytic pathway from 
glucose to 3-phosphoglycerate are located in the glycosome while the last three 
enzymes leading to the production of pyruvate are cytosolic. Thus, net ATP synthesis 
occurs only in the cytosol. 
The reason why most of the glycolytic enzymes are compartmentalized is still 
a subject of interrogations (Michels et al., 2000). 
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Pathways other than glycolysis are also present in glycosomes for example some 
enzymes involved in p-oxidation of fatty acids have been found in glycosomes as 
well as enzymes for purine salvage, pyrimidine biosynthetic, ether-lipid and sterol 
pathways (Michels et al., 2000, Clayton and Michels, 1996). 
Thus, it seems reasonable to envisage glycosomes not as an organelle devoted 
only to glycolysis but also involved in a range of other metabolic pathways. 
1.1.4.4. The mitochondrion 
Trypanosomes are unusual in that they possess only a single mitochondrion. 
This mitochondrion undergoes major changes during the life cycle of the parasite. In 
procyclic forms the mitochondrion is fully developed into a branched network of 
inner membrane foldings (cristae), while in bloodstream forms the mitochondrion is 
reduced to a linear form lacking cristae. The relative mitochondrial volume decreases 
from 25 % to 5 % of the total volume of the cell during this transformation 
(Vickerman, 1985). 
In procyclic forms the respiratory chain (cyanide sensitive) is present and 
coupled to oxidative phosphorylation as well as a fully functional Kreb's cycle 
leading to the production of C02 as an end product (Clayton and Michels, 1996). In 
procyclic forms, the end product of glycolysis is pyruvate which is subsequently 
metabolized inside the mitochondrion and transformed to acetyl-CoA. Some acetyl-
CoA then enters the Krebs' cycle and some is metabolized into acetate by an 
acetate/succinate CoA transferase generating ATP (Tiel ens and Van Hellemond, 
1998). 
In bloodstream forms a functional Krebs' cycle is absent as well as the 
classical respiratory chain (Chaudhuri et al., 1998). However a plant like alternative 
oxidase is present. This enzyme is insensitive to cyanide but sensitive to 
salicyhydroxamic acid (SHAM). The FAD linked glycerol-3-phosphate 
dehydrogenase (which converts glycerol 3-phosphate, derived from glycolysis, to 
dihydroxyacetone phosphate) and the complex I of NADH-dehydrogenase are both 
electron donors for the Ubiquinone - ubiquinol pool. This pool then acts as the 
electron donor for the alternative oxidase (which converts 02 into H20) without ATP 
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production. However NADH-dehydrogenase does pump a proton out of the inner 
membrane of the mitochondrion thus generating an electromotive force across the 
membrane (Tielens and Van Hellemond, 1998). 
The trypanosome alternative oxidase is encoded by a single copy gene and the 
transcription of this gene is down regulated during the differentiation of bloodstream 
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Figure 1.7: Major pathways of carbohydrate degradation in T. brucei procyclic (A) and 
bloodstream foms (B). End products are shown in red. Abbreviations: AcCoA, acetyl-CoA; Citr, 
citrate; DHAP, dihydroxyacetone phosphate; FBP, fructose 2,6-bisphosphate; F6P, fructose-6-
phosphate; GAP, glyceraldehyde 3-phosphate; G-3-P, glycerol 3-phosphate, G6P, glucose 6-
phosphate, MAL, malate; Oxac, oxaloacetate, PEP, phosphoenolpyruvate; Pyr, pyruvate; Succ, 
succinate; SuccCoA, succinyl-CoA, 1,3 BPGA, 1,3-biphosphoglycerate; 2-PGA, 2-phosphoglycerate; 
3-PGA, 3-phosphoglycerate (Modified from Tielens and Van Hellemond, 1998). 
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Most mitochondrial proteins are encoded by nuclear genes, however the 
mitochondrion contains an additional genome called the kinetoplast. The kinetoplast 
was the first description of the existence of an extranuclear DNA and the presence of 
this organelles lends is name to the order Kinetoplast ida. The kinetoplast DNA 
possesses a very peculiar structure and replication process. The structure of kDNA 
consists of two independent but intercatenated networks of circular DNA called maxi 
(20-40 kb) and minicircles (1-3 kb) (Borst, 1991). 
Several structural genes in kDNA were noted to have frameshifts with respect 
to mature RNAs and in 1986 (Benne et al., 1986) it was shown that non-encoded 
uridylate residues were present in the mRNA of cytochrome c oxidase subunit II. 
They discovered that these V residues were inserted into the mRNA after 
transcription and that this process corrected the frame shifts. Similar V-additions were 
subsequently identified in other genes Less frequently uridylate deletions were also 
described. This process has been named RNA editing and describes any process that 
generates an RNA nucleotide sequence different from that predicted by the gene 
(Benne, 1994). Blum et al. elucidated how the editing information was provided. 
They identified short stretches of maxi and mini circle DNA containing regions 
complementary to edited RNA. These regions, when they are transcribed, provide 
small RNAs called guide RNA (gRNA) (Blum et aI., 1990). These guide RNAs are 
made ofa complementary sequence to the mRNA to be edited, an editing site used as 
a template (if a GIU pairing is allowed), and a polyuridylate tail. By a series of 
enzymatic cleavage-ligation steps the uridylate residues present at the 3' end of the 
guide RNA are transferred directly into the transcript (Stuart et al., 1997). 
19 
Chapterl : Introduction 
polyU tail 3' Guide RNA 
l ( 
l 
(t ' 5' ( -------
RNA transcript 
5' ------------------------------~----3 ' I II Sites missing U nucleotides 
I Nucleotides in guide RNA speciliying missing U t I 3' A nucleotides Pairing of guide RNA It(:~5' 
5' ------------------------------------ 3' 
Inserted U nucleotides 
A 5' --------------------------------~--3 ' Etided mRNA 
Figure 1.8: RNA editing in the mitochondria oftrypanosomes. Guide RNAs contain a stretch 
of poly U at their 3 ' end. U nucleotides are donated to sites on the RNA transcript that mispair with the 
guide RNA. Editing generally starts near the 3' end and progresses towards the 5' end of the RNA 
transcript (modified from Alberts el al., 1994). 
1.1.4.5. Acidoca1cisomes. 
Bloodstream and procyclic trypanosomes possess an acidic compartment 
involved in the storage of Ca2+ named the acidocalcisome. The acidic component of 
these vacuoles is generated by the presence of a W-ATPase and the uptake of Ca2+ 
occurs in exchange for W and is coupled to a Ca2+ ATPase. Ca2+ release occurs in 
exchange for W by a Ca2+JW antiporter and is favoured by a Na+,tI-t antiporter 
(Vercesi and Docampo, 1996). 
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1.1.4.6. The nucleus. 
The nucleus of T. bruce; is made of an envelope containing numerous nuclear 
pore complexes and a nucleoplasm containing a large nucleolus of 0.5-1 J..lm. 
Chromatin and histones (H2A, H2B and H4) are present in both forms. Bloodstream 
forms seem to be more chromatin dense than procyclics (Ersfeld et aI., 1999). 
Organization of the nuclear genome: 
The size of haploid nuclear genome of T.bruce; is estimated at 3.5 x 107 bp 
(which compares with Saccharomyces cerevisae at 1.4 x 107 bp, and Caenorhabditis 
eiegans at 9.7 x107 bp). The nuclear chromosomes can be separated by pulsed gel 
electrophoresis (PFGE) and they have been grouped into three general classes 
according to their sizes. The megabase chromosomes (1 to 6 Mb), the intermediate 
chromosomes (from 200 to 900 kb) and the minichromosomes (50-150 kb) (El-
Sayed et a1., 2000). 
There are 11 pairs of megabase chromosomes carrying most active genes with 
the exception of VSGs and ESAGs (expression site-associated genes). 
Intermediate chromosomes have an uncertain ploidy and a variation in number 
and sizes between stocks. There are between 1 and 5 intermediate chromosomes of 
200 to 900 kb and they are known to contain VSG expression sites (VSG-ES, B-ESs 
for bloodstream forms and M-ESs for metacyclic forms) (EI-Sayed et ai., 2000). 
Ninety percent of the sequence of the minichromosomes is made of a 177 bp 
repeat of an unknown function. Between one of these repeats and one telomere, two 
GC (74 bp) rich domains are found separated by an AT rich domain of 155 bp. These 
telomeric regions contain conserved repeat elements that are highly susceptible to 
recombination and may enable VSG gene copies (also present on minichromosomes) 
to translocate to potential expression sites on large chromosomes (Ersfeld et a1., 
1999). 
There are approximately a thousand VSG genes (VSGs) in the genome of 
Trypanosoma brucei and only one gene is expressed at the time. The silent genes are 
mainly located at telomeric regions of the minichromosomes. 
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A typical expression site comprises a promoter, followed by at least eight 
expression site associated genes (ESAGs), repeats of a 76 bp unit and finally the 
VSG. The VSG genes move into and out of the expression site by different molecular 
mechanisms (see for review Borst et al. , 1998; Cross et al. , 1998). 
Promoter ESAGs 
tClCl Cl Cl 
70 bp repeat VSG 
D Telomeres • Repetitive sequence D 8-VSG Chromosome-specific sequence 
0 70 bp repeat 0 M-VSG 
0 ESAGs 11 VSG promoters 
Figure 1.9: Schematic organisation of a T. brucei megabase chromosome. Each telomeric end 
harbours a variant glycoprotein (VSG) expression site (ES). The diagram shows a bloodstream form 
ES (B-ES) at the left end, containing a repetitive sequence adjacent to the VSG gene, co-transcribed 
genes (expression site-associated genes, ESAGs) and a distant promoter; a metacyclic ES (M-ES) is 
shown at the right end, with fewer ESAGs and a VSG- specific promoter. The B-ES is separated from 
the remainder of the chromosome by large tracts of repeated sequences. The housekeeping genes are 
found in the mainly chromosome specific core of the chromosome. 
Gene expression 
In trypanosomes, genes are often organized in large clusters of repeats of 
particular open reading frames (glucose transporter genes are an example) 
(Vanhamme and Pays, 1995). Trypanosome genes lack the presence of introns. 
Transcription of arrays leads to the production of long polycistronic units of pre-
mature RNA. This polycistronic organization might relate to the fact that few 
promoters have been found in trypanosomes (ribosomal, procyc1in, and VSG genes) 
(Vanhamme and Pays, 1995). 
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The transformation of primary transcript into mature mRNA requires the addition of a 
cap at the 5' end and a poly(A) tail at the 3'end. The capping process is known as 
trans splicing. Small nuclear RNA ensures the addition at the 5'end of the cleavage 
site of a pre-capped spliced leader. There is no known consensus signal for ") 
polyadenylation but the two events are coupled. The choice of the splicing site (a ~- 1/7'-
polypyrimidine stretch in the intergenic region) of the downstream transcript seems to ~~~J <- ~ l, 
determine the choice of the polyadenylation site of the upstream transcript ~J IrG. 
l." (Vanhamme and Pays, 1995). 1;(;-
All three classical eucaryote RNA polymerases have been found in 
trypanosomes. Interestingly, while most mRNA species are produced with RNA 
polymerase II, it appears that RNA polymerase I is involved in transcription of VSG 
and P ARP genes (Lee and Vander Ploeg, 1997). 
The T. brucei genome project 
The sequencing of the T. bruce; genome is underway and involves the 
collaboration of at least ten different laboratories. The coordination is under the 
responsibility of the WHO ISpecial Programme for Research and Training in Tropical 
diseases (TDR). This network involves different approaches leading to different types 
of databases. 
- Sequences of cDNA from bloodstream and procyclic forms of trypanosomes can be 
found in the expressed sequence tags databases (dbEST). 
- Random genomic sequences can be found in EMBL or GENBANK (75% of the 
genome has been sequenced to date). 
- A chromosome sequencing project has started at the Sanger Center 
(http://www.sanger.ac.uk/) and at TIGR (http://www.tigr.org). 
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Table 1: Status of the T. brucei chromosome sequencing project. 
Chromosome number Sequencing status Sequencing center 
I Complete Sanger center 
II Almost complete TIGR 
III Not started TIGR 
IV In progress TIGR 
V Not started TIGR 
VI In progress TIGR 
VII Not started TIGR 
VIII Not started TIGR 
IX Not started Sanger center 
X Not started Sanger center 
XI Not started Sanger center 
- Four genomic libraries containing DNA from T brucei TREU927 are in use and 
high-density filters and clones from a bacteriophage PI library and a cosmid library 
are now available. 
- A genetic map is also under construction. 
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1.1.5. Sleeping sickness: 
1.5.1. An overview of the history of sleeping sickness 
Before the etiology of sleeping sickness was understood it was already known 
that the bite of the tsetse fly was "poisonous" and long tenn lethargic effects 
occurring after the bite were described by Livingstone in 1857. At this time 
trypanosomes had already been described by Gruby in 1843 in the blood of a salmon. 
The name ''trypanosome'' was given to this organism whose motion suggested the 
movement of a corkscrew. The first observations of the parasite in mammalian blood 
were made by Lewis (1879) and Evans (1881) who observed trypanosomes 
respectively in the blood of rats (Trypanosoma lewisi) and horses and camels 
(Trypanosoma evansi). 
It was David Bruce in 1895 who correlated the presence of trypanosomes in 
the blood of animals and the disease called nagana. Bruce also elucidated the role of 
the tsetse fly as the vector from which transmission occurs. David Bruce had been 
called by the Governor of Zululand to investigate the nature of nagana decimating the X 
livestock of the country. The mission was a real success (Cox, 1996). 
However the correlation between nagana and sleeping sickness in humans was 
not immediately clear. Aido Castellani was sent to Entebbe to investigate the bacterial 
cause of sleeping sickness. Castellani's hypothesis was that streptococci were 
responsible for the disease. However in 1903, he observed the presence of 
trypanosomes in the bloodstream and the cerebrospinal fluid of patients with sleeping 
sickness. At that time David Bruce was sent to take control of the investigation and a 
controversy arose as to whether Bruce or Castellani was first to identify 











Figure 1.10: Photographs of the key figures involved in the discovery of trypanosomiasis and the 
description of the parasite (These photos belong to the Well come Institute Library). 
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At the beginning of the twentieth century the cause and the mode of 
transmission ofthe disease had been elucidated. In the second half of the century that 
interest in sleeping sickness regained interest and investigations on the biochemistry, 
immunology and molecular biology of the parasite started. Professor Keith 
Vickerman pioneered these studies has to be cited. His detailed work on electron 
microscopy revealed the structure of trypanosomes throughout their life cycle and led 
to the discovery of a coat of antigens at the surface of the parasite responsible for 
antigenic variation (Vickerman, 1969). These antigens were later characterised 
biochemically by George Cross (Cross, 1975). 
Keith Vickerman 
Figure 1.10. (continued) (Personal source) 
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1.1.5.2. Geographical distribution and prevalence 
The disease is distributed over 36 African countries situated in the sub-
equatorial part of Africa between 14° North and 29° South of the equator (Kuzoe, 
1993). The distribution of the disease follows the distribution of the vector, Glossina, 
more commonly called the tsetse fly. In West and Central Africa, the endemic species 
of tsetse belong to the Palpalis group with three species G. palpalis, G. tachinoides 
and G. jucipes. These species of tsetse fly require a sustained level of humidity and 
have a preference for the riverine habitat. They transmit Trypanosoma brucei 
gambiense. The reservoir of the infection is mainly humans (Smith et al., 1998). In 
East Africa, the transmission is due to the presence of tsetse fly from the Morsitans 
group: G. morsitans, G. pallipides and G. S'wynnertoni. These species of tsetse fly 
have a preference for dry and open areas of savannah. They are vectors of 
Trypanosoma brucei rhodesiense. The reservoir of the infection in West and Central 
Africa is usually man while in East Africa wild and domestic animals also playa role 
(Smith et al., 1998). The Rift valley represents the geographical separation between 
the two forms of the disease (Welburn et al., 2001). 
Currently there are estimated to be three hundred thousand cases of 
trypanosomiasis annually_ The most severely affected countries are the Democratic 
Republic of Congo and Angola. In Zaire (now the Democratic Republic of Congo) 
the prevalence of the disease in 1994 was estimated to be the same as in 1930. 
Epidemic outbreaks occur due to the movement of populations or interruption of 




Figure J.J I : The geographic distribution of Trypanosoma brucei gambiense (in yellow) and 
Trypanosoma brucei rhodesiense (in red). Foci follows closely the western edge of the African Rift 
Valley, shown here on a digital elevation model of the continent (USCS digital elevation model) 










Figure 1.12: Number of reported cases of African trypanosomiasis and population screened 
between 1940 and 1998 (copied from Chapter 8 of WHO Report on Global Surveillance of Epidemic-
prone Infectious Diseases). 
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1.1.5.3. The disease: 
In the days following the bite of an infected tsetse fly, parasites proliferate at 
the site of infection. The site of injection becomes swollen and presents a self-healing 
chancre for three to four weeks. The parasite progressively invades the lymph nodes 
and the bloodstream. In the early stages of the infection the principal clinical 
symptoms are intermittent fever and a splenomegaly and gangliopathy. Swollen 
lymph nodes may appear in the neck and are known as Winterbottom's sign. 
In the second stage of the disease the parasite invades other organs and 
especially the central nervous system (CNS). The progression of the disease can take 
several years after an infection due to T. b. gambiense. However, in the case of an 
infection by T. h. rhodesiense, the form of the disease is acute and develops in a 
matter of weeks. 
Irypanosomes are found in several areas of the brain including the thalamus 
and the hypothalamus and the blood brain barrier (BBB) is usually extensively 
damaged (Philip et al., 1994). 
This phase of CNS invasion is characterized by the appearance of complex 
neuro-psychiatric syndrome consisting of an alteration of consciousness and the 
rhythm of sleep (diurnal somnolence and nocturnal insomnia), changes in muscular 
tone and abnormal movements. In the fmal stage the patient often presents a large 
range of psychological alterations including depression, hallucinations and manic 
episodes as well as epileptic fits (Bentivoglio et al., 1994). If the disease is not treated 
it is invariably fatal. 
1.1.5.4. Diagnosis 
The tools developed for the diagnosis of African sleeping sickness fall into 
two categories: the detection of parasite components like antigens or DNA and the 
detection of antibodies. 
A card indirect agglutination test for trypanosomiasis (CIAIT) due to T. h. 
gambiense and rhodesiense has been developed and is based on antigen detection 
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using an indirect latex agglutination assay using whole blood obtained by rmger 
prick. The specificity of this test is evaluated at 99 % (WHO report). 
A card agglutination test for trypanosomiasis (CATT) is also available and is 
based on antibody detection. This test does not identify infections due to T. h. 
rhodesiense. 
Positive diagnosis using one of these techniques must be followed by positive 
identification of the parasite. Positive diagnostic depends upon microscopic 
identification of the parasite. Different types of samples can be used: tissue fluids, 
thick blood smears, aspiration of chancres or cervical nodes (WHO Expert 
Committee, 1998). 
The symptoms developed during the flrst phase of the infection are very 
general and non-speciflc to sleeping sickness and a patient suspected to have the 
disease will probably be in the second phase of infection and have trypanosomes 
present in the CNS. 
1.1.5.5. The control of the disease 
Treatment 
Drugs in use 
There are no vaccines against sleeping sickness and the prospects for 
prophylactic immunization are severely hampered by the ability of the trypanosomes 
to escape from the host immune system by antigenic variation. Hence, chemotherapy 
is the principal means of intervention against the disease. Four drugs are currently in 
use: suramin, pentamidine, melarsoprol and difluoromethylornithine (DFMO). 
Suramin is a highly negatively charged naphthalene derivative with six 
sulphonic acid groups which are deprotonated under physiological conditions (Voogd 
et al., 1993). Such a highly charged molecule would not cross the plasma membrane 
of the parasite by simple diffusion in its anionic form. Suramin has been shown to 
bind to numerous serum proteins including albumin and low density lipoprotein 
(LDL). Two types of LDL receptor have been identified in the flagellar pocket of 
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bloodstream forms. Thus, LDL receptors have been proposed as the gate of entry of 
suramin into trypanosomes (Coppens and Courtois, 2000). 
The trypanocidal action of suramin has not been identified. Inhibition of some 
essential enzymes like glycerol-3-phosphate oxidase, protein kinases and 
phospholipases have been suggested. On the other hand suramin decreases the 
binding of LDL to the LDL receptor of trypanosomes and thus may interfere with 
cholesterol and fatty acid import (Coppens and Courtois, 2000). 
The side effects of the drug are mainly a febrile reaction to the injection, rash, 
malaise and more severely renal damage with variable recovery (Voogd et ai, 1993). 
Pentamidine is an aromatic diamidine. The drug probably enters 
trypanosomes principally via an amino-purine transporter named P2. Loss of this 
transporter is associated with a cross-resistance to diamidines and melaminophenyl 
arsenicals. However, two other transporters associated with pentamidine uptake have 
also been identified (De Koning, 2001). 
The parasites accumulate high concentrations of the drug (millimolar 
concentration) (Carter et al., 1995). The mode of action is not fully understood but 
pentamidine binds to trypanosomal kinetoplast DNA via specific interactions with 
sites rich in adenine-thymine bases. The molecule does not cross the blood brain 
barrier and is used only in the hemolymphatic phase of the disease (Sands et al., 
1985). 
The side effects of pentamidine after injection are mainly nausea, 
hypotension, hypo or hyper glycemia Pain and necrosis can occur at the injection site 
(Sands et al., 1985). 
Melarsoprol is a melaminophenyl based organic arsenical introduced as a 
drug by Freidheim in 1949. Melarsoprol may enter the trypanosomes by diffusion but 
also via the P2 nucleoside transporter. Melaminophenylarsenicals have been shown to 
inhibit the uptake of adenine via the P2 transporter and trypanosomes resistant to 
sodium melarsen show a loss of the P2 transporter (Carter et al., 1995). The mode of 
action of the drug has not been elucidated yet. Trypanothione, a trypanosomal 
equivalent of the mammalian glutathione, has been suggested as a target. Arsenic is 
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known to form stable interactions with thiols, however only a small fraction of the 
arsenicals have shown their ability to bind to trypanothione. 
Me larsopro I is a lipophilic molecule capable of crossing the blood brain 
barrier and is one of the few drugs that can be used in the late stage of the disease 
(Onyango et al., 2000). 
Melarsoprol has been used for a long time, and it is highly toxic which 
illustrates problems imposed by the lack of trypanocidal drugs available on the 
market. It is administrated by intravenous injection as a 3.6% solution in propylene 
glycol (Keiser and Burr~ 2000). The adverse effects are generally fever, headache, 
diarrhea, polyneuropathies, exfoliative dermatitis, pruritus and abdominal and chest 
pains (Burri et al., 2000) but the worst adverse effects are certainly the development 
of encephalopathy in 10% of the treated patients. These encephalopathies are lethal in 
10-50% of cases (WHO, 1998). Until recently the administration of melarsoprol 
consisted of series of three to four injections of an increasing dose of melarsoprol 
from 1.2 to 3.6 mg/kg with an interval of seven to ten days between the injections. 
This treatment schedule imposed a hospitalization of the patient for twenty-
five to thirty-six days, which is a serious drawback for the patients and their families. 
An alternative schedule has recently been proposed by Burri et al. consisting in daily 
administration of 2.2 mg/kg of melarsoprol over a period of ten days. The treatment 
showed the same level of efficacy and the same level of adverse effects but a better 
compliance of the patient probably due to the advantage of a shorter period of 
treatment (Burri et al., 2000). 
Eflomithine, also named difluoromethylornithine (DFMO), is an analogue of 
ornithine that inhibits ornithine decarboxylase (ODC). Eflornithine inhibits 
mammalian and trypano so mal ODC but the specificity of the drug against 
trypanosomes relies on the fact that the trypanosomal enzyme is degraded within the 
cell and replenished at a much slower rate than in mammals (Bacchi et al., 1983). 
Thus, the parasite is rapidly depleted in polyamines and this leads to a cessation of 
parasite growth. The immune system is then capable of killing the growth arrested 
trypanosomes. 
There are several limitations to the use of DFMO: It lacks activity against T. 
h. rhodesiense and its availability is limited (ten times more expensive than 
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melarsoprol treatment). The WHO has recently reached an agreement with Aventis to 
produce the drug for use in sleeping sickness. Recently the drug has been included in 
a formulation that removes facial hair and there is renewed optimism that the drug 
will become available to treat sleeping sickness. 
The side effects of DFMO are limited to an anemia and to a reduction in other 
blood cell number. DFMO presents another advantage in that it can be administrated 
orally. 
New drugs in development: 
The lack of new drugs aginst sleeping sickness has stimulated WHO-TDR to 
establish three centres to screen new drugs. screening of drugs is an approach that the 
TDR supports through a fmancial support at the London School of Hygiene and 
Tropical Medicine, the Swiss Tropical Institute and the Janssen Research Foundation 
(Belgium) (TDR report) 
Two classes of compound are m pre-clinical development: the triazine 
derivative SIPI 1029 and a nitroimidazole, megazol. 
The putative mode of action of SIPI 1029 IS an inhibition of the S-
adenosylmethionine decarboxylase. The molecule does not cross the BBB but present 
a low toxicity as well as an activity against both T. h. gambiense and T. h. 
rhodesiense (Keiser et al., 2001). 
Megazol is a molecule originally synthesized in 1968 and abandoned because 
of putative risks of mutagenicity. The product has recently received renewed interest 
because of its capacity of to cross the BBB (Enanga et al., 2000). Its toxicity is 
currently under evaluation. 
A compound named CG40215, an inhibitor of S-Adenosylmethionine 
pathway has also been investigated against trypanosomes. Its action is limited to 
infections by T. b. gambiense and to the early phase of the disease. Investigation on 
this molecule has therefore been stopped (Keiser et al., 2001). 
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Putative new targets: 
Extensive studies on the molecular biology and biochemistry of the parasite 
have identified a number of potentially attractive targets. 
Topoisomerases: Trypanosomatids contain an unusual network of 
mitochondrial DNA, enclosed in a structure called the kinetoplast. Topoisomerases 
are enzymes involved in the control of the structure of the network. Several 
compounds, known for their capacity to inhibit these enzymes, have been tested in 
vitro against trypanosomes. The methylendioxy derivatives of Camptothecin (specific 
to topoisomerase I) gave promising results (Shapiro, 1993, Keiser et al., 2001). 
Polyamine pathways: Bloodstream forms need to synthesize polyamines to 
proliferate. DFMO, an inhibitor of one of the enzyme of the polyamine pathway, 
ornithine decarboxylase, is one successful compound used therapeutically. Other 
enzymes of the pathway have also been investigated. Inhibitors of S-
adenosylmethionine decarboxylase such as methyl glyoxalbis(guanylhydrazone) and 
CGP40215 either failed to clear the infection in vivo or were not active against the 
late stage of the disease (Keiser et al., 2001). 
Glycolysis: Bloodstream forms rely entirely on glycolysis to produce ATP 
and numerous enzymes of the glycolytic pathway have been the subject of intense 
study (Glyceraldehyde-3-phosphate dehydrogenase, phosphofructokinase, pyruvate 
kinase) but none of the inhibitors have yet been tried in vivo. 
Trypanothione: In place of glutathione as the major low molecular weight 
thio~ trypano so mat ids possess a glutathione-spermidine conjugate called 
trypanothione. The enzyme trypanothione reductase is pivotal in keeping 
trypanothione reduced. Different inhibitors, targeting this enzyme have been tested 
(peptide inhibitors, phenothiazines, and diphenylsulfides). The activity of these 
compounds has been demonstrated in vitro but the activity in vivo needs to be 
improved. 
GPI: Glycosylphosphatidyl inositol (GPI) molecules serve as anchors at the 
plasma membrane for different proteins and especially for Variant Surface 
Glycoproteins (VSGs). These molecules contain a myristate unit and the GPI 
myristoylation has been explored as a putative chemotherapeutic target. 
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Protein farnesyltransferase: A number of cellular process including signal 
transduction require the attachment of farnesyl or geranylgeranyl groups to specific 
proteins. Inhibitors mimicking the substrate farnesyl pyrophosphate have shown to 
inhibit the growth of procyclic and bloodstream forms at concentrations that do not 
affect the proliferation of fibroblasts (Yokoyama, 1998). 
The treatment of African trypanosomiasis is still unsatisfactory. Most of the 
drugs in use to date where developed in the first half of the twentieth century. Only 
one drug has been developed recently but its use is limited by its cost. Unfortunately 
the lack of new drugs is not the only factor contributing to the problems of 
chemotherapy. Some health centers are still not sufficiently well equipped to permit a 
correct diagnosis or to differentiate the stages of the disease. Frequently patients with 
sleeping sickness present co-infections with other parasites (Plasmodium, intestinal 
helminths, filariasis) and a background of malnutrition reduces their ability to 
survive. The follow-up of the treatment is long (24 months) and requires at least four 
lumbar punctures and which results in a poor compliance (Atougia and Costa, 1999). 
Sleeping sickness in rural communities dependent on agriculture leads to 
serious economic problems when working people are infected. The disease affecting 
the livestock (nagana) can also endanger farming activity. The impact of the disease 
is not only economical but also social. Women infected by sleeping sickness are 
under sociocultural constraints (shame, ostracism, and financial dependency) and 
seek treatments less readily than men (WHO). Sleeping sickness also has an impact 
on children. Physiologically a lower weight and a delay of puberty has been observed 
compared to non infected children and psychologically infected children are 
academically less fit and drop out of school more often. 
Vector control 
While drugs represent the main tools of trypanosomiasis today, the other 
method of controlling the disease that has had a success historically is the control of 
the tsetse fly vectors of the disease 
Since the discovery of DDT in 1945, the use of insecticides has been the main 
line of defense against tsetse flies. In the middle of the century very large areas were 
36 
ChapterI: Introduction 
sprayed and in some countries including Cameroon, and Nigeria trypanosomiasis was 
kept under control for several years. 
Towards the end of the 20th century the most commonly used technique were 
bait techniques. These approaches involve the attraction of the tsetse using visual or 
olfactory bait to traps where the insect can be killed. The technique was then 
developed using life bait that have been dipped or sprayed with DIT or pyrethroides 
(more effective against the fly and less toxic for mammals) (Atouguia and Costa, 
1999). 
Tsetse flies are very susceptible to insecticides but a limitation of the vector 
control approach is its sustainability. Inadequate follow-up, leading to the re-
infestation of regions by the tsetse and the failure of the control programme, is often 
due to political instability (civil wars) and the lack offmance. 
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1.2. Transport phenomena. 
1.2.1. Principles: 
The process by which a molecule is able to cross the plasma membrane 
depends on the nature of the molecule. Water and nonpolar molecules permeate by 
simple diffusion across the membrane whereas various polar molecules (sugars, ions, 
amino acids etc) are transported using special membrane proteins named membrane 
transport proteins. There are two main classes of membrane transport protein: the 
carrier proteins (also called transporters or permeases) and the channel proteins. 
The transport of molecules through channels and some carriers is a passive 
phenomenon (also called facilitated diffusion). If the molecule is uncharged the 
driving force is the concentration gradient of the molecule only. If the molecule is 
charged the driving force is a combination of the concentration gradient and the 
membrane potential (the electrical potential difference across the membrane). The 
combination of the concentration gradient and the membrane potential is named the 
electrochemical gradient. 
Cells are also required to transport some solutes against their electrochemical 
gradient. This process is called active transport and is always mediated by a protein 
carrier tightly coupled to a source of metabolic energy (ATP hydrolysis or an ion 
gradient). If the carrier transports only one solute it is called an uniporter. For coupled 
transport, the transport of one solute depends on the transfer of a second one either in 
the same direction (symport) or in the opposite direction (antiport) (Alberts et al., 
1994). 
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Figure 1.13: Comparison between passive diffusion, facilitated diffusion and active 
transport. Passive and facilitated diffusion occur spontaneously while active transport requires an 
input of metabolic energy. Facilitated diffusion can be carried out by channels or carrier proteins while 
active transport is mediated by carriers only. 
When the energy of translocation of one solute is supplied by 
(electro )chemical gradients of other solutes the transport is named secondary active 
transport. When light or chemical energy is directly converted into an 
electrochemical energy (an ion concentration gradient for example), the type of 
transport is called primary active transport. The different types of ATPases (P-type 
at the plasma membrane, V-type in vacuoles and F-type in the mitochondrial inner 
membrane) fall into this category. These ATPases hydrolyse ATP and create an 
electrochemical gradient of protons across the membrane. Secondary and primary 
transport can be coupled. In trypanosomes most ofthe nutrient transporters studied so 
far have been shown to be dependent on a proton motive force. The nutrient is 
symported with a proton which enters the cell because of the electrochemical gradient 
which is generated by a proton ATPase. The proton motive force (PMF) is a 
combination of two components: the membrane potential and the pH gradient across 
the membrane and can be calculated using equation 1 (Appendix-Chapter I). In 
procyc1ic forms the PMF has been estimated at - 80 m V (de Koning and Jarvis, 1997) 
and for the bloodstream forms the value varies according to the authors between -52 
mV (Nolan and Voorheis, 2000) and -95.4 mV (De Koning and Jarvis, 1997). 
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In the bloodstream fonns of the parasite the membrane potential is composed 
of two distinct electrical gradients. One is located at the plasma membrane and the 
largest factor contributing to its generation is the potential due to the diffusion of K+. 
The other one is located at the mitochondrial inner membrane and is generated 
entirely by the translocation ofW catalysed by the FIFo-ATPase with no contribution 
from the electron transport chain (Nolan and Voorheis, 2000). 
The total number of plasma-membrane associated proteins in trypanosomes 
is unknown. However a reasonable prediction can be made based on the analogy with 
other organisms where around 5 % of genes encode transporters. The total number of 
genes in T.brucei is estimated at around 12 000 genes the prediction would be of 
about 600 genes encoding for transporter proteins (Borst and Fairlamb, 1998). 
1.2.2. Mechanism of transport: 
Many descriptions for the kinetics of transport rely on an analogy to typical 
reactions catalyzed by soluble enzymes. In this model, when the carrier is saturated, 
the rate of transport is maximal detennining a V max value characteristic of the 
transporter. Each carrier is also characterized by a Km value equal to the 
concentration of substrate when the rate of uptake is half of its maximum value and is 
inversely proportional to the apparent affinity of the substrate for the transporter. 
This view has been, and is still, extensively used although it is an over 
simplistic way of looking at transport mechanisms. Unlike soluble enzymes, 
,transporters are vectorial catalysts that operate between two compartments and need 
to be approached differently. 
Another model, specifically concerned with the transporter case was 
published by Deves in 1991. The mechanism of transport relies on four consecutive 
events: 1) the binding step of the substrate to the recognition site of the transporter, 
2) the translocation step of the complex carrier-substrate, 3) the dissociation of the 
substrate from the binding site and 4) the return of the free carrier to its original 
position (Deves, 1991). 
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1.2.2.1. The binding step: 
The binding step is the interaction of the substrate with its recognition site 
on the carrier. In the case of coupled transport the question of an order in binding 
steps of the two solutes can be raised. Separate studies on Na+/glutamate (Yamato, 
1992) and Na+/glucose transport (Krupka, 1989) and the lactose permease (Sahin-
Toth et ai, 2000) have shown that the cation binds first to the carrier and induces a 
conformational change that exposes the substrate binding site. 
1.2.2.2. The translocation of the complex. 
Different models have been proposed to illustrate how a protein carrier can 
conduct its substrate from one side of the membrane to the other. In one model, 
mainly used for non-coupled transport, the substrate site only shifts and the carrier is 
seen as a fixed membrane protein in equilibrium between two conformations. In 
coupled transport the hypothesis is that the complex substrate-carrier undergoes a 
reorientation involving a fall in the energy barrier between the inward and the 
outward-facing conformations. The energy source necessary for this fall of the energy 
barrier most probably comes from the binding forces of the complex (Krupka, 1989). 
The change in protein conformation improves the fit between the substrate and the 
transporter site. This gain in energy is the driving force for the carrier from the 
immobile form in the membrane to the mobile state (Krupka, 1989) and determines 
the rate of translocation. Considering transport in this way has several consequences. 
If the exchange rate depends on the increase of the binding forces that arise in the 
transition state, a good substrate is a molecule that is initially bound weakly in the 
complex and tightly bound in the transition state. This implies that the design of a 
good inhibitor should complement the transporter site in its original conformation and 
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Figure 1.14 : Energy profile for catalysis of carrier movement by the substrate. Co and Cj 
are respectively the outward-facing and inward-facing of the carrier. CoS and CjS are respectively the 
outward-facing and inward-facing of the complex carrier-substrate. 
1.2.2.3. The dissociation of the complex. 
The dissociation occurs when the carrier-substrate complex has translocated 
to the inner face of the membrane. The conformational changes due to the 
translocation lead to the liberation of the coupling ion. This liberation then causes a 
reorientation of the binding site whjch allows release of the substrate. 
1.2.2.4. The translocation of the empty carrier. 
Loss of substrate means that the binding forces are no longer present, and the 
empty carrier in its inward conformation is thermodynamically unstable and returns 
to its outward conformation. 
In the light of these considerations two questions may be asked: What is the 
real mearung of the maximum rate of transport and what is the affinity for the 
transport site. The maximum transport rate of a carrier does not only depend on the 
rate of translocation of the complex substrate-carrier but also on the rate at which the 
free carrier returns to its original conformation. Three situations can be envisaged: 1) 
the rates of translocation of the complex and the free carrier are the same 2) the 
complex translocates faster than the free carrier 3) the free carrier translocates faster 
42 
Chapter!: Introduction 
than the complex. This concept can be particularly important in the interpretation of 
inhibition studies and is known to vary for different transporters (Deves, 1991). 
The apparent affinity of the substrate for the transporter can not always be 
presumed to reflect the half saturation constant (Km value). The apparent affinity is in 
fact dependent not only on the true dissociation constant of the substrate carrier 
complex but also on the rate constants of translocation of the complex and the free 
carrier, which, as described above, can be different. 
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1.2.3 Transporters in trypanosomes 
1.2.3.1. Sugar transporters: 
Bloodstream form trypanosomes rely exclusively on glycolysis as a source 
metabolic energy (Michels et al., 2000) and glucose transporters are present in T. 
brucei to sustain this requirement. Procyclic forms can proliferate in the absence of 
glucose preferring amino acids and especially proline as an energy source. 
Two genes, THTI and THT2 have been cloned and found to be part of a 
tandemly arranged multi gene family with 80 % homology (Bringaud and Baltz, 
1993). The expression of these two genes throughout the life cycle is different. 
Bloodstream forms express forty fold more THTI than THT2, whereas procyclics 
express only THT2 (Bringaud and Baltz, 1993). The type of transport for THTI has 
been shown to be facilitated but it is still debated whether THT2 is a facilitated 
transporter or an active one with a proton dependency. The discrepancy in the results 
may be due to differences in the experimental approach. 
The recognition motif for glucose is different for THTI and THT2. In 
bloodstream forms hydrogen bonds are formed between C-l, C-3, and C-4 positions 
of glucose and THTI (Barrett et al., 1995), while in procyclics THT2 forms an 
additional hydrogen bond in C6 (Tetaud et al., 1997). The apparent affinity of both 
transporters also differs with a Km value of 1 mM for THTI and 40 J.lM for THT2. 
These apparent affinities may conceivably be attributed to the number of hydrogen 
bonds between the substrate and the transporter. 
The two transporters encoded by THTI and THT2 are proteins of 527 and 
529 amino acids respectively and possess twelve transmembrane domains as do other 







Figure 1.15: Differential expression of glucose transporter genes TIITI and TIlT2 in 
procyclic and bloodstream Trypanosoma brucei. Bloodstream forms express mainly THT I whereas 
procyclics express only THT2. 
1.2.3.2 Nucleoside and nucleobase transporters: 
Trypanosomes are not capable of de novo synthesis of purines and need to 
scavange them from the host (Hammond and Gutteridge, 1984). In the bloodstream 
forms two nucleobase transporters have been identified and named H2 and H3. They 
display a very high affinity for hypoxanthine (Km 123 nM and 4.7 f..lM respectively). 
H2 displays a broader substrate specificity including guanosine, uracil, thymine and 
the purine bases (hypoxanthine, adenine, guanine and xanthine) with HI being more 
specific for purine bases (De Koning and Jarvis, 1997b). The procyclic forms have a 
single purine nucleobase transporter named HI which is similar to H3 in terms of 
substrate specificity and in terms of affinity with a Km value of 9.3 f..lM. H2 and HI 
appear to be W symporters (De Koning and Jarvis, 1997a). 
A proton dependent uracil transporter (U1) of high affinity (Km of 0.46 f..lM) 
and high selectivity in the procyclic forms has also been characterized (De Koning 
and Jarvis, 1998). None of the nucleobase transporter genes have been cloned so far. 
Two adenosine transporters have been described in Trypanosoma bruce; 
(Carter and Fairlamb, 1993). One of these is named P2 and transports adenosine and 
its nucleobase aderune, while the other, called PI carries adenosine, guanosine and 
inosine. The bloodstream forms possess PI and P2 while the procyclic forms 
apparently possess only Pl. 
The P2 transporter stimulated sigllificant interest when Carter and Fairlamb 
showed that melaminophenyl arserucals and diamidines could inhibit adenosine 
uptake and that trypanosomes resistant to sodium melarsen had lost the P2 transporter 
(Carter and Fairlamb, 1993, Carter et al. , 1999). The combination of these data 
45 
Chapter!: Introduction 
indicated that the P2 transporter was the gate of entry for melarsen oxide and 
pentamidine. As an additional argument a recognition motif shared between these 
drugs and the amino-purines has been found (Barrett and Fairlamb, 1999, De Koning 
and Jarvis, 1999). The two genes encoding for PI (TbNT2) (Sanchez et al., 1999) and 
P2 (TbNT 1) (Maser et aI., 1999) have been cloned. The P2 gene was identified by 
yeast complementation using a Saccharomyces cerevisae strain incapable of 
adenosine uptake or synthesis to screen a T brucei cDNA library. The TbATl gene 
from an arsenical resistant strain has also been isolated and 6 point mutations, leading 
to amino acid substitutions, were identified. However TbAT1 expressed in yeast was 
not inhibited by pentamidine (Maser et ai, 1999) while the P2 transporter previously 
described in trypanosomes appears to recognise this substrate. 
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Figure 1.16: Nucleoside transporters in T. bruce; procyclic and bloodstream forms . 
1.2.3.3. Amino acid transporters 
The interest in amino acid transporters in trypanosomes started some thirty 
years ago. Unfortunately many of these studies were performed on different species 
of trypanosomes (T. gambiense (Southworth and Read, 1971), T. equiperdum (Ruff 
and Read, 1974), T. lewisi (Manjra and Dusaruc, 1972), T. cruzi (Hampton, 1970» 
which makes difficult to produce a broad picture on amino transporters in 
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trypanosomes. Secondly, most authors carried out their transport studies using a range 
of amino acid concentrations from 1 to 10 millimolar. Knowing that the most 
abundant amino acid in human plasma is glutamine, with a concentration around 700 
flM (Brody, 1994) and that half of the amino acids have a concentration below 100 
flM makes the physiological relevance of these studies questionable. These early 
studies were unlikely to identify any transporters of high affinity (Southworth and 
Read, 1972, Manjra and Dusanic, 1972, Ruff and Read, 1974). However, one key 
concept did emerge from these studies. The uptake of radio labeled amino acids was 
measured in the presence of unlabeled amino acids, and it was shown that one 
transporter was able to take up different amino acids. Hansen suggested the presence 
of five different loci: Locus A binding glutamate, arginine, and lysine, Locus B 
transporting threonine, glycine and alanine, Locus C transporting glutamate, locus D 
transporting phenylalanine and methionine and locus E taking up lysine and arginine 
(Hansen, 1979). Voorheis also pointed to overlapping specificities of the different 
transporters (Owen and Voorheis, 1976). 
Since then, few specific publications on ammo acid transporters in 
trypanosomes were published. Threonine uptake in bloodstream forms was found to 
be oflow affinity with an apparent Km value of250 JlM (Fricker et al., 1984). Proline 
transport was studied in procyclics. This transporter was of a relatively high affinity 
(Km apparent at 19 JlM) and AIP driven with no dependency on Na+, K+ or W (L' 
Hostis et al., 1993). Cysteine transport was described within the context of other 




1.2.4. Amino acid transporters in other systems 
1.2.4.1 Mammalian amino acid transporters: 
The transport of amino acids is comprised of a rather complex system in 
which amino acids are transported via a number of different carrier-proteins 
presenting overlapping specificity. 
Different amino acid transporter systems have been grouped into four 
superfamilies: 1) the ammo acid/auxin permease family (AAAP), 2) 
dicarboxylate/amino acid: cation (Na+ or W ) symporter family (DAACS), 3) the 
neurotransmitter sodium symporter (NSS) and 4) the large amino acid 
/polyamine/choline family (APC). Each of the families is represented in all of the 
main kingdoms (plants, animals, yeast, bacteria and archea). The APC family is 
divided into two clusters: the catioruc amino acid transporters (CAT) and the leucine 
amino acid transporter (LAT) system which is involved in the transport of neutral, 
cationic and atllonic amino acids. Interestingly two members of the LA T family have 
been shown to require association with a glycoprotein belonging to the 4F2hc family, 
and named gpaATS, for glycoprotein associated amino acid transporters. 
AScr 1,2 ~ AT" ('" 
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LA T (Glycoprotein associated ) 
~ L (LA T1, LA Tl) (4F2hc associated) I ~y+L (4F2hc associated) 
00+ (rBA T associated) 
Figure 1.17: Diagram of the superfamilies and families of amino acid transporters. 
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Mammalian amino acid transporters can be classified in two groups of Na + 
dependent or independent transporters. Combining this with a distribution which can 
be either very specific to a type of organ / tissue or widespread results in a 
redundancy of transporters with similar substrate specificity. The main systems found 
in mammals are the following: 
Neutral amino acids: 
The following classification is based on the review of Barker and Ellory (1990). 
N a + independent 
Five systems transporting neutral amino acid in a sodium independent 
manner have been described. They are named system L, T, asc, C and Band3. 
System L: is a widespread transporter which has been named L because of 
its high afTmity for leucine. This transporter is also able to transport large apolar 
branched chain amino acids: glutamine, methionine, leucine, isoleucine, valine as 
well as aromatic amino acids: tyrosine, tryptophan and phenylalanine. One peculiarity 
of this system is its ability to operate in an exchange mode. Its tolerance to 
extracellular variation in pH is also unusual. 
System T: is similar to system L and able to transport aromatic amino acids 
but is only found in human erythrocytes. 2 (methylamino) isobutyrate (BCH) is an 
inhibitor of this transporter. 
System ase : transports alanine, serine and cysteine. 
System C: presents the same substrate specificity as the asc system and is 
present in red blood cells. 
Band 3: is an anion exchanger also able to transport glycine when negatively 
charged. This transporter is also able to carry cysteine and serine. 
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Na + dependent 
System A: alanine, glycine and proline are transported in a sodium 
dependent manner via this sytem. The activity of this group of transporters is pH 
dependent and it is expressed in response of to substrate deprivation. 
System ASC: this system is equivalent to the asc system and is able to 
transport alanine, serine, cysteine, threonine within a broad range of pH values. 
System A and ASC are widespread. 
System N: amino acids with a nitrogen in their side chain: glutamine, 
asparagine, and histidine are taken up by this system which has a high pH sensitivity. 
This system is mainly present in liver cells. 
System Gly: glycine and sarcosine are substrates for this transporter and 
transport has a strict dependence on Na+ and cr. This system is found in erythocytes 
and hepatocytes. 
System 13: this system is used to transport taurine (a key molecule in the 
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Figure 1.18: Diagram of neutral amino acid transporters identified in mammals. 
Anionic amino acids: 
The two acidic amino acids, glutamate and aspartate, are transported into 
mammalian cells via five different transporters: ASC, GL T -I (Glutamate transporter 
1), GLAST (glutamate/aspartate transporter), EAAT4 (excitatory amino acid 
transporter 4) and EAACI (excitatory amino acid carrier I , also named X-AG) 
(Kanai, 1997, Gegelashvili, 2000). 
In human brain the glutamate transporter nomenclature is different except for 
EAAT4. Therefore GLAST is named EAATI , GLT-I is EAAT2, EAACI is EAAT3 
(Kanai, 1997). 
Glutamate transporters have channel-like properties allowing the flow of cr when the 
substrate is present. 
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Figure 1.19: Diagram of acidic amino acid transporters identified in mammals 
Cationic amino acids: 
y+ system: is widespread, sodium independent and transports lysine, histidine 
and arginine selectively. Two other systems which carry cationic amino acids, have 
been described in mammals but they also carry neutral amino acids (Rojas and Deves, 
1999). 
BO+ system: transports alanine, valine, lysine and has a distribution limited to 
blastocyts and oocytes fibroblasts (Deves and Boyd, 1998). 
bO+ system: is a sodium independent system present in blastocyts, the kidney and 
the small intestine. The substrate specificity of this system is similar to the BO+ system 
(Deves and Boyd, 1998). 
y +L system has the peculiarity of requiring sodium for the transport of neutral 
amino acids (leucine, methionine, glutamine) but not for lysine transport (Deves and 
Boyd, 1998, Kanai, 2000). 
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Figure 1.20: Diagram cationic amino acid transporters identified in mammals. 
1.2.4.2: Plant amino acid transporters: 
Plant ammo acid transporters are classified into two large superfamilies 
named ATF (amino acid transporter family) and APC (amino acid - polyamine-
choline facilitator). 
The ATF superfamily is the largest and the best characterized. Four families 
have been distinguished: Prots, AUXs, LHT, AAPs. 
The Prots family has two members named Protl (Schwacke et al. , 1999) and 
Prot2. Both of them show a strong preference for proline. 
The AUXs family has two family members AUXI an auxin carrier and ANTI 
which is able to transport aromatic amino acids and some other neutral amino acids as 
well as arginine (Ortiz-Lopez el al., 2000). 
The LHT family contains three putative family members: LHTI which carries 
lysine and histidine (Chen and Bush, 1997), LHT2 and LHT3 have also been 
identified at the genetic level. 
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AAPs is a family of six members named AAPI to AAP6 each with a different 
tissue distribution. In terms of substrate specificity AAP1, 2, 4, and 6 transport 
neutral and acidic amino acids whereas AAP3 and AAP5 have an additional high 
affinity for basic amino acids (Ortiz-Lopez et al., 2000). 
The APC superfamily includes the GABA permease related family and the 
CAT family. In the GABA permease related family only one gene has been found and 
its substrate specificity has not been determined. In the CAT family two genes have 
been identified AtCATl (basic amino acid transporter) AtCAT2 (putative amino acid 
transporter) (Fischer et al., 1998). 
1.2.4.3 : Yeast amino acid transporters: 
The transport of amino acids in Saccharomyces cerevisae has been shown to 
be an active process dependent exclusively on protons (Rest et ai, 1995). Each amino 
acid is known to be transported by at least two classes of carrier, a general amino acid 
permease called Gapt (Grenson et al., 1970) and specific permeases (lsnard et al., 
1996). Gap 1 can transport all of the natural amino acids in their L form and some in 
their D form as well as some other compounds like citrulline and ornithine. However 
the activity of this permease is regulated at the transcriptional and post-transcriptional 
level by the presence of a nitrogen source like ammonium in the medium. The 
presence of nitrogen in the medium down-regulates the general Gapl and amino acids 
are transported specific permeases (Isnard et al., 1996). 
Several genes encoding for specific perm eases have now been cloned (Figure 
1.21). Like Gapl, some of them (Put4p, Dal5p, Uga4p, Canl) are also down 
regulated in the presence of nitrogen. Two independent mechanisms of regulation are 
responsible for this phenomenon. One is named nitrogen catabolite repression (NCR) 
where repression of transcription of the permease genes, involves two 
dodecanucleotide sites called the upstream-activating sequence (UASNTR), situated 
upstream of the genes. The second is called nitrogen catabolite inactivation (NCI) and 
inactivates the permeases at a post-translational level (Didion et al., 1998). 
Some of the non ammonium sensitive amino acid permeases can also be 
induced by the presence of particular amino acids in the medium. Didion el al. have 
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shown that the transcription of genes including BAP2 and PTR2 is controlled by a 
family member called SSYJ which acts as an amino acid sensor with a particularly 
high affinity to extracellular leucine (Didion et ai, 1998). 
These specific permease genes encode for proteins with a number of predicted 
transmembrane spanning domains that varies from 10 to 13 (Horak, 1997). It is not 
known if these discrepancies are real or due to the differences between the predictive 
algorithms used. However, the high degree of identity at the amino acid level (from 
30 to 60%) for these permeases suggests that they belong to the same family (Horak, 
1997, Isnard et ai, 1996). To date most of the yeast amino acid permeases are 
classified as members of the APe superfamily. 
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Figure 1.21: Diagram of the amino acid transporters identified in S. cerevisiae 
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1.3- Transporters as gateways for drugs: 
The P2 transporter naturally transports adenine and adenosine but has also 
been shown to be a gate of entry for the trypanosomal drugs pentamidine and 
melarsoprol (section 1.2.3.2). Other nutrient transporters can also be envisaged as 
putative gateways to introduce drugs into the parasite. 
Not all nutrient transporters represent ideal gateways for new drugs. The 
glucose transporter for example has a low afTmity for its substrate and it is difficult to 
envisage delivery of drugs in quantities sufficient to enter parasites to toxic levels 
given competition from high glucose concentration in serum. 
The features of a nutrient transporter potentially useful as a gateway for drugs 
should normally carry a low plasma abundance nutrient, in which case it will have 
evolved a correspondingly high afTmity for substrate, and competition between the 
drug and the natural substrate will be minimal. Substrates should also be relatively 
complex with multiple potential binding sites, which increases the probability that the 
recognition motif will differ between the transporters found in the parasite and that 
found in mammalian host. 
Some amino acid transporters may fulfill these requirements: they play an 
essential role in the parasite's metabolism and half of the amino acids have a 
concentration in human plasma below 100 JlM (Brody, 1994). Structurally, they also 
display a certain level of complexity (aromatic amino acids in particular). Because of 
the paucity of data on amino acid transport in trypanosomes this study represents a 
fITst step towards this direction. 
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2.1. Trypanosome Strains 
The strain used routinely in this study is Trypanosoma brucei brucei strain 
EATRO 427. This strain was first described as coming from a sheep in Uganda and has 
been extensively used for experimental purposes. Although the TREU 92714 strain has 
been chosen for the T. brucei genome sequencing project 
(http://parsunl.path.cam.ac.uk/), the 427 strain was chosen for this work because a high 
parasitemia can be achieved in rats leading to the harvesting of a high number of 
parasites required for uptake studies and because most biochemical analyses in T. brucei 
have used this strain. 
2.2. Chemicals. 
Radiolabeled L- eH] glutamine (49 Cilmmol), L- eH] glutamate (33Cilmmol), 
[3,5}H] tyrosine (51 Cilmmol), L- [14C] aspartate (207 mCilmmol), L-eH] tryptophan 
(20Cilmmol), L-eH] phenylalanine (118Cilmmol), were purchased from Amersham 
Pharmacia Biotech. Radiolabelled [a32p] ATP (3000 Cilmmol) and L_[14C] methionine 
(58 mCilmmol) were purchased from NEN Life Science Products). Oligonucleotides 
were synthesized by MWG Biotech. Restriction endonucleases and Plu DNA polymerase 
were obtained from Promega. All other chemicals were purchased from Sigma and at the 
highest grade available. 
2.3. Growth and maintenance oftrypanosomes: 
2.3.1. Bloodstream form trypanosomes: 
Bloodstream form trypanosomes were stored in blood containing 20% glycerol in 
capillary tubes in liquid nitrogen. The parasites were injected intraperitoneally into 
Wistar rats. Parasitamia was monitored by examination of a thin tail blood smear using 
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phase contrast microscopy. All experiments were carried out under license in the animal 
facility at Glasgow University. 
When the parasitaemia reached lx109 parasiteslml the rat was anaesthetized under CO2 
and blood containing parasites was collected from the rodent by cardiac puncture in a 
syringe containing 120 U/ml ofheparin in separation buffer (Appendix II). 
2.3.2. Separation of bloodstream form trypanosomes from blood 
Bloodstream form trypanosomes were separated from blood cells by ion 
exchange chromatography (Lanham and Godfrey, 1970). The separation relies on 
differences in charges: the red blood cells are negatively charged and adsorb to the 
DEAE- cellulose (DE 52) while the less negatively charged trypanosomes are eluted 
using a Phosphate- Buffered-Saline-Glucose (PSG) buffer (Appendix II). The standard 
conditions of the elution buffer with pH 8, ionic strength of 0.217 and 1 % of glucose are 
crucial for the success of the purification. The blood was collected from rats with high 
parasitemia as described above and then centrifuged at 1,250 g for 15 minutes at 4°C. 
The centrifugation led to a preliminary separation of the trypanosomes from the blood 
with the formation of a white upper layer ("buffy coat") containing the parasites. This 
layer was carefully removed by pipetting and applied to the DE-52 cellulose column that 
had been pre-equilibrated using the separation buffer. 
2.3.3. Growth and maintenance of pro cyclic culture form trypanosomes: 
Cultures of procyclic trypanosomes were kept in sterile tissue culture flasks at 
28°C in SDM-79 medium (Brun et 01.,1977) containing 10% fetal calf serum that had 
been decomplemented by incubation at 56°C in a water-bath for 1.5 hours. 
The development of the culture was monitored by microscopy and the total 
number of organisms were determined using a haemocytometer (Counting Chamber, 
Weber Scientific International Ltd). Cultures reached peak concentrations of around 5 x 
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107 organisms/ml. Late log phase and early log phase contained respectively around 
1.5x107 and lx107 0rganisms/mI. 
Procyclic parasites were preserved at a density of 5xlO 6 cells Iml by diluting in 
an equal volume of 20% glycerol, cooling slowly in cooling box at -80°C for 24 hours 
and subsequently transferring vials to liquid nitrogen. 
2.4. Transport assays in trypanosomes: 
2.4.1. Preparation of cells for uptake assay 
Procyclic forms were harvested from mid-exponential phase cultures for transport 
assays. Bloodstream forms were collected from the infected rat by cardiac puncture using 
a heparinized syringe and maintained on ice. The cells were washed three times at 4°C in 
transport buffer (CBSS), then re-suspended in transport buffer at a concentration of 108 
cells Iml, and stored on ice. Prior to use cells were warmed to room temperature. 
2.4.2. Transport assays in trypanosomes 
To initiate uptake, a 100 I.d sample of parasites was added to 100 Jll of transport 
buffer (CBSS) (Appendix II) containing quantities of radiolabelled amino acid stated in 
the text. The buffer was layered over a cushion of 90 Jll oil [l-bromododecane, 98% 
(Aldrich); final density 1.038 glml] in a 0.5 ml Eppendorf tube. Transport was ended 
after varying time intervals by centrifuging the tube at 13,000 x g for 60s in a bench top 
microfuge which separates the parasites from the uptake buffer. Immediately after the 
centrifugation, tubes were flash frozen using liquid nitrogen. The pellet of parasites was 
cut from the bottom of the tube into a scintillation vial and lysed with 200 Jll of 10 % 
sodium dodecyl sulphate. 4 ml of scintillation fluid (Ecoscint A, National Diagnostics) 
were added and incorporated radioactivity was measured using a liquid scintillation 
counter (LKB Wallac 1219 Rackbeta). 
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For transport assays in the presence of inhibitors or ionophores, these were 
dissolved in ethanol (valinomycin, monensin, NEM, CCCP, FCCP, SHAM) or CBSS 
buffer (KCN, Ouabain). The compounds were added to the final concentration required 
and pre-incubated with cells for 2 min at room temperature prior to uptake. Control 
uptakes containing the same percentage of solvent (ethanol) were carried out in parallel. 
2.5. Molecular cloning techniques: 
2.5.1. Polymerase chain reactions 
All PCR reactions were performed using Pfu DNA Polymerase (Promega). The 
oligonucleotides were provided by MWG Biootech. A 50 I.d reaction contained 200 J.lM 
of dATP, 200 J.lM of dCTP, 200 J.lM of dGTP and 200 J.lM of dTTP, 5 J.lI of lOX buffer 
containing MgS04 (provided by the manufacturer), upstream and downstream primers at 
the concentration of 1 J.lM, DNA template in a range of concentrations between 200 ng-
300 ng and 1.25 units of Pfu DNA Polymerase. 
For the amplification of TbAATPl, the following primers were designed: 1) 
forward primer: 5' TAGATCTCAAA~_M~ATGACCAGCATCAATGCC 3', 
containing a BgflI site (plain underline), and a Kozak ribosome binding sequence 
(Kozak, 1986) (dashed underline) placed directly upstream of the initiation codon (bold). 
2) the reverse primer, 5' TAGATCTACGCTAATCATCCCACAG 3' containing a BgnI 
site (plain underlined) upstream of the termination codon (bold). 
The amplification was performed using a thermal cycler (Gene AmpPCR System 
2400, PerkinElmer). The annealing temperatures used were chosen based on the T m value 
of the oligonucleotides. The conditions for amplification were the following: a hot start 
at 94°C for 1 minute followed by 30 cycles composed of a denaturation step at 94°C for 1 
minute, an annealing step at 50°C for 30 seconds and an amplification step at 72°C for 4 
minutes, a final extension at 72°C for five minutes. 
The product of the reaction was checked by agarose gel electrophoresis and the 
band corresponding to the size of the expected product was removed and the DNA 
extracted. 
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2.5.2. Plasmid vectors: 
Two plasmid vectors were used for the cloning of TbAA TP}; pGEM-T (Promega) 
was used for subcloning and pSPGTl was used for in vitro transcription for oocyte 
expression (Krieg and Melton, 1984). The latter was a gift from Dr. G.W. Gould and 
contained the coding sequence of the rat brain glucose transporter GLUT} ligated into a 
BgllI site and flanked by 89 bp of 5' and 141 bp of 3' untranslated sequence from the 
Xenopus rl-globin gene (Gould and Lienhard, 1989). 
2.5.3. Preparation of the plasmid 
The pGEM-T plasmid was purchased ready to use. pSPGTl was digested to 
completion with the restriction endonuclease Bgl II in order to remove GLUTI. To 
prevent recircularization of the vector the DNA was dephosphorylated with Calf 
Intestinal Phosphatase (CIP, Gibco). The phosphatase was then heat inactivated at 5SoC. 
The product was run on an agarose gel in order to assess the degree of digestion and the 
integrity of the DNA. The digested product was then extracted using a Qiagen gel 
extraction kit which also yielded vector without the GLUT} insert. The GLUT} sequence 
was replaced by the TbAATP} sequence for expression. 
2.5.4. Ligation 
The principle used in the PGEM-T vector cloning kit is based on the presence of a 
deoxy-thymidine residue at both ends of the vector providing compatible overhangs for 
PCR products generated by DNA polymerases adding a single deoxyadenosine at the 3' 
end of the amplification product in a template-independent manner. However, because 
we were using Pfu DNA polymerase which does not have this characteristic, an 
additional tailing step was needed. This tailing procedure consisted of a reaction 
containing the purified PCR fragment generated by the Pfu DNA polymerase, 1 J.tI of Taq 
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DNA Polymerase reaction buffer (lOx), 1 J.lI of 25 mM of MgCh, 200 J.lM of dATP, 5 
units of Taq Polymerase and deionized water to a final volume of 10 J.t!. The reaction was 
then incubated for 30 minutes at 72°C. The integrity and the quantity of the DNA were 
assessed by running 0.5 J.lI of the reaction on an agarose gel. 
Ligation reactions were carried out using a 3 fold-excess in terms of molar ends 
of the insert DNA and the vector. The reactions were set up in a 10 J.lI final volume 
containing 5 J.lI of ligation buffer (2x), 1 J.lI of pGEM-T vector (50 ng), and 3 U of T4 
DNA ligase. The reactions were incubated at 4°C overnight. 
2.5.5. Transformation of Escherichia coli 
Heat shock sub-cloning efficiency competent cells of the JM109 strain were 
purchased from Promega. Competent cells were removed from -80°C and placed on ice 
until they thawed. 100 J.lI of competent cells was then transferred by pipetting using cold 
tips, in an ice-cold Eppendorf tube and 5 J.lI of the ligation mixture (25 ng) was then 
added. The tubes were put back on ice for 10 minutes and then rapidly transferred to a 
water bath at 42°C for 50 seconds and immediately put back on ice for two minutes in 
order to heat-shock the cells. 900 J.lI of cold LB medium was added to the transformation 
mix and incubated for one hour at 37°C with shaking (225 rpm). The cells were pelleted 
by centrifugation at 1, OOOg for 10 minutes and resuspended in 100 J.lI of LB and plated 
on LB agar plates containing ampicillin (50 J.lg/ml), X-Gal (50 J.lg/ml) and IPTG (I mM). 
2.5.6. Plasmid DNA preparation 
Single transformed colonies were picked from plates into 5 ml of LB/ampicillin 
and incubated overnight at 37°C with vigorous shaking. For small scale plasmid 
preparation 5 ml cultures were taken and spun for 10 minutes at 2, 500 rpm. The pellets 
were then processed using a Miniprep kit according to the manufacturer's specification 
(Qiagen). 
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For the preparation of large scale plasmid DNA a pre-culture of 5 ml was grown 
overnight and then transferred to 250 mls of LB/amp which was grown overnight at 
37°e with shaking. The culture was then spun and the pellet was processed using a 
Midiprep kit according to Manufacturer's specifications (Qiagen). The quality and the 
quantity of the plasmid DNA was then assessed by agarose gel electrophoresis. 
2.5.7. Restriction digestion of DNA 
The digestion of plasmid DNA by restriction endonucleases was carried out in a 
water bath at 37°e for one or two hours. The reaction was carried out in a volume of 20 
J..lI using 5 units of restriction enzyme, 2 J..lI of lOx buffer recommended by the 
manufacturer and 50 ng to 100 ng of plasmid. 
The digestion of genomic DNA was carried out in a volume of200 J..ll and with 20 
units of restriction endonucleases and was incubated at 37°e for at least 6 hours in order 
to achieve a complete digestion. 
2.5.8. Agarose gel electrophoresis of DNA: 
Agarose gels were prepared in T AE buffer (Appendix II) according to Sambrook 
et al.(2nd edition) with 1 % agarose and ethidium bromide. Gel volumes were either 250 
ml and run in 21 ofTAE buffer overnight at 25 mV (Southern) or 40 ml run in 200 ml of 
TAE buffer between 1 and 2 hours at 80 mY. 
After running the gels were viewed by trans-illumination over an ultraviolet trans-
illuminator (UVP Laboratory Products). 
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2.5.9. Purification of DNA from Agarose gels 
In order to purify particular fragments of DNA from agarose gels, DNA samples 
were separated by electrophoresis alongside DNA size markers. Fragments were 
identified by V.V. transillumination and physically excised from the gel using a scalpel. 
The fragments were collected in an autoclaved Eppendorf tube and processed using a 
Qiagen gel extraction kit according to the manufacturer's specifications. 
2.5.10. Preparation and Purification of DNA and RNA from Trypanosoma brucei. 
Bloodstream and procyclic forms of trypanosomes were harvested as described 
above. The RNA was extracted using TRIzol® Reagent (Life Technologies) following 
the manufacturer's protocol. 
The DNA was extracted by adding 450 III of extraction buffer, 20 III of 10% SDS, 
25 III of proteinase K (20 mg/ml) to pelleted trypanosomes and incubated for 2 hours at 
37 0 C with intermittent gentle shaking. An equal volume of phenol was added and the 
contents of the tube were mixed for five minutes, then centrifuged for five minutes at 
15,000 rpm. The supernatant was collected into a new tube and an equal volume of 
phenol: chloroform (1:1) was added. The suspension was mixed and centrifuged. To the 
supernatant an equal volume of chloroform was added and the content of the tube was 
mixed and centrifuged. The supernatant was collected and the DNA was precipitated 
using 3M sodium acetate as described in Sambrook et al.(2nd edition). 
2.5.11. Formaldehyde gel electrophoresis of RNA 
A formaldehyde gel was made by adding a solution containing 9.74 ml of 
formaldehyde, 3 ml of 20x Northern Gel Buffer and 17.3 ml of ddlhO to solution of 30 
ml of 2% agarose melted in a microwave. The mix was poured into a minigel casting-
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block form and allowed to solidify. A Ix Northern Gel buffer was prepared by mixing 25 
ml20 x Northern Gel Buffer, 44 ml of formaldehyde and 430 ml of distilled water. 
The RNA samples were prepared in a fmal volume of20 JlI by adding to the RNA 
sample 1JlI of Northern gel buffer, 3.5 III formaldehyde, 10 JlI offormamide and ddlhO 
to 20 Ill. The mixture was heated at 55°C for 15 minutes, then chilled on ice and 2 JlI of 
RNAse-free loading buffer was added before loading the samples on the gel. The gel run 
was at 25 V overnight with a magnetic stirrer placed inside the box once the RNA 
samples had entered the gel matrix. The stirrer keeps the buffer circulated. 
2.5.12. Southern Hybridization: 
In order to detect restriction fragments in the genomic DNA of T. brucei which 
hybridize to a variety of probes, 3 Ilg of DNA was digested to completion with restriction 
endonucleases and electrophoresed through a 1% agarose gel in TAE buffer. After 
electrophoresis, gels were stained with ethidium bromide and photographed. Following 
electrophoresis the gel was processed for blotting. The first step involved a depurination 
of the DNA by placing the gel in a solution of 0.125 M HCI for 20 minutes under a 
gentle agitation. The gel was then denatured by in a solution containing 1.5 M NaCI and 
0.5 M NaOH for 30 minutes and then soaked in neutralization solution containing. 
Each step was processed under gentle agitation and at room temperature. Between 
each step the gel was rinsed in distilled water. 
At this stage the DNA was ready to be transferred to the nylon membrane 
(Hybond N, Amersham) using the blotting technique described by Sambrook et al.(2nd 
edition) using 20x SSC. After transfer the DNA was fixed to the membrane by using an 
UV cross-linking procedure (Spectrolinker XL-IOOO UV linker, Spectronics 
Corporation). 
Once the DNA was fixed to the membrane it was treated for hybridization either 
at high stringency (to detect sequences with high similarity to the probe of interest) or at 
low stringency (to detect sequences with a lower homology). 
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The nylon membrane was pre-hybridized with the hybridization solution 
containing 50% formamide, 5 x sse, lOx Denhardt's solution, 0.1 % SDS, 20 mM 
NaH2P04, 5mM EDT A and 0.2 mg/ml of denatured hearing sperm DNA, pH 6.5 for 2 
hours at 42°e. The radioactive probe was then added to the solution. Hybridization was 
then carried out overnight at 42°e. After hybridization, the hybridization solution was 
removed and the filters were rinsed at room temperature in 3 x SSC and 0.1 % SDS to 
remove any excess of probe left in the hybridization tube. The washing conditions then 
varied for high or low stringency Southern blots. For high stringency the membrane was 
washed 3 times at 60°C for 30 minutes in 0.1 % SDS and 0.1 x SSC. For low stringency 
washes the membrane was washed 3 times for 30 minutes in 0.1 % SDS and 5 x sse at 
42°C. 
After washing the membrane was kept wet (using the washing solution), wrapped 
in plastic film and exposed to X-ray film (Konica Medical Film) using an intensifying 
screen. The exposure was performed at -70oe for a variable length of time (from 1 to 
three days). Autoradiographs were then developed using a film processor (X-Ograph 
imaging system Compact X4) according to the manufacturer's specifications. 
2.5.13. Northern hybridization: 
RNA was extracted and 4 Jlg was electrophoresed using denaturing conditions on 
a formaldehyde gel. The gel was then directly blotted onto a nylon membrane (llybond 
N, Amersham) according to the technique described in Sambrook et al.(2nd edition), 
using 20 x sse. 
The nylon membrane was then probed and washed (high stringency conditions) as 
described for the Southern hybridization. 
2.5.14. Labeling of DNA probes: 
DNA probes were labelled using the Prime-It II random primer labeling kit 
(Stratagene ). 
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The procedure relies on the use of random hexanucleotides that anneal to mUltiple 
sites along the DNA template. Purified DNA templates (25 ng) were boiled for 5 minutes 
in the presence of the random oligonucleotides in a fmal volume of 34 ~l. The mix was 
then allowed to cool and 1 0 ~l of 5 x primer buffer, 5 J!l of [a32p] ATP (3000 Ci I mmol, 
10 mCilml, NEN Life Science Products), and 1~1 of Klenow fragment (5U/ml) was 
added. The reaction was incubated at 37°C for 2 to 10 minutes and stopped by adding 2 
~l of stop mix. The probe was then purified to separate the unincorporated dATP from 
the labeled probe using a spun column procedure (MicroS pin TM S 200HR columns, 
Amersham Pharmacia Biotechnology, USA). The labeled DNA was then denatured by 
boiling for 5 minutes. 
2.6. Expression of TbAATP1 in the Xenopus laevis oocytes : 
2.6.1. Preparation of the mRNA: 
Capped mRNA was obtained by in vitro transcription using the mRNA Message 
Machine SP6 ™ kit (Ambion) using the TbAATP 1 DNA template in pSPGTI linearised 
by SalI. The reaction was carried out according to the manufacturer's indications and 
incubated for two hours at 37°C. After two hours, 1~1 of DNAse 1 was added to the 
reaction and incubated at 37°C for 15 min in order to degrade the template DNA. 
2.6.2. Preparation of the Xenopus oocytes: 
Mature female Xenopus laevis were anaesthetised by immersion in a solution 
(2g/l) of 3-amino benzoic acid ethyl ester (tricaine) in tap water. Stage V-VI oocytes 
were harvested and then defolliculated with 1000 U rnl-1 of Type lA collagenase (Sigma) 
dissolved in Barths saline buffer without Ca2+ (Colman, 1984). Once defolliculated, the 
oocytes were washed three times in Barths saline buffer and kept at 16°C in Barth's 
supplemented with 2.5 mM sodium pyruvate and 2% foetal calf serum. 
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Twenty-four hours after collagenase treatment, oocytes were micro- injected 
using glass micro- pipettes with 10 to 20 ng of RNA per oocyte in a volume of27 n1. 
2.6.3. Transport Assays in Xenopus oocytes: 
Xenopus oocytes injected with TbAATP 1 or with water as a control, were assayed 
for transport 3 days after injections. The uptake of eH]-glutamine, eH]-glutamate or 
eH]-tyrosine was measured on groups of four oocytes at room temperature in transport 
buffer at pH 7.4 for a length of time stated in the results section. The assays were ended 
by transferring the oocytes to ice, quickly followed by 3 washes with ice cold CBSS. 
Each oocyte was transferred individually to a scintillation vial containing 200 ~l of 2% 
SDS and the incorporation of radio label was quantified by liquid scintillation 
spectrometry. Kinetics of tyrosine uptake was obtained by incubation of TbAATP 1 
injected oocytes and water injected in a range of tyrosine concentrations from 3.125 ~M 
to 100 JlM for 50 min. Assays for inhibition studies were carried out with 0.2 ~M ell]-
tyrosine in the presence of 5 mM of each individual amino acid. 
2.7. Software 
Grafit 4.09 (Erithacus software) was used to handle the biochemical kinetic data. 
This includes the fitting of the different kinetics of transport of all the amino acids 
studied and the determination of the kinetic constants and the ICso values. 
The Vector NTI suite 6 package was used to handle DNA and protein 
sequences. This package includes Vector NTI for the handling of DNA and protein 
sequences (search for open reading frame and restriction sites), AlignX for sequence 
alignments (based on Clustalw) and ContigExpress which was used to associate 
overlapping sequences and create contiguous sequences. 
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ClustalX 1.5 b was used to build the phylogenetic trees. 
The different Web pages used in order to search databases or analyze sequences 
are the following: 
Databases 
TI G R databases: http://www . tigr.orgltdb/mdb/tbdb/gene.shtm I 
Parasite-genome (European Bioinfonnatic Institute): http: //www.ebi.ac.uklblast2/parasites.htm l. 
The Sanger Center: http://www.sanger.ac.uklProjectsff bruceiIToolkitiblast server.shtml 
NCBI : http://www.ncbi.nlm.nih.gov/BLAST/ 
Prediction of transmembrane domains 
TMpred: http://www.ch.embnet.org/sofiware/TMPRED forrn .html 
SOSUI: http://.sosui.proteome.bio.tuat.ac.jp/sosuiframeO.html 
Prediction of the presence of signal peptide 
SignalP : http://www.cbs.dtu.dklservices/SignalP/#submission 
TargetP: http: //www.cbs.dtu.dkiservicesffargetP/ 
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Chapter III: Methionine transport in T. brucei 
3.1. Introduction 
Methionine is an amino acid found with relatively low abundance in human 
plasma (around 30 JlM). In trypanosomes, methionine plays a number of crucial roles in 
the biochemistry of the parasite. In addition to its role as a component of proteins it is 
adenosylated within the cell by S-adenosylmethionine synthetase, and used as a precursor 
in various macromolecular methylation reactions (a,bGoldberg et 01., 1997). S-
adenosylmethionine is also decarboxylated by S-adenosylmethionine decarboxylase and 
the decarboxylated metabolite is used as the source of amino-propyl groups in polyamine 
synthesis (Bacchi, 1991). The methylthioribose which results from this reaction is 
reconverted to methionine via a cycle eponymous with this vital amino acid (Berger et 
al., 1996). Methionine or its precursor in the methionine cycle, a-ketomethiobutyrate 
(KMTB), can relieve the toxic effect of methionine cycle inhibition (Bacchi et 01., 1991), 
indicating that these metabolites must be taken up by trypanosomes. Considering these 
characteristics, the methionine transport represents a good candidate to investigate as a 
potential gateway into trypanosomes. In this chapter are presented the kinetic of 
methionine uptake in procyclic and bloodstream form trypanosomes as well the substrate 
specificity's and the ion dependency. 
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3.2. Results 
3.2.1 The uptake of L-methionine 
Time course of methionine uptake 
Uptake of 200 JlM methionine by procyclic and bloodstream fonns was allowed 
to proceed for 60 minutes, with internalised radio label measured at set time points over 
the uptake period (Figure 3.1). The results showed an accumulation of methionine for 7 
minutes followed by a release of methionine to finally reach a plateau. Within the 
constraints set by the centrifugation through oil technique it appeared that uptake 
remained linear during this initial phase. To measure the kinetics of initial velocity 
transport, a 10 second time period was chosen to measure transport as a function of 
substrate concentration. 
Kinetics of methionine uptake 
Measuring initial velocity of methionine transport versus substrate concentration 
for procyclic (figure 3.2.A) and bloodstream fonns (figure 3.2.B) revealed the process to 
fit a typically hyperbolic curve. Taking data points from the curve of the hyperbola, non-
linear regression was used to detennine a Km value of 30.9 ± 7.6 JlM and a V m8ll value of 
16.2 nmol minot (l08 cellsr· for procyclic fonns and a Km value of32.8 JlM ± 3.4 and a 
V m8ll of 28.8 ± 0.1 nmol minot (10 8 cellsrt. 
The thennodynamics of the transporter were also studied, measuring the activity 
of the transporter over a range of temperatures. The accumulation of radio labelled 
methionine was dependent upon temperature with temperature quotients Q)O of 2.22 for 
procyclic fonns and 2.43 for bloodstream fonns respectively. The activation energy was 
detennined by linear regression from the negative slope of the Arrhenius plot. Apparent 
E. values of 54.2 Kj mol' 1 and 63.4 Kj mol' 1 were found respectively for procyclic and 
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Figure 3.1: Time course of methionine uptake in procyclic and bloodstream forms of 
Trypanosomabrucei. Methionine transport was measured in the presence of 200 ~M methionine at 25°C 
for a range incubation time varying from 5 seconds to 60 minutes. Panel A) Time course for procyclics, 
Panel B) Time course for bloodstream forms. 
75 




..:.: 0.2 ~ 
§-~ .~ 8 0.16 ~oo 
~~ 















Q.l,gj .~ 8 0.15 
~"'b §3 





o 20 40 60 80 100 120 140 
L-Methionine [J.1M] 
Fig 3.2: L-Methionine uptake in T. brucel. Methionjne transport was measured in the presence 
of various methionine concentrations at 25° C and at 37°C for the bloodstream forms. Kinetic constants 
were determined by non linear regression anaJysis using the Michaelis-Menten equation. Panel A) Kinetic 
of methionine uptake in procyclic forms, B) Kinetic of methionine uptake in bloodstream forms. 
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Fig 3.3: Arrhenius plot for L-methionine transport in procyclic and bloodstream forms of T. 
brucei. The rate of L-methionine (200 ~M) transport was measured over a range of temperatures from SoC 
to 35°C. The Ln of the velocity was plotted versus the inverse of the absolute temperature in Kelvin. The 
results represent the mean of six points over two experiments. Panel A) Arrhenius plot for procyclic forms, 
Panel B) Arrhenius plot for bloodstream forms. 
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3.2.2. Specificity of the methionine transporter 
In order to test the specificity of the transporter, zero-trans uptake of 
radiolabelled methionine was measured in the presence of non-radiolabelled amino acids 
using a ratio of [14C] methionine lunlabelled amino acid of 1/625 to test for inhibition 
(Table 1). In the case of procyclic form organisms this vast excess of D,L-homocysteine, 
L-Ieucine, L-phenylalanine, and L-tryptophan inhibited methionine transport by more 
than 50%, while other amino-acids did not. To distinguish between "weak" or "partial" 
inhibition rv an Winkle, 1999) amino-acids which inhibited total methionine uptake by 
more than 50% in procyclic form organisms were tested over a range of concentrations. 
In each case these amino acids gave a progressive dose-dependent inhibition to beyond 
90% indicating that inhibition was weak and not partial (Fig. 3.4). 
The same amino-acids which were the best inhibitors of methionine uptake in 
procyclic forms also were among the best inhibitors in bloodstream forms, however, 
other amino-acids e.g. D-methionine, L-isoleucine and L-glutamine also inhibited by 
over 50% in bloodstream forms. 
The combined data give information on the structure-activity relationship of the 
transporter (Table 3.1). D, L-homocysteine inhibited methionine uptake substantially 
better than L-cysteine which indicates that the a-carbon should be separated from the 
sulphur group by two carbons. The fact that L-glutamine has a weak affinity for the 
carrier while L-asparagine has less, also supports this hypothesis. Sulphur or a similar 
electronegative group appears to be critical for high affinity binding. None of the charged 
amino acids had a substantial impact upon uptake indicating an affinity for neutral amino 
acids. 
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Table 3.1: Effect the amino acids on the uptake of L-methionine by procyclic and bloodstream forms 
of Trypanosoma brucel brucel. 
Percentage of uptake compared with control 
Procyclic forms Bloodstream forms 
None 100 100 
L-Alanine 84±5 59±5 
L-Arginine 91 ± 7 97±7 
L-Asparagine 97±8 78±9 
L-Aspartic acid 97±8 101 ± 1 
L-Cysteine 83 ± 5 65±4 
L-Glutamine 62±9 42±2 
L-Glutamic acid 104 ± 8 79±3 
Glycine 96±3 80±3 
L-Histidine 85 ± 11 72 ± 1 
L-Isoleucine 75 ±5 41 ± 5 
L-Leucine 40±2 30±5 
L-Lysine 90± 1 108 ± 3 
L-Methionine 8 ± 1 18 ± 4 
L-Pheny lalanine 45±2 51 ±2 
L-Proline 77±9 78 ±4 
L-Serine 64±8 66±7 
L-Threonine 113 ± 3 60±4 
L-Tryptophan 48 ±6 64±4 
L-Valine 85 ±2 82 ± 14 
D-L Homocysteine 25 ±9 16±2 
D-Methionine 69±3 48 ± 1 
DL-Methylcysteine 65 ±5 33 ±5 
L-Tyrosine is not soluble at the concentration of 5 mM in the conditions required for this experiment. 
Consequently inhibition of [14C] methionine uptake was not determined in the presence of tyrosine. 
Non radiolabelled amino acids were used at 5 mM and were added simultaneously with [14C] methionine 
(58 JlCi / Jlmol) at 8 JlM. 
The results represent the percentage of L-methionine uptake over a time period of 10 seconds against a 
control containing only 8 /lM ['4C] methionine. 
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Fig. 3.4 : Inhibition of [14 C] L-methionine uptake with phenylalanine. The uptake of 14C L-
methionine (811M) over 10 seconds was measured in the presence of cold L-methionine (dotted line) or L-
phenylalanine (solid line). The concentration range was from 1 flM to 10 mM for L-methionine and 62.5 
11M to 40 mM for L-phenylalanine. The percentage of methionine uptake was calculated against a control 
without unlabelled L-methionine or L-phenylalanine. 
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The core amino-acid structure appears to be essential since analogues consisting 
of the side chain alone, including 3-(methylthio )-acetic acid, ethyl methyl sulfide, 3-
(methylthio) propionic acid had no inhibitory effect (Table 3.2 and figure 3.5). Moreover, 
substitution of the carboxyl group of the amino acid with a hydroxyl group in 
methioninol, as well as the alteration of the amino group by a hydroxyl group in 2-
hydroxy-4 (methylthio) butanoic acid or with a hydrogen with methyl-4-(methylthio) 
butyrate also abolished the interaction. L-Ieucine had a weak inhibitory effect on uptake 
indicating that the presence of sulphur rather than a methyl group adds two orders of 
magnitude to uptake efficacy. Substitution of sulphur with selenium or with 
electronegative suI phone or sulphoxide groups indicated that it is conservation of 
electronegativity at this site rather than sulphur per se which is important. Addition of an 
extra methyl group at the end of the chain with ethionine had little impact on recognition. 
Methionine containing dipeptides were not recognized by the transporter and neither was 
• 
S-adenosylmethionine where adenosine is complexed to methionine at the sulphur atom. 
Homocysteine was recognised, but again high concentrations were required to inhibit 
methionine uptake indicating that the terminal carbon/methyl group is important in 
recognition. Azoxybacilin, a methionine analogue with antimicrobial activity (Aoki et 
01., 1995) containing an azoxy group in place of the single sulphur atom, had a limited 
inhibition against methionine uptake by the transporter. 
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Table 3.2: Inhibition (IC50) of L-methionine uptake by methionine analogs in procyclic and 
bloodstream forms of Trypanosoma bruce; brucei. 
Compounds IC 50 (IlM) 
Procyclic forms Bloodstream forms 
Methionine sulfoxide 77 ± 10 132 ± 20 
(CH3S0CH2CH2CH(NH2)C02H) 
Methionine sulfone 78 ± 12 108 ± 10 
(CH3S02CH2CH2C(NH2)HC02H) 
Selenomethionine 79± 6 62 ± 12 
(CH3SeCH2CH2CH(NH2)C02H) 
Ethionine 179 ± 24 125 ± 5 
(C2HsSCH2CH2CH(NH2)C02H) 
Azoxybacilin ND 775 ± 203 
(CH3NN(O)CH2CH2CH(NH2)C02H) 
Rates of uptake of 7 IlM methionine were plotted against the concentration of inhibitors using a range of 
concentration from 20 mM to \0 IlM except for selenomethionine from 2.5 mM to \0 IlM. 
Methyl 4 (methylthio) butyrate (CH3SCH2CH2CH2C02CH3), 2 hydroxy 4 (methylthio) butanoic acid 
(CH3SCH2CH2CH(OH)C02H), 3(methylthio) acetic acid (CH3SCH2C02H), 
Methioninol (CH3SCH2CH2CH(OH)CH20H), Ethylmethyl sulfide (CH3SCH2CH3), 3 (methylthio) 
propionic acid (CH3SCH2CH2C02H), S-Adenosyl methionine, Methionine-Glycine, Methionine- Glutamic 
acid are not inhibiting methionine uptake. ND means not determined 
Figure 3.5: Schematic structure of methionine. carbon atoms of are represented in grey, hydrogens in 
white, oxygens in red, nitrogen in blue and sulfur in yellow. The circle around the molecule represents the part of 
methionine irnoortant for the recolrnition bv the transoorter (based on the results shown table 3.2), 
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3.2.3. Ion dependence for methionine transport 
Transport studies were carried out in the presence of a selection of ionophores 
(Table 3.3) to determine whether co-transport of a counter ion was involved in uptake. 
Neither the sodium ionophore, monensin, nor ouabain, an inhibitor of the Na+-K+ 
ATPase, had a significant inhibitory effect on methionine transport. Incubation of the 
cells with valinomycin, (a K+ ionophore) and different proton ionophores including 
CCCP and FCCP or NEM (an inhibitor of the plasma membrane proton ATPase), 
inhibited transport in a dose dependent fashion in both forms of the parasite. The 
potassium ion electrochemical gradient is the principal component of the membrane 
potential in both forms of the parasite (Nolan and Voorheis,1991; De Koning and Jarvis, 
1997). Protons, migrating with this gradient, appear to be the most common counter ion 
used by trypanosomes for a number of transport processes (De Koning and Jarvis, 1997). 
The fact that both protonophores and plasma membrane potential dissipating reagents 
inhibit uptake indicate that the proton motive force contributes to methionine uptake. 
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Table 3.3: Effects of ionophores, thiol reagents, KeN and SHAM on the uptake of L-methionine 
on procyclic and bloodstream forms of Trypanosoma brucei brucei. 
Percentage inhibition compared to the control 
KCN 5mM 
2.5mM 
SHAM 25 J.lM 
12.5 J.lM 
6.25 J.lM 
CCCP 10 J.lM 
5J.lM 




Valinomycin 6 J.lM 
3~M 
1.6 J.lM 
Monensin 30 J.lM 
Ouabain 500 J.lM 
250~M 
Procyclic forms 
53 ± 1 
48±3 
16± 3 





58 ± 1 
68 ± 5 
46± 10 





19 ± 3 
Bloodstream forms 
16±6 
15 ± 9 
72± 7 






73 ± 8 
52±4 
54 ± 1 
44±4 




aND means not determined. A stock of cells was kept on ice and an aliquot was pre-heated at 25 degrees 
for the procyclic and at 37 degrees for bloodstream forms for 5 min in a heating block and then pre-
incubated at the same temperature in the presence of the inhibitor at the concentrations indicated in the 
table during 2 minutes except for valinomycin and SHAM incubated respectively 6 and 10 minutes before 
adding L-methionine at the concentration of 6 JIM. The results represent the percentage inhibition of L-
methionine uptake during 10 seconds compared with a control without any inhibitor. 
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3.3. Discussion 
Methionine is a relatively low concentration amino acid playing a key role in the 
metabolism of the parasite. Structurally, methionine is characterised by the presence of 
sulphur within an aliphatic side chain. In both forms of the parasite, methionine is 
transported using a relatively high affmity transporter (Km value around 30 ,uM), 
consistent with the abundance of this amino acid in plasma. 
There have been inconsistencies in the literature about the impact of various 
inhibitors on the proton motif force in bloodstream for trypanosomes (Viera, 1998). 
However, our inhibitor studies point to an involvement of both energy and protons in the 
uptake of methionine. Although this has not been verified using electrophysiological 
techniques it seems likely that the proton motive force also plays a role in methionine 
uptake into trypanosomes. 
The transporter for methionine in both bloodstream and pro cyclic form 
organisms, has similar kinetic constants, a similar substrate recognition profile and 
similar thermodynamic constants (Ea and QIO). 
To determine the specificity of the methionine transporter in procyclic T. bruce; 
uptake of methionine was measured in the presence the other amino acids. Of the 
nineteen amino acids only the aromatic ones (phenylalanine and tryptophan), isoleucine 
and glutamine demonstrated substantial inhibition of methionine transport. Similar but 
not identical results were obtained in bloodstream forms. It is not yet clear whether 
different transporters operate in the different forms or whether the differences in 
measured function are a result of the experimental protocols used. 
Inhibition of overall methionine transport by other amino acids was weak rather 
than partial. That is to say that total inhibition could be achieved provided sufficiently 
high concentrations of competitor were used. This indicates that these amino acids are 
probably poor substrates for a single, measured transporter, rather than potent inhibitors 
for one of multiple transporters. It is important to stress that inhibition of uptake of a 
labeled substrate by unlabelled competitors gives information only on the ability of that 
competitor to inhibit transport of the label. These data are often used to extrapolate 
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infonnation about the structure-activity relationship between transporter and substrate, 
however, caution should be exercised in interpreting these results. Hence the role, if any, 
that the methionine transporter plays in the transport of these other amino-acids remains 
to be detennined. 
Analysis of the recognition of the transporter with other amino acids and 
analogues of methionine revealed that most of the structure is critical for the recognition. 
The length of the side chain is also crucial to the recognition process. 
None of the cationic or anionic amino acids have any interaction with the 
transporter. The importance of the sulphur atom was further investigated by replacing it 
with other electronegative groups (selenomethionine, methionine sulphoxide or 
methionine sulfone). All of these analogues were recognised by the transporter with 
affinities in the same order as methionine itself. Substitution of a single sulphur by an 
azoxy group at this position with azoxybacilin, however, led to a dramatic reduction in 
affinity. 
A methionine transporter previously characterised in Leishmania tropica 
promastigotes (Simon and Mukkada, 1977) showed some similarities to the T. bruce; 
transporter measured here. An apparent Km value of 33 f.lM was measured and in 
addition to L-methionine the L. tropica transporter also had some affinity for D-
methionine. L-Ieucine, and L-ethionine. However under the conditions used the aromatic 
amino acids, L-tryptophan and L-tyrosine, did not significantly inhibit the uptake of 
methionine, unlike in trypanosomes. 
Methionine transport has also been characterised in various other systems. The 
yeast Saccharomyces cerevisiae possesses at least three transporters for methionine 
including a high affinity. high specificity methionine pennease (Mupl) (Km apparent 12 
f.lM) (lsnard et al .• 1993). In mammalian cells the situation is complex, with multiple 
transporters possessing affinity for methionine and other aliphatic amino acids (Mcgivan, 
1996). The fact that the T. brucei methionine transporter does not appear to have high 
affinity for other amino-acids. as judged by the inhibition data presented here, indicates 
that transport of this amino acid differs markedly in trypanosomes and mammalian cells. 
The present study suggests that some flexibility in the recognition motif does 
exist for the T. bruce; methionine transporter. For example. other electronegative groups 
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Transport of aromatic and anionic amino acids in Trypanosoma 
bruce; 
Chapter IV: Transport of aromatic and anionic amino acids in T. bruce; 
4.1. Introduction 
Amino acid transporters which have a high affinity for substrate are of particular 
interest in this study. This chapter presents data on the uptake of the least abundant 
amino acids in human serum: aspartate, glutamate and the aromatic amino acids: 
phenylalanine, tyrosine and tryptophan (Brody et al. 1994). 
Glutamate is a precursor for proline, glutamine and arginine (Alberts et al., 1994). 
In mammals, serum levels are low (around 45 J..lM) (Brody et al. 1994), while the 
concentration of glutamate in the cerebrospinal fluid (CSF) is much higher at around one 
millimolar (Garattini, 2000). Glutamate is one of the main neurotransmitters in the brain 
and to date five mammalian glutamate transporters have been described (Kanai, 1997). It 
is also the precusor of another neutransmitter named y-Aminobutyrate (GABA) (Alberts 
et al., 1994). Aspartate is the least abundant amino acid in human serum, with a 
concentration below 10 J..lM (Brody et al.,1994). Structurally glutamate and aspartate are 
both negatively charged amino acids (at physiological pH) that differ in the presence of 
an additional carbon in the glutamate side chain. 
Phenylalanine, tyrosine and tryptophan are of similar abundance in human serum 
with a concentration of around 50 J..lM (Brody et al., 1994). In mammals phenylalanine 
and tyrosine are key amino acids in the synthesis of L-dopa and dopamine while 
tryptophan is the precursor of serotonin. Structurally, tyrosine is an analogue of 
phenylalanine and contains a hydroxyl group on the phenyl ring. Tryptophan is also an 
aromatic amino acid with the presence of an indole ring that distinguishes this amino 
acid from phenylalanine and tyrosine. 
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4.2. Results: 
A systematic study of each amino acid, involved the measurement of the rate of 
uptake and the substrate specificity of each transporter identified. 
The rate of uptake of L-phenylalanine, L-tryptophan, L-tyrosine, L- glutamate 
and L- aspartate was measured in bloodstream forms over a lOs time period as a function 
of the number of parasites. 
Substrate specificity was determined by measuring uptake of radio labelled amino 
acids in the presence of an excess of each of the other amino acids. The results were 
expressed in percentage of uptake compare to a control containing only the radiolabelled 
amino acid. 
4.2.1. Aspartate 
Kinetics oj transport 
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Figure 4.1: Inhibition of L-e 4C)aspartaLe uptake with non-labeled aspartate. TIle concentration 
range was from 1 I-lM to 10 mM. The percentage of aspartate uptake was calculated against a control 
without unlabelled aspartate. 
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The uptake of radio labelled aspartate was not inhibited by an increased 
concentration of non radio labelled aspartate, indicative of the absence of a transport 
phenomenon for this amino acid detectable with the conditions used. 
4.2.2. Glutamate 
Kinetics of transport 
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Figure 4.2: L eH) glutamate uptake in T. b. bruce; bloodstream forms. Rate of glutamate 
uptake was measured in a concentration range between 7.8 11M to 250 flM. 
Investigation of glutamate uptake revealed the presence of a low affinity 
transporter with an apparent Km value calculated at 158 ± 30 JlM and a Vm value at 30 
± 5 pmoles/s/lxl08ceUs. Kinetics in ranges of concentration from 350 JlM to 10 mM 
and below 10 JlM did not reveal the presence of any other transporters. 
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Figure 4.3: Inhibition of L-eH)glutamate uptake by non radiolabelled amino acids in 
bloodstream forms of T. b. bruce;. The uptake of 150 nM of L-e H) glutamate was measured in the 
presence of 5 mM of non radiolabelled amino acids. The results represent the percentage of L-glutamate 
uptake over a time period of lOs against a control containing only 150 nM of eH)glutamate. 
Glutamate uptake in bloodstream fonns was strongly inhibited (90%) by 
glutamine and tyrosine and more weakly (70%) by glycine, leucine, methionine and 
serine. Two amino acids, arginine and asparagine, actual1y increased glutamate uptake 
when used in a vast excess. 
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Figure 4.4. L- eH) phenylalanine uptake in T. b. brucei bloodstream forms. Rate of uptake 
was measured in the presence ofa range of concentration from 3.9 ~M to 125 ~M (panel A) and 0.325 ~M 
to 1 0 ~M (panel B). 
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Measuring initial velocity of phenylalanine as a function of concentration using 
different ranges of concentration revealed the presence of at least two transporters of 
high and relatively high affinity. The apparent Km and Vm values were calculated at 
3.2 ± 1.3 JlM and 16.8 ± 1.3 pmoles /s/ 1xl08 cells for the high affinity transporter and 
at Km at 36 ± 9 JlM and Vmax at 94 ± 10 pmoles/s/lx108 cells for the relatively high 
affinity transporter. 
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Figure 4.5: Inhibition of L-eH) phenylalanine uptake by non radiolabelled amino acids in 
bloodstream forms of T. b. brucei. The uptake of 42 nM of L- eH) phenylalanine was measured in the 
presence of 5 mM of non radio labelled amjno acids. The results represent the percentage of L-
phenylalanine uptake over a time period of lOs against a control containing only 42 nM of eH) 
phenylalanine. 
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Since more than one transporter is contributing to the overall measured uptake, these 
results can not be interpreted as indicating substrate specificity of an individual 
transporter. Among the different amino acids tested for their effect on phenylalanine 
uptake leucine, methionine, and tryptophan were the most potent inhibitors. A weaker 
inhibition was observed with serine and tyrosine. 
Methionine was shown to be a good inhibitor of phenylalanine uptake, therefore 
various analogues of L-methionine were also tested for inhibitory activity against 
phenylalanine uptake. 
Methionine analogues 
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Figure 4.6.: Inhibition of L-eH) phenylalanine uptake by non radiolabelled methionine 
analogs in bloodstream forms of T. b. bruce;. The uptake of 42 nM of L- eH) phenylalanine was 
measured in the presence of 5 roM of non radiolabelled methionine analogs. The results represent the 
percentage of L-phenylalanine uptake over a time period of lOs against a control containing only 42 nM of 
eH) phenylalanine. 
Phenylalanine uptake in bloodstream fonn trypanosomes is strongly inhibited by 
L- ethionine and homocysteine. The inhibition by methionine was stereospecific for the 
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L fonn of the amino acid. Methionine sulfoxide and methionine sulfone gave relatively 
weak inhibition of L-phenylalanine uptake. 
Phenylalanine analogues 
i L-phenylalanine 





~ DL-hydroxylactic acid ell 
Q) 







0 20 40 60 80 100 120 140 
Percentage of(3H) phenylalanine uptake 
Figure 4.7: Inhibit ion of L- eH) phenylalan ine uptake by non rad iolabelled phenyla lanine 
analogues in bloodstream forms of T. b. brucei. The uptake of 42 nM of L- eH) phenylalanine was 
measured in the presence of 5 roM of non radio labelled phenylalanine analogues. The results represent the 
percentage of L-phenylalanine uptake over a time period of lOs against a control containing only 42 nM of 
CH) phenylalanine. 
The uptake of phenylalanine is strongly (76%) inhibited by L-dopa while no 
significant inhibition was observed in the presence of dopamine. Hydroxylactic acid 
apparently stimulates phenylalanine uptake. 
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4.2.4. Tryptophan 
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Figure 4.8.: L-eH) tryptophan uptake in bloodstream forms of T. b. brucei. Rate of L-
tryptophan uptake was measured over a range of concentrations from 0.315 IlM to IO IlM (panel A) and 
from 15.6 IlM to 250 IlM (panel B) and from 62.5 IlM to 2 mM (panel C). 
Measurements of tryptophan uptake in a range of concentrations between 0.315 
/-lM and 2.5 mM revealed the presence of three distinct transporters of high and 
relatively high affinity and low affmity. The apparent Km values were calculated 
respectively at 1.7 ± 0.4 J.lM and 43 ± 17 J.lM and 867 ± 34 J.lM the maximal rates of 
uptake at Vm 3.2 ± 0.3, 22 ± 3 pmoles/s/lxl08 cells and 241 ± 43 pmolcs/s/1x108 cells. 
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Specificity of tryptophan transport 
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Figure 4.9: Inhibition of L-eH) tryptophan uptake by non radiolabelled amino acids in 
bloodstream forms of T. b. brucei. The uptake of 250 nM of L- eH)tryptophan was measured in the 
presence of 5 rnM of non radio labelled amino acids. The results represent the percentage of L-tryptophan 
uptake over a time period of lOs against a control containing only 250 nM of eH)tryptophan. 
None of the amino acids tested significantly inhibited tryptophan uptake with the 
exception of tryptophan itself. 
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4.2.5. Tyrosine 
Kinetic of transport 
60 
o 
o 20 40 60 80 100 120 140 
Tyrosine ijJM] 
Figure 4.10: LeH) tyrosine uptake in T. b. brucei bloodstream forms. L-tyrosine rate of 
uptake was measured in a range of tyrosine concentration from 4.2 IlM to 135 IlM. 
Due to the presence of an additional hydroxyl group on the phenyl ring, tyrosine 
solubility in water is reduced compared to that of phenylalanine, and the highest 
concentration tested was 135 J,lM. Over a tyrosine concentration range of 4.2 J,lM to 135 
J,lM, a single relatively high affinity transporter was identified. The apparent Km and 
Vm values were respectively determined at 55 ± 20 J,lM and 37 ± 6 pmoles/s/lxl08 cells 
respectively. 
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Figure 4.11 : Inhibition of L- eH) tyrosine uptake by non radiolabelled amino acids in 
bloodstream forms of T. b. brucei. The uptake of 98 nM of L- eH) tyrosine was measured in the presence 
of5 mM of non radiolabelled amino acids. Tbe results represent the percentage ofL-tyrosine uptake over a 
time period of lOs against a control containing only 98 oM of L- CH)tyrosine. 
Tyrosine uptake in bloodstream fOnDS of T brucei was inhibited at around50% by 
alanine, glutamine, histidine, isoleucine, tryptophan and strongly inhibited (80% 
inhibition) by leucine, methionine and phenylalanine. 
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4.3. Discussion. 
Bloodstream form trypanosomes have the ability to transport glutamate, 
phenylalanine, tryptophan and tyrosine while uptake of the anionic amino acid, aspartate, 
was apparently not carrier mediated. An illustration of the transporters identified is 





















~,.. pmoleslsl ~ lxlOSceUs 




::():: 158 J.lM 




-4....J-- 1x108 cells 
--f\-- 241 pmoleslsl 
~lxl08cells 
Figure 4.]2: Schematic representation of the transporters identified for L-aspartate, L-glutamate, 
L-phenylalanine, L-tryptophan and L-tyrosine in the bloodstream form of T brucei. Panel A) represents 
the Km values of the transporters, Panel B) represents the Vmax values. 
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Phenylalanine and tryptophan, have been found to use at least two routes of 
entry while a single high affinity transporter was identified for tyrosine. In this study, the 
term "high affinity" is used for Km values below 30 ,....M, ''relatively high affinity" for Km 
values between 30 and 100 ,....M and "low affinity" for Km values above 100 ,....M. 
Analysis of the different inhibition profiles of uptake of glutamate, 
phenylalanine, tryptophan, tyrosine and methionine presented in Chapter III allows a 
tentative hypothesis to be presented in which some amino acids share the same 
transporter. 
Phenylalanine uptake was inhibited by leucine, methionine, tryptophan, and the 
uptake of methionine is inhibited by phenylalanine. This suggests that phenylalanine and 
methionine could share the same transporter. The inhibition of phenylalanine uptake by 
methionine is stereospecific towards the L form of methionine. Methionine transport has 
also been shown to be stereospecific (c.f. Chapter III). Moreover, methionine analogues 
that inhibit methionine uptake also inhibit phenylalanine uptake, reinforcing the 
hypothesis that methionine and phenylalanine share the same transporter. 
Phenylalanine uptake was significantly inhibited by L-dopa but not by dopamine 
which suggests that the integrity of the motif defining an amino acid is essential for the 
substrate recognition (as it has been shown for methionine uptake). 
Glutamate weakly inhibits methionine uptake but methionine strongly inhibits 
glutamate uptake. Phenylalanine uptake is inhibited by tryptophan while tryptophan 
uptake is not inhibited by phenylalanine. 
The lack of reciprocal inhibition profiles between glutamate and methionine 
may seem inconsistent. However, an explanation for this phenomenon lies in the 
mechanism of transport itself as discussed in the work of Deves and Krupka (detailed in 
part 2.2.2 of chapter I). The mechanism of transport involves a series of events. These 
include the binding of the substrate to the exofacial site of the transporter, the 
translocation of the transporter/substrate to the endofacial site, the release of the substrate 
and the reorientation of the empty carrier to the exofacial site. Thus, the rate of uptake of 
a substrate measured by kinetic experimentation is a sum of the rates of these different 
steps. Considering, as an example, a transporter and two its substrates named A and B. 
The rate of reorientation of the carrier from the endofacial to the exofacial site after the 
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release of A or B is the same because the carrier is empty. However the rate of 
translocation of the carrier when A is substrate can be different from the rate of 
translocation of B depending on the strength of the binding forces of the substrate with 
the transporter. The fact that the rate of translocation of these two substrates by the same 
transporter is different will necessarily lead to a difference in the percentage of inhibition 
of the uptake of one by the other. In the case of methionine and phenylalanine uptake the 
rate of methionine uptake is 12 times higher than the "high affinity" phenylalanine 
transporter and twice as fast as the "relatively high affinity" phenylalanine transporter. 
This means that measuring the inhibition of methionine uptake by phenylalanine or 
measuring the inhibition of phenylalanine uptake by methionine does not give the same 
profile of inhibition because the carrier is faster in the translocation of methionine than in 
the translocation of phenylalanine. 
Although inhibition experiments have been extensively used to characterize the 
substrate specificity of various transporters, there are serious limitations to the 
interpretation of these data. A molecule able to significantly inhibit the uptake of a 
particular substrate is a candidate for being a substrate for this transporter (although this 
should then be proven directly with radiolabelled substrate). However, a molecule that 
does not inhibit, or is a weak inhibitor, can not necessarily be excluded from being a 
potential candidate for this transporter. 
The hypothetical model that can be suggested in the context of the inhibition 
profiles obtained for the different amino acids is that: methionine, phenylalanine, 
tyrosine and glutamate could share the same transporter. But it is difficult at this stage to 
draw any definitive conclusion which of the multiple phenylalanine or tryptophan 
transporters would be involved in the uptake of methione, tyrosine and glutamate. 
This model is hypothetical and a definitive answer to the substrate specificity is 
unlikely to come from a biochemical approach alone. The identification and the 
expression of the genes encoding these transporters, one by one, will be a key step in this 
direction. The biochemical approach has, nevertheless, given a broad view on the uptake 
of these amino acids in the bloodstream forms of the parasite. 
104 
Chapter V 
Cloning and functional expression of TbAATPl, an amino acid 
transporter gene from Trypanosoma bruce;. 
Chapter V: Cloning and functional expression o(TbAATP I 
5.1. Introduction 
The functional expression of genes encoding amino acid transporters is a key 
step in studying amino acid transport in T. brucei. Two approaches have been undertaken 
in attempts to achieve this aim: a yeast complementation approach and the search of the 
T. brucei genome sequence databases. 
The yeast complementation technique involved the use of different strains of 
Saccharomyces cerevisae lacking the general amino acid permease gene (gap 1) as well 
as individual transporter genes. These were transformed with a T. bruce; DNA library in 
a yeast expression vector. 
Transfonnants were screened on selective media for complementation, which 
would allow the selection of transfonnants containing a plasmid bearing a T. bruce; 
sequence corresponding to an amino acid transporter gene provided that the gene is 
expressed. This yeast complementation approach has been used to identify numerous 
plant amino acid transporter genes and in trypanosomes the cloning of the TbAT] 
nucleoside transporter gene was also identified with such an approach (Maser et al., 
1999). 
As a second approach the T. bruce; genome databases were periodically 
searched at TIGR and the Sanger center using the sequences of amino acid transporter 
genes from other organisms. The investigation of the databases led to the identification of 
a putative amino acid transporter gene and the yeast complementation approach was then 
abandoned. The gene found was named TbAATPl which stand for Trypanosoma bruce; 
Amino Acid Transporter 1. 
This chapter presents the identification and molecular characterisation of 
TbAATP] and its functional characterization in Xenopus laevis oocytes. 
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5.2. Results 
5.2.1. The identification of TbAA TPI: 
TbAATPI was identified using the TIGR End Sequences Database and the 
sequence of an amino acid transporter gene from Arabidopsis thaliana. The first 
sequences encompassing the putative amino acid transporter were 23MII, 16C II , 42120 
rev and 16C II. These sequences were then assembled using the ContigExpress program 
from the Vector NTI suite. The assembled fragment was 2155 bp in length. An open 
reading frame (ORP) based on the presence of an ATG start codon and TGA stop codon 
was identified within the fragment. The ORP of 1404 bp is shown figure 5.1. 
TbAATP1 
23M1~37 II. 2155 (colllP1emenlarv) 
f '20 Ie- 1338 Ii 2078 (compJ~) 
lfiC11 IE' 1082..«.1683..(comp'fme ntary) 
f 2t20 IE' 520 n 1160 > 
~ 6C11 IR 1 u 660 > 
600 11 000 11 500 
Figure 5.1: Illustration of a contiguous sequence formed by five overlapping sequences 
16CII.TR, 16CII.TF, 42120.TR, 42120.TF and 23MIl.TR from the T. brucei genome project. The open 
reading frame corresponding to TbAATPI is indicated by a blue arrow. 
TbAATPI was amplified by the polymerase chain reaction using Plu polymerase 
from T. brucei 927 genomic DNA using primers upstream and downstream of the open 
reading frame. The PCR product was sub-cloned into pGEM-T vector and sequenced. 
The nucleotide sequence obtained differed only at one nucleotide from the sequence 
obtained from the database which had no effect on the amino acid translation (Figure 
5.2). 
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M T S I N A Q P P N S A T y P R o 0 H G s A E A G 
1 ATG ACC AGe ATC AAT GeC eM CCA CCC AAC TCA GeC ACT TAT CCT CGG GAT GAT CAT GGC AGe GCA GAA GCT GGG 
QANAEVERPQTKKQKDGGGCFARVS 
76 eM GeG AAT GeT GAG GTG GAA CGe CCA CAG ACA AAA AAA CAG AAA GAT GGT GGT GGT TGe TTT GeC AGG GTG AGT 
LFMATIIPPGGIAASAFNIGSTT G 
151 CTA TTT ATG GCA ACT ATC ATe CCA CCG GGA GGT ATC GCC GCA AGT GeC TTC AAC ATC GGA TCA ACT ACC ATT GGT 
A G I F G L P A A A N SSG L V M A M I Y L I I I 
226 GeC GGC ATT TTT GGC TTG CCA GCA GeC GeC AAC AGe AGT GGG CTT GTG ATG GeG ATG ATT TAT CTT ATT ATC ATT 
TAM T IF SlY A L G V AA E R TN I R T Y E G 
301 ACC GeC ATG ACT ATT TTC TCC ATA TAT GeT CTT GGT GTe GCC GeT GAA AGA ACA AAC ATT CGT ACA TAC GAA GGA 
V A R ALL G P W G A F C T A A ART F F C r S A 
376 GTT GeC CGT GCA CTA CTG GGT CCA TGG GGT GCA TTT TGe ACT GeT GCA GeC CGT ACT TTC TTC TGe TTT AGT GeR 
C V A Y V I S V G 0 I L SAT L K G T NAP 0 F L 
451 TGT GTG GCA TAT GTG ATT TCT GTG GGT GAT ATC CTG AGT GCT ACC TTA AAG GGT ACC AAT GCC CCT GAT TTC CTG 
K Q K S G N R L L T S L M W L C F M L P L V I P R 
526 AAG CAG AAG TeA GGC AAC CGG CTA TTG ACA TCC CTC ATG TGG TTA TGe TTC ATG CTT CCA CTT GTA ATA CCT CGG 
HID S L R Y V S T I A F S L M I Y V V V V V V V 
601 CAe ATT GAC TCC CTA CGT TAT GTT TeA ACC ATe GCA TTC AGe CTC ATG ATA TAT GTT GTG GTT GTA GTG GTG GTG 
H S C M N G L P E N I K N v s v G K o 0 N A E 
676 CAe TCA TGC ATG AAT GGG TTA CCG GAA AAT ATC AAG AAC GTC AGT GTG GGA AAG GAT GAC AAT GeT GAG ATT ATA 
L F N S G N R A lEG L G V F I F S Y L F HIT A 
751 TTG TTT AAC AGT GGG AAC AGA GeC ATC GAA GGT CTT GGG GTG TTC ATC TTT TCC TAT CTT TTT CAT ATT ACC GeG 
Y E V Y M D M T N R S V G K r v L V V T I A M G M 
826 TAT GAG GTC TAT ATG GAC ATG ACA AAC CGT TCG GTG GGT AAG TTe GTT CTG GTT GTC ACC ATT GeG ATG GGT ATG 
C L PlY A L TAr F GYM 0 F G R N V T G S V L 
901 TGT CTT CCC ATT TAT GCA CTG ACA GeC TTC TTT GGT TAC ATG GAT TTT GGT CGe AAC GTT ACC GGC TeT GTG CTC 
L Q Y 0 P V N Y P A I M V G r v G V L V K L C V S 
976 CTA CAG TAC GAC CCT GTG AAC TAC CCA GeG ATT ATG GTe GGT TTC GTT GGT GTG CTC GTC AAG CTA TGe GTA TCG 
Y ALL G LAC RNA L Y 0 V I G W 0 r REV A F 
1051 TAT GCA CTT TTG GGA TTG GCT TGC CGe AAT GeG CTG TAT GAT GTe ATC GGG TGG GAC TTC AGA GAG GTT GeC TTC 
W K H C I A V V T L S V V M L L C G L F P KIT 
1126 TGG AAG CAT TGe ATT GeC GTe GTT ACT CTC TeT GTC GTC ATG TTG CTG TGT GGC TTA TTC ATC CCC AAA ATC ACA 
T V F G F A G S I S G G L L G r I L P A L F r M Y 
---------------------------------------------------------------------------------------------------
1201 ACC GTA TTC GGA TTC GeT GGT TeC ATC TeT GGT GGA TTG TTG GGT TTC ATT CTT CCT GCG CTA TTC TTC ATG TAT 
S G G F T W Q K V G P F Y Y STY V L LIT G V 
1276 TCT GGT GGC TTT ACG TGG eM AAG GTT GGT CCC TTT TAT TAC ATT TCC ACT TAT GTT CTA CTG ATC ACA GGT GTT 
I A A V r G T GAT I W A V T V G • 
1351 ATe GCA GeC GTA TTT GGC ACA GGT GeT ACC ATT TGG GCA GTT ACT GrG GGA TGA 
Figure 5.2: TbAATPJ nucleotide sequence. The nucleotide sequence was obtained by sequencing 
of the peR product of the putative gene cloned into a pGEM-T vector. The predicted am ino acid sequence 
is indicated above the nucleotide sequence. 
108 
Chapter V: Cloning and functional expression o(TbAA TP I 
The predicted amino acid sequence of TbAA TP I was then probed against the 
general databases using a tBlastN search at NCB!. Significant homology scores were 
found with amino acid transporters from various organisms, among which the highest 
levels of homology were with mammalian amino acid transporters. 
AF075704 Rattus norvegicus neuronal glutamine transporter, score 2e-28 
AF298897 Homo sapiens amino acid transporter system A, score 2e-24 
NM006841 Homo sapiens system NI glutamine transporter, score l e-17 
Figure 5.3: Results of a tBlastN search at NCBI for TbAA TPI homologues. 
5.2.2. Predictive structural Analysis ofTbAA TPI 
Hydropathy analysis 
Transporters are transmembrane proteins consisting of helices of hydrophobic 
amino acids which are connected by loops of hydrophilic amino acids. The loops can be 
of variable length, however for amino acid transporters the number of helices varies 
generally between ten and twelve. The number of transmembrane domains can be 
predicted using software based on the detennination of hydrophobic regions. The 
predicted amino acid sequence of TbAATPl was analyzed using Kyte-Doolittle and 
TMpred hydropathy analysis programs. Eleven transmembrane domains were predicted 
by both algorithms (Figure 5.4). Four putative glycosylation sites, based on the presence 
of a consensus sequence Asn-Xaa-Ser/Thr and the predicted folding of the protein were 
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100 400 
Figure 5.4: Hydrophobicity plot of TbAA TPt. A Hydrophobicity plot of TbAA TP I was 
constructed based on Kyte-Doolittle hydropathy analysis. Hydophobic peaks corresponding to putative 













Putative N- glycosylation 
~itp. 
Figure 5.5: Schematic representation of the predicted topology of TbAATPJ. The topology 
was predicted by a Kyte-Dolittle hydropathy analysis including an extracellular N terminus and II 
transmembrane domains. Blue circles represent each individual amino acid. Amino acids bearing a red 
label represent putative glycosylation sites. 
The amino acid sequence alignments of TbAA TP 1 with the mammalian amino 
acid transporter sequences reveals 11.1 % of identity with conserved regions scattered 
along the sequence (Figure 5.6). 
110 
TbAATP1 
System N [B . sapiens] 
System N [M . musculus] 
System A1 [B . sapiens] 
System A [R . norveqicus] 
TbAATP1 
System N [B . sapiens) 
System N [M . musculus] 
System A1 [B . sapiens) 
System A [R. norvegicus] 
TbAATPl. 
System N [B . sapiens) 
System N [M . musculus] 
System A1 [B . sapiens) 
System A [R. norvegicua] 
TbAATP1 
System N [B . sapiens] 
System N [M. musculus] 
Sy.tam A1 [B. sapiens) 
System A [R . norvegicus] 
TbAATP1 
System N [B. sapiens) 
System N [M . musculus] 
System A1 [B . sapiens) 
System A [R. norveqicus] 
TbAATP1 
System N [B . sapians) 
System N [H . musculus] 
Sy.tam A1 [B . sapiens) 
System A [R . norveqicus) 
TbAATP1 
System N [B . sapiens) 
System N [H . muscul.us) 
System A1 [H . sapiens] 
System A [R . norvaqicus] 
TbAATP1 
System N [R . sapiens] 
System N [H . musculus] 
System Al. [H . sapiens] 
System A [R . norveqicus) 
TbAATPl 
System N [H. sapiens] 
System N [H. musculus] 
System Al [H . sapiens] 
System A [R . norvaqicua] 
TbAATPl 
System N [H . sapians) 
System N [H. musculus] 
System A1 [H. sapiens] 
System A [R. norvegicus] 
TbAATP1 
System N [H. sapiens] 
System N [H. musculus] 
System A1 [H. sapiens] 





















Chapter V: Cloning and functional expression o[TbAATP I 
----------HE INAQISATYp~BGSAEVVNLNAEVE -- RPQPR E 
-----Ht PLQ MVEL KBSE LPVIT IMAGN E VEDPARSCM E G 
-----H IPRQ MVEL KBLE LPVGV~TDT TED - TQBCG E G 
HHBFKSGLELTELQNHT DDNISN NDFTEVENG INSKFISDR - RS 
--MKKT IMGRFNISPDEOSSSYSSN NYSY~KQAALKSBYVDVDP RN 
1M I 




.:c:Jllll"- _c-~ET HV YI: K QV f; G 




































-!!:~!~;~~;~;~;~~;;Ie~~~~;;;------AEII S.GNRAIIEG~IG BNLANATGNFSHMVVAEE~QLQGEPD I 
ELNSTIS---------------ANSTN L 
VALHANETVNGTFTQVALAALASNSTA IF V 
1M6 TM7 
VG I LI HGMCLPHT AL TAF roy 
S KK I IAVI I HT OY 
S KR I IAV V~Y GT 
QK FA VHY TAl rGY 
RRR N FA LHT L L OY 
HD F GRN VTGSVL LQ lC D 
I;v~.-r. 
-~AVT~~--;---; Il s~IH'H Y CSS SOE -
L HOA G --
Figure 5.6: Amino acid sequences alignments of mammalian system A and N with 
TbAATPl. The predicted amino acid sequence of TbAATPI was aligned with system N and system A 
from Homo sapiens and Rattus norvegicus based on the ClustalW algorithm. The positions of predicted 
transmembrane domains for TbAA TPI are indicated by the solid lines above the sequence. Identical amino 
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Predictive structural analysis of TbAATPl along with sequence similarity to 
other amino acid transporters indicates that this sequence presents features of an amino 
acid transporter. However, this assumption needed to be assessed by functional 
expression. Xenopus laevis oocytes were chosen as an expression system. 
5.2.3. Functional expression of TbAATPl in Xenopus laevis oocytes. 
Gurdon et al. (1976) first demonstrated the possibility of using of Xenopus 
oocytes as a heterologous expression system, showing that oocytes injected with rabbit 
globin mRNA were able to synthesized a large amount of globin. Xenopus laevis oocytes 
have been used extensively for functional expression of a variety of membrane transport 
proteins. These include numerous mammalian amino acid transporters as well as several 
T. brucei transporters including glucose and nucleoside transporters (Barrett et al., 1995, 
Sanchez et al., 1999). TbAATP 1 was cloned into the pSPGTI vector which was designed 
for in vitro transcription of genes for oocytes expression. A capped cRNA was obtained 
by in vitro transcription and the RNA produced was then micro-injected into the oocytes. 
The oocytes were incubated for at least three days after injection before being assayed for 
transport using radiolabelled amino acids. 
Determination ofTbAATP 1 substrate specificity 
To determine the substrate specificity of TbAATP1, a pilot experiment using 
radio labelled amino acids was performed in order to determine which amino acids could 
be substrates for TbAATPl. The uptake of e4C)L-leucine, e4C)L-isoleucine, eH)L-
tryptophan, e4C)L-methionine, e4C)L-phenylalanine, eH)L-glycine, e4C)L-aspartate, 
eH)L-glutamate and e4C)L-arginine and e4C)L-tyrosine was measured in mRNA 
injected oocytes and compared to control oocytes. The results are shown figure 5.7. In 
this pilot experiment L-glutamate was the only amino acid to give an uptake significantly 
higher in the TbAATPl RNA injected oocytes compared to the controls indicating that 
glutamate was a substrate for this transporter (Figure 5.7) 
112 




tU ~ 0 
~'§ 3000 §"'§ 3000 0 g.. !~ .~ 8 0 0 0 0 ~~ 8 ~ 0 2000 2000 0 
'""'>- 0 ....':l g ::r:: g 0 0 
1::~ 0 53'~ 
o 0.. B ~ 0.. Q::(o B~ 1000 o~ 1000 ~ B ~ 
0 0 




tU 8000 0 ~ 
~ §" 200 • jl g.'§ 0 §. • 6000 0 
-ao 0 0 0 e~ 150 r .9~ 0 .B~ 8 ~~ • 0..0 0 
I 0 4000 ...J 0 0 ~ 0 G~ 100 ~~ 0 ~ 0.. 0 ~o.. - 0 
t...,. 0 4:;"~ 0 0 
o~ 0 
B 2000 ~ 50 ~ 
0 0 
0 1 2 0 1 2 
Group Group 
Figure 5.7: Pilot experiment measuring the rate of uptake of eH)L- tryptophan, (14C)L_ 
phenylalanine, eH)glycine, eH)L-glutamate by TbAATPl injected oocytes (20ng /oocyte) (grey circles) 
compared to water injected controls (open circles) over a 30 min time period. 
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Figure 5.8: Pilot experiment measuring the rate of uptake of (14C)L-methionine, (14C)L_ 
aspartate, (14C)L-arginine and (14C)L-tyrosine by TbAATP I injected oocytes (20ngloocyte) (grey circles) 
compared to water injected controls (open circles) over 30 min time period. 
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Enhanced uptake of glutamate by TbAATP J injected oocytes was reproduced in 
five independent experiments as shown figure 5.9 and the uptake of radiolabelled 
glutamate could be inhibited by addition of 10 mM unlabelled glutamate. Glutamate 
uptake was also measured in T. brucei bloodstream forms where it was shown that 
glutamine and tyrosine were the most potent inhlbitors of glutamate uptake (c.f. Chapter 
IV, section 4.2.2). Although tyrosine did not give any positive result in the orig inal pilot 
experiment the uptake of eH) tyrosine and eH) glutamine was then measured in 
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Figure 5.9: Functional expression of TbAATPJ in Xenopus oocytes: Uptake of 100 IlCi/ml of 
eH) L-tyrosine (51 Ci/mmol), eH) L-glutarnate (33 Cilmmol) or eH) L-glutarnine (49 Ci/mmol) by 
TbAATPI injected oocytes (20 ng/oocytes) (dark grey) or water injected oocytes (light grey) was measured 
for 30 min. Each time point is an average for four individual oocytes. (**, P<O.OI , Dunnet's multiple 
comparison test). 
In conclusion L-glutamate, L-glutamine and L-tyrosine are transported by TbAA TP 1. 
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TbAATP1 substrate specificity was further examined by measuring tyrosine 
uptake in the TbAATP I injected oocytes in the presence of 5 mM of non radiolabelled 
amino acids. The results presented in figure 5.10 revealed that tyrosine transport was 
strongly inhibited by L-phenylalanine and L-leucine. A weaker inhibition was observed 
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Figure S.IO: Substrate specificity profile of TbAA TPI mediated transport. Uptake of 40 nM 
of eH)L-tyrosine by TbAATPI injected and control oocytes was determined over a 30 min time period in 
the presence of 5 mM of each amino acid. Tyrosine is insoluble at 5 mM and was used at 100 11M. Results 
are expressed as a percent of uptake compared with tyrosine uptake in the absence of amino acids. C .... , 
P<O.O I, ... , P<0.05; Dunnet's multiple comparison test). 
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Kinetics of tyrosine uptake in TbAA TP 1 injected oocytes. 
L-tyrosine appeared to be the preferred substrate for TbAATPI hence the kinetics 
of tyrosine uptake were measured in the presence of an increasing concentration of 
tyrosine in TbAA TP 1 injected oocytes and compared to the control oocytes. The results 
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Figure 5.11: Kinetics of L-tyrosine uptake mediated by TbAATPI. Uptake of eH)L-tyrosine 
by injected oocytes was determined over a 30 min time period using a range of concentrations from 3. 125 
IlM to 100 IlM. The kinetic constants were determined by non linear regression analysis using the 
Michaelis-Menten equation . 
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5.2.4. Differential expression of TbAATP 1: 
The level of steadystate RNA from TbAATP 1, in different the life cycle stages of 
the parasite was examined by probing a Northern blot containing RNA from procyclic 
and bloodstream forms with TbAATP1 (entire ORF). The same blot was also probed with 
a J3-tubulin gene probe, which is constitutively expressed throughout the life cycle. The 
results shown figure 5. 12 indicate that TbAATP1 is expressed in bloodstream and 
procyclic form parasites. 





Figure 5.12: Northern blot analysis of RNA from T. bruce; (Pro: procyclic, SS: short stumpy, 
LS: long slender) was performed and probed with TbAATPI (entire ORF) and with ~ tubulin as a control. 
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5.2.5: Gene organization and localization: 
The chromosomal position of TbAA TP 1 was determined by probing a membrane 
of a gel on which chromosomes from T brucei had been separated by pulsed field gel 
electrophoresis. This work was done by the service offered by Dr Melville 's group at the 
T. brucei genome project (University of Cambridge). The results are shown Figure 5.13 







Figure 5.13: Pulse field gel electrophoresis of T. brucei chromosomal DNA probed with 
TbAATPJ. 
High stringency Southern blot analysis of T brucei genomic DNA digested with 
a restriction enzyme cutting once within the gene (Kpnl) displays two bands while DNA 
cut by ApaJ, EcoRI, BamHI, enzymes cutting outside the gene showed the hybrisation of 
only one band. This indicates that TbAATPl is a single copy gene. Low stringency 
Southern blotting was then used to look for the presence of other related sequences. 
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Figure 5.15 revealed the presence of multiple hybridizing bands indicative of the 
presence of a putative family of amino acid transporters. 
Probe 
2 





J- Kpnl (1 site) 
2 -EcoRl (0 site) 
3- BamHJ (0 site) 
4- Apar (0 site) 
Figure 5. 14: High stringency Southern blot analysis of T. bruce; genomic DNA digested with 
Kpnl (lane I), EcoRl (lane 2), BamHI (lane 3), Apal (lane 4) and probed with TbAATPI (entire ORF). A 
schematic representation of TbAATP J and its flanking regions is shown above the Southern blot. 
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1\ Figure S.JS: Low stringency Southern blot analysis of T. brucei genomic DNA digested with 
CI4!}Iane I), Hi III (I ne 2), Kp 1 lane 3), P I ( ane 4), Taq (ane 5) and probed with TbAATP I (entire 
ORF). A schematic representation of TbAA TP J and its flanking regions with the localisation of the 
restriction enzyme sites for enzymes used is shown above the Southern blot. 
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5. 3. Discussion 
A gene encoding an amino-acid transporter has been identified from 
Trypanosoma brucei. This gene, named TbAATP J, encodes a protein of 468 amino acids 
showing a strong degree of homology with mammalian amino acid transporters 
especially system A and system N. 
In terms of topological structure, predictions based on hydropathy plot analysis 
suggest the presence of 11 transmembrane domains in the TbAA TP 1 sequence. A similar 
topology has been described for mammalian system A (Varoqui et aI, 2000). Other 
similarities between system A and TbAA TP 1 include a long stretch of amino acids at the 
N terminus of the protein predicted to have a cytoplasmic localization, a long loop 
between transmembrane domains five (TM5) and TM6 and a very short loop of two to 
three amino acids between TM9 and TMIO. Conserved residues are scattered throughout 
the protein, however levels of homology are highest in the loops between the predicted 
transmembrane domains 1-2 and 7-8. Mutagenesis studies involving these amino acids 
would be of interest to determine their role in the function or the folding of the protein. 
System N displays a slightly different topology with 12 predicted transmembrane 
domains. 
Functional characterization of TbAA TPI indicates that this transporter carries 
tyrosine with a high affinity (Km 25 JlM). The transporter has also been shown to carry 
glutamate and glutamine, and based on inhibition analysis the carrier protein also has 
affinity for L-phenylalanine and L-Ieucine, and apparently low affinities for L-cysteine, 
L-methionine, L-threonine, and L-isoleucine. In mammals, system A is responsible for 
the uptake of the neutral amino acids alanine, serine, and glutamine while system N is 
specific for glutamine, asparagine and histidine. Although TbAA TPI and system A and 
N resemble each other in sequence and topology, they display functional differences that 
could be exploited in the design of drugs to selectively enter trypanosomes. 
The molecular characterisation of TbAATPJ revealed the presence of a putative 
family of related genes (this is confirmed in the next chapter). 
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The characterization of TbAA IPt in Xenopus oocytes showed that kinetic 
characteristics and substrate specificity appear to be similar to those measured for a 
transporter which carries tyrosine in bloodstream form T. brucei (c.f. Chapter IV, section 
4.2.5). In procyclic forms, the principle transporter appears to have a substantially higher 
affinity for substrate, indicating that the main route of entry for tyrosine in the two 
different forms of the parasite is different. However, interpretation of data on the kinetics 
of transport obtained by heterologous expression have to be treated with caution. The 
data obtained are only conclusive of the nature of the transporter and its substrates. 
Northern blot analysis indicates that TbAA TP 1 mRNA may be present in 
bloodstream and procyclic form organisms. It is difficult at this stage, however, to draw a 
definitive conclusion of whether TbAATPI is expressed in procyclic form or bloodstream 
forms or in both forms. 
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6.1. Introduction: 
A mUltiplicity of amino acid transporters, distributed in large families, have been 
shown to be present within most organisms including mammals, yeast, plants and 
bacteria (c.f. Chapter I, section 2.4). In Trypanosomes the assumption that there are 
multiple amino acid transporters was originally proposed by Hansen (Hansen, 1979) and 
the transport studies presented in this thesis on methionine and aromatic amino acids 
support this hypothesis. A search of the T. bruce; databases led to the discovery of 
TbAA TP 1 which has been functionally characterised and shown to encode for an amino 
acid transporter. 
The purpose of this chapter is to describe the search of the T. bruce; databases for 
putative members of a family of amino acid transporter genes and the use of 
bioinformatic tools to analyze the structural and phylogenetic characteristics of the 
different members of the family. 
6.2. Results 
6.2.1. Identification of a family of amino acid transporter genes from T. bruce; 
TbAATPl was characterized functionally as being an amino acid transporter 
(results presented in Chapter V) thus the predicted amino acid sequence encoded by this 
gene was used to re-screen the T. brucei databases using a tBlastN search (which 
identifies homology to translations of nucleotide sequence). Sequences presenting 
between 30 and 90 % homology were retrieved from the databases and each seed 
sequence was used to re-screen the databases using a blastN search in order to find 
overlapping fragments presenting a minimum of 98 % of identity in the overlapping 
region). Contiguous sequences with a minimum length of 1.6 kb were searched for the 
presence of an open reading frame. In this manner ten contiguous sequences, 
corresponding to ten additional TbAA TP 1 homologues, were found. These ten genes 
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were translated and the predicted amino acid sequence was used to search for 
homologous sequences in the general databases at NCBI using a tBLASlN search. The 
ten open reading frames displayed a high homology score with mammalian amino acid 
transporters and the predicted peptides named TbAATP2 to TbAATPll. The length of 
the different members varies between 376 and 490 amino acids (Appendix V-I). 
TbAATP5 is the shortest open reading frame reported and most probably does not 
correspond to the full-length gene. However, no sequences with overlapping the ) 
/ 
upstream region of this putative start codon could be retrieved from any of the T. bruce; ( ? 
\ 
databases. The length of TbAATP2 (402 amino acids) has also been the subject to) .. 
detailed investigation but no likely upstream start codon could be identified. 
As will be discussed later, these eleven amino acid sequences displayed a strong 
homology with mammalian amino acid transporters and particularly with system A and 
N which mainly transport neutral amino acids. The question of whether separate families, 
with homology to other mammalian amino acid transporter systems, also exist in the T. 
bruce; genome was then raised. In order to address this question the T. bruce; databases 
were searched with amino acid sequences of members of different families of amino 
acids including the glutamate family, system ASC and the different members of the 
cationic amino acid transporter (y+, bo+). This search led to the discovery of a twelfth 
gene, named TheM TP. This gene is highly homologous to mammalian cationic amino 
acid transporters. The predicted amino acid sequence encoded by this gene is of 539 
amino acids making TbCAATP the longest member of the family. 
System A and N, and the cationic amino acid transporters were the only 
mammalian families of amino acid transporter showing any significant homologies with 
sequences in the T. bruce; databases. 
6.2.2. Degree of homology between the T. bruce; amino acid transporters and 
members of the amino acid transporter superfamily. 
In order to determine the degree of homology between the eleven sequences an 
alignment of the predicted amino acid sequences from TbAA TP 1 to TbAA TP 11 was 
performed using AlignX from the vector NTI suite. This alignment showed a percentage 
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of strict identity of 10.8 % betwwen the eleven members. The first 50 to 70 amino acids 
at the amino tenninus of the eleven amino acid sequences was revealed to be the most 
diverse portion of the alignment with no globally identical amino acids while the most 
conserved domains are found at the carboxy tenninus (Figure 6.2). Conserved residues 






N- glycosylation site 
o Conserved amino acids among TbAATPl-ll members 
o Identical amino acids among all TbAA TP members 
Figure 6.1: Schematic representation the topology of the predicted structure of TbAATPl and the conserved amino acid among the different members of the 
TbAA TP family. The yellow circles indicate identical amino acids among TbAA TP 1 to TbAA TP 11 family members and the orange circles represent identical amino acids 
among the entire TbAATP family. 
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Figure 6.2: Amino acid sequence alignment with eleven members of the TbAATP family . The 
predicted amino acid sequences of TbAATPI to TbAATPll were aligned using the ClustalW algorithm. 
The identical amino acids among the eleven sequences are indicated in yellow, and blocks of similar 
residues are highlighted in blue. Asterisks indicate conserved residues of a consensus motif of the AAAP 
family. TbAATPl was peR amplified to verify sequence. TbAATP 2, 4, 5, 6 represent preliminary 
sequences produced by assembling indjvidual single pass sequences from the TIGR database. TbAATP 3, 
7, 8, 9, 10, II were present on the assembled sequence of chromosome IV. 
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Based on this sequence alignment a neighbor-joining tree including the eleven 
putative amino acid transporters was constructed (Tree 6.1). The tree reveals the presence 
of three clusters. One cluster is formed by TbAA TP 1, 3, 9 and the other by TbAA TP 4, 
2, 6, 7, 8, 10, 11. The position of TbAATP5 forming a single branch outside ofthese two 
clusters is probably due to the fact that this sequence is incomplete. 
The second cluster is subdivided into two sub-groups TbAA TP2, 4, 6, 11 and 
TbAATP 7, 8, and 10. The tree was bootstrapped (based on 1000 random runs) and the 
bootstrap values indicate the robustness of the tree. The percentage of identity according 
to a pairwise alignment is indicated Table 6.1. 
Table 6.1 : Percentage of identical amino acids among the different members of the 
TbAA TPI-ll family. In red are indicated the highest percentage of identity between two genes. In bold 
are indicated percentages higher than 50 % of identity. 
TbAATP 1 2 3 4 5 6 7 8 9 10 11 
1 100 34 36 53 34 49 50 49 37 
2 100 35 36 32 30 32 36 31 37 
3 100 35 55 33 53 54 53 37 
4 100 35 35 31 34 36 32 39 
5 100 28 40 41 40 28 
6 100 34 34 34 35 
7 100 92 54 35 
8 100 55 35 
9 100 53 36 
10 100 35 
11 100 
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Tree 6.1: Phylogenetic trees for the TbAATPl-1l family members. The trees were generated with 
the Neighbor-joining program of Saitou and Nei using ClustalX 1.5. Panel I-A) displays a distal 


























Tree 6.2: Phylogenetic trees the entire TbAA TP family (including the TbCAA TP 
representative) . The trees were generated with the Neighbor-joining program of Saitou and Nei using 
ClustalX 1.5. Panel 2-A) displays a distal representation of the tree, panel 2-8) displays a rectangular 
c1adogram. 
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The addition of TbCAATP to Tree 6.1 brought some modifications to the organization of 
the different clusters with the presence of a large cluster containing TbAATP5, 7, 8, 10, 
11, 6 and two other clusters containing TbAATP2 and 4 and TbCAATP. The 
organisation within the sub-clusters however stayed the same. TbCAATP forms a single 
long branch not clustering with the other clusters. The length of the branch is indicative 
of the distance of this gene with the rest of the sequences (Tree 6.2). 
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6.2.3. Structural analysis of the TbAATP family. 
The fingerprint of membrane protein structure consists of a helix-loop-helix 
feature with helices corresponding to hydrophobic regions of the protein spanning 
through the membrane and loops corresponding to more hydrophilic stretches in contact 
with the aqueous phase. Therefore, hydropathy profiles of proteins provide strong 
indications as to whether a polypeptide is a membrane protein. As hydropathy profiles 
reflect the structure of proteins, which is generally conserved within a family, these 
profiles represent a tool that can be used beside amino acid alignments, to find structural 
homologues of a particular membrane protein (Lolkema and Siotboom, 1998). 
Structural analysis of the TbAA TP family using hydropathy plots based on 
different algorithms ofKyte Doolittle (Appendix V-2), TMpred and SOSUI revealed the 
presence of a variable number of putative transmembrane domains from nine to twelve 
among the different family members. The numbers varied depending on the software 
package used, and must be interpreted with extreme caution as they represent only 
predictions. However they indicate that all members of the TbAA TP family are 
transmembrane proteins. 
Table 6.2: Number of transmembrane domains predicted within the amino acid sequences of 
each TbAATP family member according to TMpred and to SOSUI. 
TbAATP TMpred SOSUI 
TbAATPI 11 11 
TbAATP2 10 12 
TbAATP3 10 11 
TbAATP4 10 11 
TbAATP5 10 10 
TbAATP6 10 9 
TbAATP7 9 10 
TbAATP8 10 12 
TbAATP9 10 II 
TbAATPIO 9 II 
TbAATPl1 10 II 
TbCAATP 12 11 
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Amino acid transporters in general have been classified into four different 
superfamilies among which conserved motifs have been identified and recognized has 
being signatures for some for these superfamilies. A motif GY-AFG in which the G is 
conserved, the Y is substitute only by F, the A is not well conserved and the F is 
substituted only by Y has been described as a signature for the amino acid, auxin family 
(AAAP) (Young et al., 1999). Analyzing the alignment of the TbAATP family, a 
corresponding motif was found: GY- DFG (Figure 6.1). This motif is localised at the end 
of the predicted transmembrane helix seven of TbAATPl which corresponds to the 
localisation of this motif in the AAAP family described by Young et al. 
The twelve amino acid sequences were also searched for the presence of peptide 
signals at the amino terminus using two different software SignalP and TargetP. 
ThCAA TP was the only sequence in which a putative signal peptide sequence possibly 
involved in targeting for the mitochondria was found. More specifically, some motifs 
have been published in the literature as being protein targeting motifs in kinetoplastids 
for the flagellar membrane (Snapp and Landfear, 1999), the flagellar pocket (llill et al., 
1999) and the peroxisome (or glycosome) (Jardim et al., 2000; Chudzik et al., 2000). 
None of these motifs are found to be present among the TbAA TP members. 
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6.24. Gene localization and organization: 
The localization of TbAATPl and TbAATP2 was obtained by probing a 
membrane on which chromosomes had been separated by pulsed field gel 
electrophoresis. This was done as part as the service offered by Dr.S. Melville at the T. 
bruce; genome project in Cambrige. The two genes were localized on chromosome VIII 
although there is insufficient information to comment on their relative position. 
The assembly of sequences of some of the T. bruce; chromosomes has also been a 
source of information in terms of gene localization and organization. TbAA TPJ, 7, 8, 9, 
10 and 11 appear to form a cluster on chromosome IV. The position of each gene on the 
BAC clone 3M17 (AC079815) is indicated figure 6.3. Based on the percentage of 
identity at the nucleotide level, two groups of genes presenting more than 95 % identity 
within each group, could be distinguished within the cluster. Representative members of 
the two groups show 62% identity to each other. The possibility that these genes are 
isoforms of two different amino acid transporters can be envisaged but can only be 
answered by functional expression of each gene. Furthermore, these genes are not 
organized in two sub clusters of the two putative isoforms but one gene from one 
putative isoform alternates with a gene from the other putative isofonn. In the case of T. 
congolense glucose transporters a similar alternating arrangement is seen. In this later 
case, however, members of each isoform are identical. 
Further analysis of sequence from the 3M17 BAC clone revealed the presence of 
a cluster of seven genes with a high homology with galactosyl transferase genes, strictly 
identical to each other, located upstream of the TbAATP cluster. The lack of sequences 
downstream the TbAATP cluster on the 3M17 clone did not permit the identification of 
the nature of the genes situated in this region. However, TbAAP II and TbAA TP 1 0 have 
been localised to the 3112 BAC clone (Figure 6.3) and this clone according to Dr El-
Sayed overlap with 3M17 on the left hand side (Personal communication). 
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Figure 6.3: Schematic representation of the localisat ion of TbAATP7, 3, 8, 9, 10, lion chromosome IV. The two sub-groups are indicated in yellow and red. 
The blue boxes represent the open reading frame of a sequence of high homology with galactosvl transferase 
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The localization of TbCAA TP has also been possible by interrogating the 
databases at the parasite-genome database. This gene was localized to chromosome VI. 
To date it seems that this gene is a single copy gene flanked downstream by a gene 
encoding for a phosphatidyl inositol phosphatase and upstream a homologue of RAD23 
(encoding for ubiquitin like protein). The chromosomal localizations of TbAA TP4, 5, 6 
has yet to be determined. 
Chromosome VI- clone 2609 
PIK3 





Figure 6.4: Schematic representation of the genomic organisation of the genes flanking the 
putative cationic amino acid transporter TbCAATP. The blue box represents the amino acid transporter 
gene, the pink and yellow boxes represent respectively open reading frames with high homology to 
phosphatidylinositol3 kinase and RAD23 . 
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6.2.5. Phylogenetic analysis: 
In order to relate TbAA TPI-ll family members to known amino acid 
transporters that have been described in other organisms, a sequence alignment including 
the TbAATP family members, but excluding TbCAATP, with a large number of amino 
acid sequences from other organisms including plants, mammals and yeast was created 
(Tree 6.3). The TbAATP family appeared to be more closely related to the mammalian 
amino acid transporters than to representatives from plants or yeast. Examination of Tree 
4 revealed that among the numerous neutral amino acid transporters known in mammals 
the eleven members of the TbAA TP family are closest in terms of amino acid sequence 
similarity, to systems A and N. 
The highest homology score obtained for TbeAA TP (using a tBLASTN search 
at NCBI) was to mammalian cationic amino acid transporters. Several sequences 
encoding cationic amino acid transporters from plants (Arabidopsis thaliana), yeast 
(Saccharomyces cerevisae), and from mammals (Homo sapiens and Rallus norvegicus) 
were aligned with the TbCAA TP amino acid sequence and a separate phylogenetic tree 
was created. As expected the sequences clustered according to the different kingdoms 
and interestingly TbCAA TP was found to cluster with the mammalian cationic amino 
acid transporters. In mammals, four families of cationic transporters have been described: 
the y+ family, also named the CAT family, which encompasses three members, the y+L 
family that also carries some neutral amino acids when associated with a heavy chain 
(4F2hc): the bo+ family which is also associated to a side chain named rBAT and the 
Bo+ system. Among these four families of cationic amino acid transporters, TbCT AAP 
seems to be most similar to the CAT family (Tree 6.4). 
A more general picture is given in Tree 6.5 in which the entire putative 
TbAA TP family is compared to amino acid sequences including neutral and charged 
amino acid transporters from mammals, plants and yeast. In this tree all the amino acid 
transporters for Saccharomyces cerevisae are grouped in one cluster. The same is 
observed for those from Arabidopsis thaliana while for mammalian amino acid 
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transporters the neutral amino acid transporters form a separate cluster form the charged 
amino acid transporters. The TbAATPI-11 family forms a cluster related to mammalian 
system A and N and TbCAA TP forms a cluster with mammalian cationic amino acid 
transporters. 
This large tree which provides a position of the TbAA TP family among 
sequences representing each family of known amino acid transporter sequences from 
three different kingdoms confIrms the observations brought out from previous trees 
1) the T. bruce; amino acid transporter family is closer to the mammalian amino 
acid transporters than to yeast or plants. 
2) the eleven TbAATP members resemble system A and N in mammals. 
3) one putative T. bruce; transporter is signifIcantly different, in terms of amino 
acid sequence, from the other members of the TbAA TP family, and this relates closely 
the cluster of mammalian cationic amino acid transporters, and in particular with the 
CAT family. 
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Histidine pennease [SO cerevisae] Arginine pennease [SO cerevisae] 
ytL[ R norvegicus] 
CationicAA transporter [A thaliana] 
Lysine permease [oS: cerevisae] 
Cationic amino acid pennease [A fha/iCDw] 
CAT1 [H sq7iens] 
CA 1'3 [H sapiens] 
Tree 6.3: Phylogenetic tree for the putative T. brucei cationic amino acid transporter 
TbCAA TP and cationic amino acid transporters from Saccharomyces cerevisae, Arabldopsls thaliana, 
Homo sapiens and Rattus norvegicus. The tree was generated using the Neighbor-joining program using 
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TbAA TP3 TbAA TP8 








Tree 6.4: Phylogenetic tree for proteins of the TbAATP1-ll family and mammalian neutral 
and charged amino acid transporters. The trees were generated using the Neighbor-joining program 
using ClustalX 1.5. Bootstrap values correspond to 1000 random runs. Panel 3-A) dipJays a dista l 
representation of the tree, panel B) displays a rectangular representation of the same data 
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.Tree 6.5: Phylogenetic tree for the entire TbAA TP family and charged and neutral amino acid transporters from S. cerevisae, mammals and A. tllaliana. The 
tree was generated using the Neighbor-joining program using ClustaJX 1.5. Boostrap values correspond to 100 random runs. 
Chapter VI: Identification of afamily of amino acid transporter genes 
6.3. Discussion 
In this chapter the presence in Trypanosoma bruce; of a family of amino acid 
transporters genes containing at least 12 members was described. To date approximately 
84% of the T. bruce; genome has been sequenced (S. Melville, personnal 
communication) indicating that additional genes could be members of this family. 
A comparison based on amino acid sequence alignment showed ten percent of 
residues are shared between the eleven members of the TbAA TP family. This level of 
identity is similar to that observed in other systems including mammals and yeast and 
reveals a relatively heterogeneous family. 
An alignment of TbAATPI-ll with TbCAATP indicated that these proteins are 
structurally relatively distantly related with only nine amino acids strictly identical 
among all the TbAA TP members. This is also observed between the neutral amino acid 
transporters and the cationic amino acid transporters in mammals. 
A phylogenetic analysis based on an amino acid sequence alignment of the 
TbAATPI-ll family revealed that the highest degree of homology was found between 
the T. brucei amino acid transporters and the mammalian amino acid transporter systems 
A and N. While TbCAATP was closest to mammalian CAT family. Trypanosomes 
belong to the order Kinetoplastida which branched from the eukaryotic evolutionary tree 
very early. It is therefore surprising that trypanosome transporters are more similar to 
mammals than they are to other eukaryotes including yeast and plants. It is possible that 
since trypanosomes have co-existed with mammals for millions of years their amino acid 
transporters are similar because they face the same environment. Convergent evolution or 
lateral gene transfer, might explain the similarities. However, during its life cycle 
trypanosomes also reside in the tsetse fly and it would be of interest to know where 
insect amino acid transporters cluster relative to the mammalian and trypanosome ones. 
Moreover, it would be of interest to compare the trypanosome sequences to those of 
other kinetoplastids which are either parasites of insects (e.g. Crithidia) or free living 
organisms (e.g. Bodonids). 
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Most of the genes have been localised to particular chromosomes within the 
genome, with the exception of TbAA TP 4, 5, 6. They are present on three different 
chromosomes: IV, VI and VIII. TbCAATP was found as a single copy gene on 
chromosome VI. The clustered organization of TbAATP 3, 7,8,9,10, 11 on chromosome 
IV has also been observed for the THT1 and THT2 genes encoding glucose transport in 
trypanosomes. However in T. bruce; the genes encoding the TIITI isoform are followed 
by the genes encoding the THT2 isoform, while in T. congolense TcoHTl and TcollT2 
alternate (Bringaud et al., 1998). Seven identical genes encoding for a putative 
galactosyltransferase were clustered upstream of this cluster. Many other genes in 
trypanosomes including ubiquitin and tubulins are also present in tandem arrays. 
The genomic organization of the flanking region of TbCAA TP revealed the 
presence of a phosphatylinositol 3 kinase gene. Interestingly a similar gene was found to 
be present in the flanking region of the glucose transporter gene cluster. This enzyme is 
involved in the regulation of the vesicle trafficking and could possibly be involved in the 
targeting of TbCAATP. 
It is most likely that the transport of amino acids occurs at several membranes in 
trypanosomes including 1) the plasma membrane for the acquisition of amino acids from 
the host 2) the mitochondrial membrane, since protein synthesis occurs in the 
mitochondria and amino acids also need to be carried into this compartment 3) 
membranes of the lysosomallendosomal system which possess both acquired and 
endogenously produced proteins which are degradated and released back to the cytosol. 
The localisation of the different transporters of the TbAA TP family within the cell is not 
known at this point. However, a putative signal peptide for the mitochondrion is found at 
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7.1- Overview 
The aim of this project was to investigate amino acid transport in Trypanosoma 
brucei with a particular interest in transporters with high affinity for substrate. The long-
term goal underlying this study was to identify putative gateways for drugs to enter 
trypanosomes. 
The project consisted of two separate approaches: (1) a biochemical approach 
based on measurements of the uptake of radiolabelled amino acids by bloodstream or 
procyclic form trypanosomes, (2) a cloning and expression approach of a putative T. 
brucei amino acid transporter gene, identified by searching the T. bruce; genome 
databases, using Xenopus oocytes. 
Using the biochemical approach the uptake of methionine was studied in 
procyclic and bloodstream forms of T. brucei. Methionine appeared to be taken up only 
via only one transporter and could therefore be studied in detail in the parasites. 
Methionine transport appeared to be dependent on the proton motive force and the amino 
acid core is essential for the recognition of substrate by the transporter. Phenylalanine 
and tryptophan was shown to be transported by at least two different routes. The 
presence of mUltiple transporters for the same substrate was an obstacle to the detailed 
characterization of each individual transporter. This problem highlighted the limitations 
of this biochemical approach and emphasised the necessity of studying individual 
transporters in isolation. 
Towards this goal, a putative amino acid transporter gene, TbAATP}, was cloned 
and expressed in Xenopus oocytes. This gene encodes a protein containing 11 putative 
transmembrane domains and functional expression of this gene showed that glutamate, 
glutamine, and tyrosine were substrates for this transporter. Methionine, phenylalanine, 
tryptophan, leucine, and isoleucine were significant inhibitors of tyrosine uptake which 
suggest that these amino acids are also possible substrates. 
The expression of TbAATPl in Xenopus oocytes was technically difficult 
because of the irregular quality of the oocytes, and the presence of a relatively high 
endogenous amino acid uptake. Xenopus oocytes possess multiple amino acid 
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transporters at the plasma membrane and the level of endogenous transport can greatly 
vary from one batch of oocytes to the other made systematic reproducibility of TbAATP J 
expression. 
Other expression systems including mammalian CHO (Chinese Hamster Ovary) 
cells could have been used but these too would have had endogenous transport activity 
and presented similar difficulties. 
The identification of TbAA TP J led to the discovery of others genes using the T. 
brucei databases. These genes form a famiJy of twelve members and four of these genes 
are found in a cluster on chromosome IV. A putative cationic amino acid transporter 
gene was also found on chromosome VI. The presence of at least twelve genes in the T. 
bruce; genome encoding for amino acid transporters is relatively high. However, some of 
these genes could be isoforms differentially expressed throughout the life cycle of the 
parasite. Amino acid transporters are also abundant in plants, mammals and yeast (Cf. 
part 2.4.1 and 2.4.2 of Chapter 1). 
Phylogenetic analyses comparing TbAA TP family members with amino acid 
transporters from plants (Arabidopsis thaliana), yeast (Saccharomyces cerevisae) and 
mammals (Homo sapiens) were based on amino acid sequence alignments. This choice 
of trees based on amino acid sequences and not DNA sequences, is justified for several 
reasons: 1) the question addressed was a comparison in terms of function and this 
information is carried by protein sequences, 2) multiple codons encode for the same 
amino acid and the different codons can be used with a different frequency by different 
species (known as "codon usage"), 3) The genetic code is based on the use of A, 0, C, T 
while protein sequences are based on 20 amino acids. Thus, the probability of residues 
randomly aligning is significantly higher with DNA sequences than with amino acid 
sequences (particularly if gaps are allowed). 
This study revealed that T. brucei amino acid transporters are more closely related 
to mammalian amino acid transporters than to yeast or plant amino acid transporters. It is 
tempting to speculate that this may arise from horizontal gene transfer or of co-evolution 
due to the fact these transporters face in the same environment. 
~-~---------~---.--/-. --------' 
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7.2. Interpretation 
7.2.1. A window on trypanosome metabolism 
Methionine and aromatic amino acids 
The presence of at least three transporters involved in the transport of aromatic 
amino acids points to the importance of these molecules for parasite metabolism. Other 
than incorporation into proteins, the main use of aromatic amino acids in trypanosomes 
appears to be for transamination of a-ketomethiobutyrate into methionine (Berger el al., 
1996). Berger suggested that trypanosomes have a high capacity to transport aromatic 
amino acids and that blocking this uptake could be a putative target for chemotherapy. 
The data obtained on aromatic amino acid transport in this study confinns the high 
capacity of trypanosomes to scavenge these molecules. However, the presence of 
mUltiple transporters for aromatic amino acids would make the inhibition of their uptake 
a goal difficult to achieve. It is also interesting to note that methionine and the aromatic 
amino acids appear to share one transporter. This observation raises questions about the 
potential of regulating the transport activity according to the metabolic requirements 
related to methionine cycle. Future studies seeking such regulation would be of interest. 
Glutamate and glutamine 
In bloodstream fonn trypanosomes glutamate is abundant (12% of the free pool 
of amino acids) and represents the second most abundant amino acid after alanine. The 
data obtained on glutamate transport revealed a relatively poor capacity of trypanosomes 
to scavenge glutamate and this data suggests that most glutamate is probably synthesised 
from other amino acids. Glutamine is a candidate and has been shown to be a relatively 
good substrate of TbAATP1. There is also some evidence of the presence ofa glutamate-
pyruvate transaminase in bloodstream fonn trypanosomes, allowing the fonnation of 
alanine from glutamate and vice versa. 
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7.2.2. Consequences for the mammalian host 
The definition of a parasite is an organism that "eats at the table of another one". 
In the context of a study on amino acid transporters the question of the impact of the 
parasite on the level of amino acids in the infected host can be addressed. 
A dramatic decrease in tryptophan and tyrosine concentrations has been measured 
in the serum of mice infected with T. bruce; (Newport et al., 1977, Vincendeau et al., 
1999). However, the presence of a mUltiple transport system for the aromatic amino acids 
in trypanosomes is not likely to be directly involved in the decrease because of the 
regular input from the diet. As suggested by Hall and Seed, this decrease is more likely 
to be due to a disturbance of the host aromatic amino acid metabolism (Ilall and Seed, 
1984) with a very limited conversion of phenylalanine to tyrosine in infected Micro/us 
(Seed et al., 1982) and an increased urinary excretion of aromatic amino acid catabolites 
(Hall and Seed, 1984). 
Amino acid availability plays an important role in the regulation of 
neurotransmitter synthesis. Phenylalanine and tyrosine are precursors of the 
catecholamines: dopa, dopamine, noradrenaline and adrenaline. Tryptophan is the 
precursor of serotonin. The transport of essential amino acids from blood to brain is 
regulated at the blood brain barrier (BBB) by the presence of a variety of amino acid 
transporters. Boado et al., have shown the presence of system L (or LAT) at the BBB 
with a much higher affinity (1-100 JlM) than system L in peripheral tissues (1-10 mM) 
(Boado et ai, 1999). Multiple behavioral disorders are associated with African 
trypanosomiasis: dementia, sleep disorders, and affective disorders are observed in 
sleeping sickness patients (Keita et al., 1997, Buguet el al., 1999). Studies comparing the 
level of various neurotransmitters in the brains of mice infected by T. bruce; and non 
infected mice showed an alteration in monoamine neurotransmitters. A fall of more than 
20% in serotonin levels has been observed in experimental trypanosomiasis (Stibbs, 
1984, Stibbs and Curtis, 1987). In this context several hypothesis can be made: 
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1) the presence of trypanosomes in the brain might deplete the CSF of amino 
acids crucial for the synthesis of neurotransmitters 
2) the parasites could have the ability to deregulate the function of these 
transporters mammalian transporters 
3) the parasites could also affect the metabolism of different neurotransmitters. In 
infections by T. cruzi an alteration of acethylcholine receptors has been shown to 
occur in the brain as well as an alteration in the activities of choline 
acetyltransferase and acethylcholine esterase (Tanowitz el al., 1983). 
7.3. Future Work 
Further characterization of TbAA TPI should consist of a complete investigation 
of the substrate specificity of TbAA TPI by measuring the kinetics of uptake of 
radiolabelled phenylalanine, leucine and isoleucine. 
Mammalian system A and N have been shown to be dependent onto Na + and 
although none of the nutrient transporters characterized in trypanosomes have shown any 
Na + dependency it would be of interest to investigate the ion dependency ofTbAA TPI. 
In order to determine if TbAATPI is essential for the parasite a gene knock-out 
would have to be undertaken. This can be achieved either by replacing both alleles of the 
gene with antibiotic resistance markers, or using RNA interference technology (Shi, 
2000). Uptake of tyrosine, glutamine and glutamate should then be measured in the 
knock-out mutant and compared to the wild type. 
Hydropathy plots of the amino acid sequences of TbAA TP 1 predicted the 
presence of eleven transmembrane domains. A more comprehensive topology of the 
transporter could be determined by assessing the extracellular accessibility of single 
cysteines to sulfhydyl-modifying reagents (Loo and Clark, 1995). The technique is based 
on the creation of transporter mutants in which the cysteines have been removed by site-
directed mutagenesis and a single cysteine is introduced in different parts of the 
sequence. The availability of these individual cysteines to impermeant reagents that react 
with the sulfydryl residue of the amino acid determines its extracellular accessibility. 
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The role of particular residues in the amino acid sequence of the transporter could 
be investigated by altering these by site directed mutagenesis and measuring uptake of 
labelled amino acids and inhibition by various analogues. 
The localization and distribution of TbAA TPI could be investigated by the 
production of polyclonal or monoclonal antibodies against the parts of the protein which 
are predicted to be extracellular. 
TbAATPl is member of a family of amino acid transporter genes and the T. 
bruce; genome project is close to completion. However approximately 20 % of the 
genome is still unknown, suggesting that other members of the amino acid transporter 
family could still be found. In order to identify the complete family, the databases should 
be searched regularly and a systematic cloning and expression approach should be 
undertaken for all the family members. 
7.4. Amino acid transporters and drug design. 
Although TbAATPl possess structural homologies to mammalian amino acid 
transporters, functional differences between the two systems are indicative of the 
presence of different recognition motifs. 
Using these transporters as gateways for drugs is a long term goal and the first 
step towards this goal is to characterize this family of transporters in trypanosomes. The 
role of the P2 nucleoside transporter as a gateway for trypanocidal drugs and its role in 
the mechanism of resistance to these drugs has set various precedents on features making 
a transporter a good potential drug carrier. Theoretically, the best strategy in terms of 
drug design would involve the use of a cocktail of drugs able to enter the cell via 
different transporters. Practically this requirement would increase the cost of drugs and 
make them less affordable to the third world countries facing sleeping sickness. 
Studies into amino acid transporters will also provide key information about 
amino acid metabolism in trypanosomes. For example the inhibition of an enzyme 
involved in the synthesis of one that is not scavenged would represent an ideal target for 
chemotherapy. 
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Saccharomyces cerevisiae possesses transporters that are sensors for glucose 
(Kruckeberg, 1998) and amino acids (Iraqui et ai., 1999), the presence of such sensors or 
of a mechanism of regulation of amino acid transporters in trypanosomes would be of 
interest to investigate. 
Ultimately amino acid transporters in T. brucei represent potential gateways for 
new drugs by fulfilling the criteria set out in part 3 of Chapter I. The identification of a 
family of genes and establishment of a functional expression system leads to optimism 
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Amino acid concentrations in human serum 
Amino Acid Concentration Amino Acid Concentration 
Glutamine 0.7 mM Histidine 0.09mM 
Alanine 0.3 mM Arginine 0.08 mM 
Cysteine 0.25 mM Isoleucine 0.07 mM 
Valine 0.2SmM Asparagine 0.06 mM 
Glycine 0.23 mM Tyrosine 0.06 mM 
Proline 0.2 mM Phenylalanine 0.06 mM 
Lysine 0.19mM Tryptophan 0.04mM 
Threonine 0.14mM Glutamic acid 0.04 mM 
Leucine 0.13 mM Methionine 0.02mM 
Serine 0.11 mM Aspartic acid O.OOSmM 
Amino acid concentrations in human serum Amino acids with a concentration above 100 JlM 
are indicated in blue, in red are the amino acids with a concentration below 100 JlM ( Modified from 
Brody, 1994). 
Proton Motive Force (Equation 1) 
PMF = Vm-(2.3RTIF)(pHi-pHo) 




Name Abbreviations Linear structure formula 
Alanine Ala A CH3-CH(NH2)-COOH 
Arginine Arg R HN=C(NH2)-NH-(CH2)3-CH(NH2)-COOH 
Asparagine Asn N H2N-CO-CH2-CH(NH2)-COOH 
Aspartic acid Asp D HOOC-CH2-CH(NH2)-COOH 
Cysteine Cys C HS-CH2-CH(NH2)-COOH 
Glutamine GIn Q H2N-CO-(CH2)2-CH(NH2)-COOH 
Glutamic ac Glu E HOOC-(CH2)2-CH(NH2)-COOII 
Glycine Gly G NH2-CH2-COOH 
Histidine His H NH-CH=N-CH=C-CH2-CH(NH2)-COOH 
Isoleucine lIe I CH3-CH2-CH(CH3)-CH(NH2)-COOH 
Leucine Leu L (CH3)2-CH-CH2-CH(NH2)-COOH 
Lysine LysK H2N-(CH2)4-CH(NH2)-COOH 
Methionine Met M CH3-S-(CH2)2-CH(NH2)-COOH 
Phenylalanine Phe F Ph-CH2-CH(NH2)-COOH 
Proline Pro P NH-(CH2)3-CH-COOH 
Serine Ser S HO-CH2-CH(NH2)-COOH 
Threonine ThrT CH3-CH(OH)-CH(NH2)-COOH 
Tryptophan Trp W Ph-NH-CH=C-CH2-CH(NH2)-COOH 
Tyrosine Tyr Y HO-p-Ph-CH2-CH(NH2)-COOH 









CaCh 0.55 rnM 
MgS04 0.4 rnM 
Na2HP04 5.6rnM 
D-glucose 11.1 rnM 
Adjust to pH 7.4. Store at -20°C 
BUFFER FOR ELUTION OF TRYPANOSOMES FROM DEAE COLUMN 







Make up to a final volume of 1000 rnl in distilled water at pH 8. 
Preparation of Phosphate-buffered Saline-Glucose (PSG 6:4) (Separation buffer) 
To 6 volumes ofPS add 4 volumes of H20 and 1% of glucose (w/v). Adjust at exactly 
pH 8. 
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CaC12.6H20 0.41 mM 
MgS04.7H20 0.82mM 
Sodium penicillin lOJ-lg/ml 
Streptomycin sulphate 10J-lg/ml 






Sodium penicillin 10J-lg/ml 
Streptomycin sulphate 10J-lg/ml 
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MOLECULAR BIOLOGY 
SOLUTION FOR DNA ELECTROPHORESIS 
50 xTAE 
Trizma base 242 g 
EDTA 18.6g 
Make up to 800 ml and adjust to pH 8 with glacial acetic acid. Make up to a final 
volume of 1000 ml. Store at Room temperature. 
SOLUTION FOR NORTHERN GEL BUFFER 
20 X Northern Gel Buffer 
0.36M 
O.04M 
Ix Northern Gel Buffer 
For 500 ml 

















Make up to 1000 m!. Store at room temperature. 
Neutralization solution 
NaCI 87.66 g 
Trizma base 60.5 g 
Add 800 ml of distilled water and adjust to pH 7.5 with HC!. Make up to a final 




SOLUTIONS FOR HYBRIDISA TION 
88.23 g 
175.32 g 
Check the pH is 7-8. Make up to a final volume of 1000 m!. Store at room 
temperature. 
100 x Denhardt's solution 






Make up to a final volume of 100 m!. Store at -20 0 C. 
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SOLUTIONS FOR E. COLI TRANSFORMA TION 
Luria Bertani medium (LB) 
Bacto-tryptone 109 
Bacto yeast extract 5 g 
NaCI 10 g 
Make up to 800 ml and adjust at pH 7 with NaOH. Make up to a final volume of 1000 
ml. Sterilise by autoclaving. 
For solid LB medium add Bacto agar 15g!1. 
Ampicillin (Stock solution) 
50 mg! ml dissolved in distilled water. Sterilised by filtration using a syringe filter 
(0.2 J,lm). Store at -20 0 C. 
X-Gal (Stock solution) 
50 mg/ml in dimethylformamide. Store at -20 0 C 
IPTG (stock sloution) 
0.4 M dissolved in dd H20. Store at -20 0 C. 
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Appendix-Chapter VI 
PREDICTED AMINO ACID SEQUENCES OF THE TWELVE MEMBERS OF THE TbAA TP 
FAMILY. 
TbAATPl (467 AA) 
MTSINAQPPNSA TYPQDDHGSAEVVNLNAEVERPQPEEQKDGGGCF ARVSLFMA TIIPPGGIAASAF 
NIGSTTIGAGlFGLP AAANSSGL VMAMIYLIIITAMTIFSIY ALGV AA ERTNIRTYEGV ARALLGPWGA 
FCTAAARTFFSFSACVA YVISVGDILSATLKGTNAPDFLKQKSGNRLL TSLMWLCFMLPLVIPRHIDS 
LRHVSTlAFILMIYMVLVVVVHSCMNGLPENIKNVSVGKDDNAEIILFNSGNRAIEGLGVFIFSYLFQI 
TA YEVYMDMTNRSVGKFVLVVTIAMGMCLPMY AL TAFFGYMDFGRNVTGSVLLQYDPVNYPA V 
MVGFVGVL VMLFVSY ALLGLACRNAL YDVIGWDFREVAFWKHCIA VVTLSVVMLLCGLFIPKITT 
VLGFAGSFCGGLLGFILPALFFMYSGGFTWQKVGPFYYISTYVLLlTGVIAA VFGTGATIWA VTVG 
TbAATP2 (402 AA) 
MVDCTRSCALNLASATLGAGlCSLPAGFNLSGlVMSCTYLVCVA VGTVYSLNLLAKV A VKTGSRNY 
GEAAKA VMGPLAGYYTAALMIVMCFGGSVA YIIIIGIILKAVLNRDGVPEYLKSESGNRLMTSMVW 
L VIILPMCIPKQVNSLRHLSFVGVMFIVYFSCVVIGHSINKIINEGV ADGIVYMRTGNSALDGLSLFLF 
SFICQPNAFEIFREMKHRSPQRFTIYGTVGMSMCA VL YFLVGLFGYLEFGGDAIDTVLSL YDPGENV 
A V AlA YIGVAAKVCV AFALHIIPMRDALYHCTGWHVDTVPYWKHSLlVTSITLAALLMGLFIPKAST 
VFGL VGAFCGGHIGL VLPPLFYMYSGGFTREKVGNlDFFGTYLLLFVGVV AGVFGTVSTIYNTVP 
TbAATP3 (450 AA) 
MEVRNEPIGCCDAA VDPKSQEQREGTGFLARMSTFVATAIPPGGIAASAFNIASSTVGAGIVGLPSA 
ANSSGLVMAlVYLIIITVMTIFSIY ALGVAADKTKTHDFEGVAKVLFGAKGSYL V AATRAFHGFSGC 
V A YIISVGDlLSAILKGTDAPDFLKEKWGNRLLTFIMWLCFMLPLAIPREVNSLRYVSTFA VSFIVYL 
VIVIVVHSCMNGLPENIKNVSVGRNDVAAIVLFNSGNKAIEGLGVFIFA YVSQITA YEVYVGMTNRS 
VGKFVMASTIAMA VCFTMYVL T AFFGYLDFGRDVTGSVLLMYDPVKEPAIMVGFIGLLVKLF ASY 
ALLGMACRNAL YSIIGWDAEKVMFWKHCVA VVTLSVIMLLCGLFIPNINTVLGLAGSISGGLLGFIF 
PALLLLYAGGFTWQKVGPFHYIATYTVLITGVIArVFGTGASIWGAINI 
TbAATP4 (460 AA) 
MRA TKKHPNDGKGA TTDPFVDGSDPIPSEV AAFDPSQQEHVDVVKEVKPSLFTVLLEKFIPHGGL W 
SCALNLASATLGAGICSLPAGFNLSarVMSCIYL VCVA VGTVYSLNLLAKVA VKTGSRNYGEAAKA 
VMGPLAGYYTAALMIVMCFGGSV A YIIIIG IILKA VLNRDGVPEYLKSESGNRLMTSMVWL VII LPM 
CIPKXVNSLRHLSFVGVIAIA YFAFFSVGHSINKIINEGVADDIVYMRXGNSALDGXSLFLFSFICQPN 
AFEIFREMKHRAPQRFTIYGTVGMSICA VL YFLVGLFGYLEFGGKSVDTVLSL YDPGQGVA VTIA YI 
GVAIKITVAYALHAIPIRDSVYHCVGWHVDTVPYWKHVVVVVAINFTSLlTGLFIPKATTVFGLVGA 
FCGGHIGL VLPPLFYMYSGGFTREKVGNIDFFGTFLLLFVGVV AIVFGTVTTIYNTVP 
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TbAATP5 (376 AA) 
MGILYLVIINCMTIYSMYNLALAAERSKALTYEGVTFVVLGRWAA YAIAAVRAFDGFTSCIA YVISV 
GDIFSSrLKGTDAPEFWKGNTGNRLL TALL WLCCMLPL VIPRHVDSLRHVSTCA VTFMVYFVIVrVV 
HSCLNGLPENJKDVSVGKSDT AAlILFNSGNAA VEGLG VFMFSYTCQDT A YEJYMDMKDRSVRKFV 
ISSAlAMCMCTVLYIL TVXXGYMDFGRDVTGSILLMYDPVNEPA VMVGMIGVLVKLlASYALLAM 
ACRNAL YSlAGKNADVLPFWKHCASVVTLSVAAL VLGLFIPKVNTVLGF AGSTTGGSLGYTFPSLLL 
MYSGGFTWQRVGPFHYL VA YGLLISGVVGVVFGTGATIWGTIVG 
TbAATP6 (459 AA) 
MLSPTEPLGSGKAHTEVVTDEGEXYGAMSAADEKSHHKNGDTXTTDSKFMQCINAIIPHGGALSTT 





GVLGFCIARIVPXCNCGXWGfSQVGVVNYVCTYLLLlSGVIA VVFGT AASfYNV A V 
TbAATP7 (490 AA) 
MHVSAQARQTLCYHYCWMASA VVPTTDREQINKADVTSPFGSCEVJSGDDEGLKGKNALPANEGE 
GEQSSMKCFTSMlPPGGL VST AFSLASJCJGAGILGLPAAANSTGL VMAFVYPIIIYFLCVYSL YCLGA 
QMERHGFRSYEGMARALLGQPCL YFJGVLRVVEAFGAA VAQIIATGDfVSTILKGTDAPNFLKEKW 
GNRLL TFIMWLCFMLPL TIPREVNSLRYVSTISVFFVFYLMVVIVVHSCMNGLPENlKNVHVTGAPG 
DEGIHLFGTSNRAVEGPGVFTFAFLCHISVFEIYFGMAKPSAHRFTAYSAIAMGICLVLCVMTAFFGY 
LDFGRDV AGSVLLMYDPVKEPAIL VGFVGLL VKLF ASY ALLAMTCRNGLCGIIGLDTEKLSFFKHC 
TIIGTISIIMLLCGLFfPNINTVLGFVGSVCGGFLAFILPSLFMMYGGNWSLSTVGWLHYIATY A VLFA 
GV ALSVFGTGA TIYGV A VGW 
TbAATP8 (490 AA) 
MHVSAQARQTLCYHCCWMASAVVPTTDREQINKADVTSPFGSCEVIGGEDEGLKGKNALPANEGE 
GEQSSMKCFTSMlPPGGL VST AFSLASICIGAGILGLPAAANSTGL VMTFVYPIIlYFLCVYSL YCLGA 
QMERHGFRSYEGMARALLGPYGAHLTGVLRVVNAFGACVA YIISVGDIVSTlLKGTDAPNFLKEK 
WGNRLL TFIMWLCFMLPL TIPREVNSLR YVSTF A VVFIFYLMGVIVVHSCMNGLPENIKNVHVTGA 
PGDEGIHLFGTSNRA VEGPGVFTFAFVCQCYAFEIYFGMAKPSAHRFTA YSAIAMGICLVLCVMTAF 
FGYLDFGGKVTGSVLLMYDPVKEPAIL VGFVGVL TKLF ASY ALLAMSCRNGLCGIVEWDAEKLSFF 
KHCTIIGJLSVIMLLCGLFJPNINTVFGFVGSVCGGFLGFILPSLFMMYGGNWSLSTVGWLHYIATYA 
VLF AGV ALSVFGTGA TlYGV A VGW 
TbAATP9 (451 AA) 
MEVRNEPJGCCDAA VDPKSQEQREGTGFLARMSTFV ATAIPPGGfAASAFNIASSTVGAGIVGLPSA 
ANSSGLVMAfVYLlIITVMTIFSIY ALGVAADKTKTHDFEGVAKVLFGAKGSYL VAATRAFHGFSAC 
V A YIISVGDJLSAJLKGTDAPDFLKEK WGNRLL TFIMWLCFMLPLA fPREVNSLRYVSTF A VSFIVYL 
VIVIVVHSCMNGLPENIKNVSVGRNDV AAIVLFNSGNKAIEGLGVFIF A YVSQITA YEVYMDMEDRS 
VRKFIVATSIAMATCSVLYAMTAFFGYLDFGRDVTGSVLLMYDPVKEPAIMVGFIGLLVKLFASYA 
LLGMACRNALYSHGWDAEKVIFWKHCVA VVTLSVIMLLCGLFIPNINTVLGLAGSISGGLLGFIFPA 
LLLLY AGGFTWQKVGPFHYlA TYTLLLSGVLAfVFGTGA TIHGVVVGN 
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TbAATPIO (490 AA) 
MHVSAQARQTLCYHCCWMASA VVPITDREQINKADVTSPFGSCEVISGEDEGLKGKNALPANEGE 
GEQSSMKCFTSMIPPGGL VST AFSLASICIGAGILGLPAAANSTGL VMTFVYPIIIYFLCVYSL YCLGA 
QMERHRFRSYEGMARALLGQPCLYFTGVLRVVNAFGAA VAQIIATGDlVSTILKGTDAPNFLKEKW 
GNRLL TFIMWLCFMLPL TIPREVNSLRYVSTISVFFVFYLMVVIVVHSCMNGLPENIKNVHVTGAPG 
DEGIHLFGTSNRAVEGPGVFTFAFLCHISVFEIYFGMAKPSAHRFTAYSAIAMGICLVLCVMTAFFGY 
LDFGRDV AGSVLLMYDPVKEPAIL VGFVGLL VKLF ASY ALLAMTCRNGLCGIIGLDTEKLSFFKHC 
TIIGTISIIMLLCGLFIPNINTVFGFVGSVCGGFLGFILPSLFMMYGGNWSLSTVGWLHYIATY A VLFA 
GV ALSVFGTGATIYGVA VGW 
TbAATPll (473 AA) 
MTFEAAAQAPNKCPTNEATAEPLRTPNVLADNLLARSNLSEGESPEKSGEAQKPEEQGNALMRCFH 
FILPRGGALSGIFNLASVTLGAGIMSIPSAFNTSGMlMAIIYLLLVTVFTVFSIFLIVSAAEKTGYRSFES 
MARNLLGPRADlA VGFLL WLLCFGGASGYVVAIGDVLQGLLSHEKVPA YLQSKGGRRLL TSAIWF 
VFIFPL TLPKRVNSLRY ASAIGVSFILFFAICVVEHSAEKMVTDGGIKQELVMFRSGNDA VAGLSLFIF 
A YLCHVNSFSIFFEMKKRSVTRMTRDAA VSCSICCCVYLL TGFFGYAEFGPTVEGSVLKL YDPY ANP 
VFFVCFIGIIVKLCAGFSLNMLACRTALFQVLR WDLDTMSYVRHSIVSVSF A VGSL VLGLFVPDlNVI 
FGL VGAFCGGFrGFIFPALFIMYAGGWTRQSVGWVQYIL TYVLLlLGVVAIVFGTSASVYYTIKRYS 
TbCAA TP (539 AA) 
MVSWSRPEFAEAFFGKL VRRRCIY ATKAALDSSPFVRVLGLLSLVSLGVGA VVGAGIFVITGQAAA 
QY AGPGL TlSFVLCMFPCFL T ALCYGELAAMLPV AGSA YTHTSV ALGEFASWTV A VCMTLECL VS 
GCA VSVSWSA YVQAFLKRFSFVLPQPLRKSPfDVVGGRFVL TGSVVNFPA VVITVVCFVVLCLGVE 
QTASMNSFFVVVKLAAL VCFVFYGlYYSLGNWAEVNANL TPFVPPNDGHFGHFGVSGrLRGASVVF 
FANVGFDTICASAQECRSPQRDIPRGHL TLLLCSTL YVMVTVSL TGL VKYTELGTDAPVrAALEKVK 
APSFLRLFfEVGTVAALSSVCFVSFY AMPRLJMA VAKDGLLPALLTHVHEQFRTPJNATIFCGJPATFI 
CA VFPLGMLGELlSFGTLlALACVCVSMWKIRIDHPEFHRPFV APLFPYVPILGALLNAAQLFFLPL IT 
WRNYFVVMA TTSL WYIVYGJRHSTVGEDGITRRPDSLLGTVEPPLCEALEGVQGAGGSLSIEL TERY 
VHN 
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TIGR REFERENCE NUMBERS OF OVERLAPPING SEQUENCES USED TO PRODUCE 
CONTIGUOUS SEQUENCES IN CONTAINlNG ORF CORRESPONDING TO TbAATP 2,3,4,5,6 
TbAATP2 
1WCS.rev. 1232 • 1829 
L! ______________ ~> 
72t:8.1F: 1104 . 1656 
! > 
84G10.1R 631 .1400 
! ~ 
1 D11.1P. 623» 900 
! > 
101C8.1R 107» 749 
L! ________________ ~> 














101G1llF: 1493 • 2m) 
c= } 
3al<2.1R: 1229. 1997 r== ------ J 
29P1o. T\f. 1193 .1585 (<XIT!lI8lleItay) 
< ~ 
11OC11.1R: 1072 . 1519 
I ) 
4Ql\3.lF: 879. 1007 (<XIT!lI8lleItlIY) 
37E1.1R: 745.914 (caTfAementay) 
<==J 
10100 1R: 343.981 
2!l.16.17: 92 .783 (<XIT!lI8lleItlIY) 
<~--------------------~ 119E10.1R: 1.300(CCJT1*m!rtay) 
< ~ 
TbAATP5 
59P.i "IF. !188. lIn 
'-------------> 




41E1a1R9Ili ( 111)4(~I'f) 
~'--____ ----l 
75C3.1F: 6S:z, 1175 
1711l11Jcr:461 . 1012 
41A1QlR 1 . &;4 (etnpI!mtDy) 
('---------' 
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HYDROPATHY PLOTS BASED ON KYTE-DOOLITTLE ANALYSIS OF THE TWELVE MEMBERS 
OF THE PUTATIVE TBAA TP F AMIL Y 
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